{
  "dd11dde6": {
    "title": "Abducens Nerve (CN VI)",
    "primaryType": "anatomy",
    "tags": [
      "Neurology",
      "Cranial Nerves",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Cranial Nerves"
    ],
    "content": {
      "definition": "<p>The <b>Abducens Nerve (CN VI)</b> is a somatic <i>motor cranial nerve</i> that originates from the pontomedullary junction and <u>exclusively innervates</u> the [[f7b5ee5d|Lateral Rectus muscle]], which is responsible for abduction of the eye (looking laterally).</p>",
      "atAGlance": "<ul><li><b>Function:</b> Motor innervation to the ipsilateral [[f7b5ee5d|lateral rectus muscle]], enabling abduction (lateral eye movement).</li><li><b>Pathway:</b> Exits the brainstem at the pontomedullary junction, traverses the subarachnoid space, passes through the [[c260efc8|cavernous sinus]] near the internal carotid artery, and enters the orbit via the superior orbital fissure.</li><li><b>Palsy Presentation:</b> Damage results in an inability to abduct the affected eye, leading to a medially directed strabismus at rest and horizontal [[9914d433|diplopia]] that worsens on attempted lateral gaze toward the side of the lesion.</li><li><b>Vulnerability:</b> Its long intracranial course makes it highly susceptible to downward traction from <mark>increased intracranial pressure</mark> ([[7c4e7c74|idiopathic intracranial hypertension]], tumors, hydrocephalus).</li><li><b>USMLE Tip:</b> An isolated CN VI palsy is often a <mark>\"false localizing sign\"</mark> of elevated ICP rather than a direct brainstem lesion. It is the most commonly affected cranial nerve in [[c260efc8|cavernous sinus syndrome]].</li></ul>",
      "takeAway": "<p>The <b>Abducens Nerve</b> has the longest intracranial course of all cranial nerves, making it uniquely vulnerable to stretching and compression from <u>increased intracranial pressure</u>, often presenting as a nonlocalizing palsy that signals a generalized brain pressure problem rather than a specific brainstem lesion.</p>",
      "mermaid": "graph LR; A[PPRF] --> B[CN VI Nucleus]; B --> C[Ipsilateral Lateral Rectus]; B --> D[Contralateral MLF]; D --> E[Contralateral CN III Nucleus]; E --> F[Contralateral Medial Rectus];"
    },
    "connections": [
      {
        "type": "innervates",
        "to": "f7b5ee5d"
      },
      {
        "type": "is_vulnerable_to",
        "to": "7c4e7c74"
      },
      {
        "type": "palsy_causes",
        "to": "9914d433"
      },
      {
        "type": "is_affected_in",
        "to": "9a089fd7"
      }
    ]
  },
  "c0b7a1ca": {
    "title": "Abnormal Motor Posturing",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pathology",
      "Coma",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Brain Lesions"
    ],
    "content": {
      "definition": "<p><b>Abnormal motor posturing</b> refers to involuntary flexion or extension of the arms and legs, indicating <i>severe brain injury</i>. It occurs in patients who are comatose and reflects damage to motor pathways between the cerebral cortex and the brainstem.</p>",
      "atAGlance": "<ul><li><b>Decorticate (Flexor) Posturing:</b> Characterized by flexion of the arms, wrists, and fingers with adduction of the upper extremities, alongside extension, internal rotation, and plantar flexion of the lower extremities. Mnemonic: Hands are near the '<b>cor</b>' (heart).</li><li><b>Decorticate Lesion Level:</b> Indicates damage <u>above the red nucleus</u> in the midbrain, such as in the cerebral hemispheres or internal capsule. The rubrospinal tract (flexor tone) is intact and overrides the vestibulospinal tract.</li><li><b>Decerebrate (Extensor) Posturing:</b> Characterized by extension, adduction, and internal rotation of the arms with extension of the legs.</li><li><b>Decerebrate Lesion Level:</b> Indicates damage <u>at or below the red nucleus</u> (e.g., midbrain tegmentum, pons). The loss of the rubrospinal tract leads to unopposed extension tone from the vestibulospinal tract.</li><li><b>USMLE Tip:</b> Decerebrate posturing generally indicates a more severe brain injury and carries a <u>worse prognosis</u> than decorticate posturing.</li></ul>",
      "takeAway": "<p>The type of abnormal posturing provides a crucial clue to the anatomical level of severe brain injury; <b>decorticate</b> posturing implies a lesion above the red nucleus preserving flexor pathways, whereas <b>decerebrate</b> posturing signifies a more caudal lesion below the red nucleus, leaving only extensor pathways unopposed.</p>",
      "mermaid": "graph TD; A[Cerebral Cortex] --> B[Red Nucleus]; B --> C[Rubrospinal Tract Flexion]; A --> D[Vestibular Nuclei]; D --> E[Vestibulospinal Tract Extension]; F(Lesion Above Red Nucleus) --> G{Decorticate}; B --x F; H(Lesion Below Red Nucleus) --> I{Decerebrate}; C --x H;"
    },
    "connections": [
      {
        "type": "is_a_sign_of",
        "to": "e9a47751"
      },
      {
        "type": "differentiates_lesion_level_in",
        "to": "a584135d"
      }
    ]
  },
  "a0c128f4": {
    "title": "Absence Seizures (Petit Mal)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pediatrics",
      "Epilepsy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Seizures"
    ],
    "content": {
      "definition": "<p><b>Absence seizures</b>, formerly known as <i>petit mal seizures</i>, are a type of generalized seizure characterized by a sudden, brief lapse of consciousness without loss of postural tone, typically lasting for seconds. They are most common in childhood and are often mistaken for daydreaming or inattentiveness.</p>",
      "atAGlance": "<ul><li><b>Clinical Presentation:</b> Sudden cessation of activity with a blank stare, lasting about 10 seconds. May be accompanied by subtle automatisms like eyelid fluttering or lip smacking. There is <u>no postictal confusion</u>; the patient immediately returns to baseline.</li><li><b>EEG Hallmark:</b> The pathognomonic finding is a <mark>generalized 3 Hz spike-and-wave discharge</mark> on EEG.</li><li><b>Provocation:</b> Seizures can often be triggered by <mark>hyperventilation</mark>.</li><li><b>Treatment:</b> <u>First-line</u> treatment is [[ethosuximide]]. [[valproic_acid|Valproic acid]] is also effective and used if tonic-clonic seizures are also present.</li><li><b>USMLE Tip:</b> A classic vignette describes a child whose teacher complains of 'daydreaming' or 'not paying attention' in class. The diagnosis is confirmed by a 3 Hz spike-and-wave pattern on EEG, often induced by having the child hyperventilate.</li></ul>",
      "takeAway": "<p><b>Absence seizures</b> are unique among generalized seizures for their brief, non-convulsive nature, lack of postictal confusion, and a pathognomonic <mark>3 Hz spike-and-wave</mark> EEG pattern, making [[ethosuximide]] the specific and preferred treatment.</p>",
      "mermaid": "graph TD; A[Thalamic T-type Ca2+ Channels] -- Overactivity --> B(Absence Seizure); C(Ethosuximide) -- Blocks --> A;"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "64c08e92"
      },
      {
        "type": "treated_by",
        "to": "a90f6fb4"
      },
      {
        "type": "presents_with_eeg_finding",
        "to": "eeg_3hz_spike_wave"
      }
    ]
  },
  "e62961a0": {
    "title": "Absence Seizure Anticonvulsants",
    "primaryType": "concept",
    "tags": [
      "Neurology",
      "Pharmacology",
      "Epilepsy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Anticonvulsants"
    ],
    "content": {
      "definition": "<p><b>Absence seizure anticonvulsants</b> are medications specifically effective in treating [[a0c128f4|absence seizures]], primarily by targeting the T-type calcium channels in thalamic neurons, which are implicated in the generation of the characteristic <mark>3 Hz spike-and-wave</mark> discharges.</p>",
      "atAGlance": "<ul><li><b>First-Line Agent:</b> [[a90f6fb4|Ethosuximide]] is the <u>first-line</u> and most specific drug for treating isolated absence seizures.</li><li><b>Mechanism of Ethosuximide:</b> Blocks T-type Ca<sup>2+</sup> channels in thalamic neurons, disrupting the oscillatory rhythm between the thalamus and cortex that generates absence seizures.</li><li><b>Alternative Agent:</b> [[valproic_acid|Valproic acid]] is also effective and is preferred if the patient has concomitant generalized tonic-clonic seizures. It works by blocking T-type Ca<sup>2+</sup> channels and increasing [[5aa5cb91|GABA]] levels.</li><li><b>Contraindicated Agents:</b> Certain anticonvulsants, such as [[eddd2bc5|carbamazepine]] and [[5aea213f|phenytoin]], can <u>worsen</u> absence seizures.</li><li><b>USMLE Tip:</b> For a child with staring spells and a 3 Hz spike-and-wave EEG, the answer for treatment is almost always [[a90f6fb4|Ethosuximide]]. If tonic-clonic seizures are also mentioned, consider [[valproic_acid|Valproic acid]].</li></ul>",
      "takeAway": "<p>The treatment of [[a0c128f4|absence seizures]] is highly specific, with [[a90f6fb4|Ethosuximide]] being the drug of choice due to its targeted blockade of thalamic T-type calcium channels, while other common anticonvulsants like carbamazepine are paradoxically contraindicated.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "a0c128f4"
      },
      {
        "type": "includes",
        "to": "a90f6fb4"
      },
      {
        "type": "includes",
        "to": "valproic_acid"
      }
    ]
  },
  "8558c64b": {
    "title": "Acalculia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Cognitive Deficit",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Brain Lesions"
    ],
    "content": {
      "definition": "<p><b>Acalculia</b> is an acquired neurological deficit characterized by the <i>inability to perform simple mathematical calculations</i>, resulting from damage to specific brain regions, most notably the dominant (usually left) parietal lobe.</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Acalculia is a key localizing sign for a lesion in the <mark>dominant angular gyrus</mark> of the parietal lobe.</li><li><b>Associated Syndrome:</b> It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]].</li><li><b>Gerstmann Syndrome Tetrad:</b> The full syndrome includes <b>Acalculia</b>, <b>Agraphia</b> (inability to write), <b>Finger Agnosia</b> (inability to distinguish fingers), and <b>Left-Right Disorientation</b>.</li><li><b>Vascular Territory:</b> These symptoms often result from a stroke in the territory of the [[143bb23d|Middle Cerebral Artery (MCA)]] that supplies the dominant parietal lobe.</li><li><b>USMLE Tip:</b> When a patient presents with difficulty with calculations along with any of the other components of Gerstmann syndrome, immediately suspect a lesion in the dominant parietal lobe.</li></ul>",
      "takeAway": "<p><b>Acalculia</b> is more than just 'bad at math'; it is a specific neurological sign that strongly points to a lesion in the dominant angular gyrus, often as part of the clinically distinct [[38f3ed1f|Gerstmann syndrome]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_component_of",
        "to": "38f3ed1f"
      },
      {
        "type": "is_caused_by_lesion_in",
        "to": "26efa771"
      },
      {
        "type": "is_caused_by_stroke_in",
        "to": "143bb23d"
      }
    ]
  },
  "f218aebf": {
    "title": "Accessory Nerve (CN XI)",
    "primaryType": "anatomy",
    "tags": [
      "Neurology",
      "Cranial Nerves",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Cranial Nerves"
    ],
    "content": {
      "definition": "<p>The <b>Accessory Nerve (CN XI)</b> is a <i>motor cranial nerve</i> that provides innervation to the <u>sternocleidomastoid (SCM)</u> and <u>trapezius</u> muscles, which are crucial for head turning and shoulder shrugging, respectively.</p>",
      "atAGlance": "<ul><li><b>Function:</b> Innervates the ipsilateral <b>Sternocleidomastoid (SCM)</b> muscle, which turns the head to the contralateral side, and the ipsilateral <b>Trapezius</b> muscle, which elevates and stabilizes the scapula (shoulder shrug).</li><li><b>Pathway:</b> Uniquely arises from both the brainstem (medulla) and the spinal cord (C1-C5). The spinal root ascends through the foramen magnum to join the cranial root, and the combined nerve then exits the skull via the [[jugular_foramen|jugular foramen]].</li><li><b>Lesion Presentation (SCM):</b> Weakness in turning the head <u>away</u> from the side of the lesion. (e.g., Left CN XI lesion causes weakness turning head to the right).</li><li><b>Lesion Presentation (Trapezius):</b> <mark>Shoulder droop</mark>, weakness in shrugging the shoulder on the ipsilateral side, and winging of the scapula.</li><li><b>USMLE Tip:</b> A common iatrogenic cause of an isolated CN XI lesion is injury during procedures in the <mark>posterior triangle of the neck</mark>, such as lymph node biopsy.</li></ul>",
      "takeAway": "<p>The <b>Accessory Nerve (CN XI)</b> is unique in its dual origin from both the medulla and cervical spinal cord, and a lesion presents with the distinct combination of weakness turning the head to the contralateral side and an ipsilateral shoulder droop.</p>",
      "mermaid": "graph TD; A[CN XI Nuclei Medulla & C1-C5] --> B(CN XI); B --> C[Exits via Jugular Foramen]; C --> D[Innervates SCM]; C --> E[Innervates Trapezius];"
    },
    "connections": [
      {
        "type": "innervates",
        "to": "sternocleidomastoid_muscle"
      },
      {
        "type": "innervates",
        "to": "trapezius_muscle"
      },
      {
        "type": "exits_skull_via",
        "to": "jugular_foramen"
      }
    ]
  },
  "81b5f5fe": {
    "title": "Accommodation (Eye)",
    "primaryType": "physiology",
    "tags": [
      "Ophthalmology",
      "Neurology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Physiology"
    ],
    "content": {
      "definition": "<p><b>Accommodation</b> is a reflex action of the eye in response to focusing on a near object, involving a coordinated triad of changes: <i>ciliary muscle contraction</i>, <i>pupillary constriction (miosis)</i>, and <i>convergence of the eyes</i> to maintain a clear image on the retina.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> It is a parasympathetic response mediated by the [[68c66997|oculomotor nerve (CN III)]].</li><li><b>Ciliary Muscle Contraction:</b> Contraction of the ciliary muscle relaxes the zonular fibers, allowing the lens to become more convex (rounder), which increases its refractive power for near vision.</li><li><b>Pupillary Constriction (Miosis):</b> The sphincter pupillae muscle contracts, narrowing the pupil to increase the depth of field.</li><li><b>Convergence:</b> The medial rectus muscles contract to direct both eyes medially toward the near object.</li><li><b>USMLE Tip:</b> Loss of accommodation with age is called [[presbyopia]]. A pupil that accommodates but does not react to light is an [[08cb577f|Argyll Robertson pupil]], a classic sign of neurosyphilis.</li></ul>",
      "takeAway": "<p>The <b>accommodation reflex</b> is a parasympathetically driven process via [[68c66997|CN III]] that allows for clear near vision by increasing the lens's refractive power through ciliary muscle contraction, a mechanism that becomes less effective with age, leading to presbyopia.</p>",
      "mermaid": "graph TD; A[Focus on Near Object] --> B[Visual Cortex]; B --> C[CN III Nucleus Edinger-Westphal]; C --> D[Ciliary Ganglion]; D --> E[Ciliary Muscle Contraction -> Lens rounds]; D --> F[Sphincter Pupillae Contraction -> Miosis]; B --> G[CN III Motor Nucleus]; G --> H[Medial Rectus Contraction -> Convergence];"
    },
    "connections": [
      {
        "type": "is_mediated_by",
        "to": "68c66997"
      },
      {
        "type": "is_impaired_in",
        "to": "presbyopia"
      },
      {
        "type": "is_dissociated_from_light_reflex_in",
        "to": "08cb577f"
      }
    ]
  },
  "1df262e8": {
    "title": "Acetazolamide",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Ophthalmology",
      "Renal",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Glaucoma Therapy"
    ],
    "content": {
      "definition": "<p><b>Acetazolamide</b> is a <i>carbonic anhydrase inhibitor</i> used as a diuretic and to reduce pressure in the eye and brain by decreasing the formation of aqueous humor and cerebrospinal fluid, respectively.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Inhibits the enzyme carbonic anhydrase in the ciliary body epithelium and choroid plexus, which reduces the formation of bicarbonate ions (HCO<sub>3</sub><sup>-</sup>) and subsequently decreases fluid secretion (aqueous humor and CSF).</li><li><b>Clinical Use (Ophthalmology):</b> Treats [[3ce6c035|glaucoma]] (both open-angle and acute angle-closure) by <mark>decreasing aqueous humor synthesis</mark>.</li><li><b>Clinical Use (Neurology):</b> Treats [[7c4e7c74|idiopathic intracranial hypertension]] (pseudotumor cerebri) by decreasing CSF production. Also used for altitude sickness.</li><li><b>Adverse Effects:</b> Causes a <mark>hyperchloremic metabolic acidosis</mark> (non-anion gap), paresthesias, ammonia toxicity in liver disease, and promotes calcium phosphate kidney stones (due to alkalinization of urine). It is a sulfa drug, so watch for sulfa allergies.</li><li><b>USMLE Tip:</b> Remember the mnemonic 'ACID-azolamide' to recall that it causes a metabolic <b>ACID</b>osis.</li></ul>",
      "takeAway": "<p><b>Acetazolamide</b>'s therapeutic effect in both [[3ce6c035|glaucoma]] and [[7c4e7c74|idiopathic intracranial hypertension]] stems from the same core mechanism: inhibiting carbonic anhydrase to reduce the production of bicarbonate-driven fluids, namely aqueous humor and cerebrospinal fluid.</p>",
      "mermaid": "graph TD; A[Acetazolamide] --|Inhibits|--> B(Carbonic Anhydrase); B --|Blocks|--> C(H2O + CO2 <--> H2CO3 <--> H+ + HCO3-); C --|Leads to|--> D[Decreased Aqueous Humor/CSF Production];"
    },
    "connections": [
      {
        "type": "treats",
        "to": "3ce6c035"
      },
      {
        "type": "treats",
        "to": "7c4e7c74"
      },
      {
        "type": "causes_adverse_effect",
        "to": "metabolic_acidosis"
      },
      {
        "type": "is_a_type_of",
        "to": "carbonic_anhydrase_inhibitor"
      }
    ]
  },
  "6a005559": {
    "title": "Acetylcholine (ACh)",
    "primaryType": "molecule",
    "tags": [
      "Neuroscience",
      "Pharmacology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Neurotransmitters"
    ],
    "content": {
      "definition": "<p><b>Acetylcholine (ACh)</b> is a major <i>excitatory neurotransmitter</i> synthesized from choline and acetyl-CoA that functions at the neuromuscular junction, in all autonomic ganglia, at parasympathetic postganglionic nerve endings, and at various sites within the central nervous system.</p>",
      "atAGlance": "<ul><li><b>Synthesis:</b> Synthesized by Choline Acetyltransferase (ChAT) from choline and acetyl-CoA.</li><li><b>Degradation:</b> Rapidly broken down in the synaptic cleft by Acetylcholinesterase (AChE) into choline and acetate.</li><li><b>CNS Role:</b> Crucial for memory and cognition. Levels are significantly decreased in [[77ae6148|Alzheimer disease]] due to degeneration of neurons in the [[361438f2|Basal nucleus of Meynert]]. Levels are also decreased in [[ffd7e743|Huntington disease]].</li><li><b>PNS Role:</b> Neurotransmitter at all preganglionic autonomic synapses (nicotinic), all parasympathetic postganglionic synapses (muscarinic), sympathetic postganglionic synapses to sweat glands (muscarinic), and the neuromuscular junction (nicotinic).</li><li><b>USMLE Tip:</b> Diseases affecting ACh are high-yield. [[77ae6148|Alzheimer's]] (↓ CNS ACh), Myasthenia Gravis (antibodies to ACh receptors), Lambert-Eaton (↓ presynaptic ACh release). Drugs targeting AChE (e.g., [[47d0372e|donepezil]]) are used to treat Alzheimer's.</li></ul>",
      "takeAway": "<p><b>Acetylcholine</b> is a versatile neurotransmitter whose function is critically dependent on its location; its depletion in the [[361438f2|Basal nucleus of Meynert]] leads to cognitive decline in [[77ae6148|Alzheimer disease]], while its blockade at the neuromuscular junction causes paralysis.</p>",
      "mermaid": "graph TD; A[Choline + Acetyl-CoA] --ChAT--> B(Acetylcholine); B --AChE--> C[Choline + Acetate]; B --> D{Receptors}; D --> D1[Nicotinic]; D --> D2[Muscarinic];"
    },
    "connections": [
      {
        "type": "is_decreased_in",
        "to": "77ae6148"
      },
      {
        "type": "is_decreased_in",
        "to": "ffd7e743"
      },
      {
        "type": "is_involved_in_pathophysiology_of",
        "to": "myasthenia_gravis"
      },
      {
        "type": "is_involved_in_pathophysiology_of",
        "to": "lambert_eaton_syndrome"
      },
      {
        "type": "is_synthesized_in",
        "to": "361438f2"
      }
    ]
  },
  "87d19a70": {
    "title": "Achilles Reflex",
    "primaryType": "physiology",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Spinal Cord"
    ],
    "content": {
      "definition": "<p>The <b>Achilles reflex</b>, also known as the ankle jerk reflex, is a deep tendon reflex that involves plantar flexion of the foot in response to tapping the Achilles tendon, testing the integrity of the <mark>S1 and S2</mark> spinal nerve roots.</p>",
      "atAGlance": "<ul><li><b>Nerve Roots:</b> Primarily tests the <b>S1</b> nerve root, with contribution from S2. Mnemonic: S<b>1</b>, 2, buckle my shoe.</li><li><b>Pathway:</b> Tapping the tendon stretches the gastrocnemius muscle, activating stretch receptors. The afferent signal travels via the tibial nerve to the S1/S2 spinal cord segments, synapses, and an efferent motor signal returns via the tibial nerve to cause plantar flexion.</li><li><b>Diminished/Absent Reflex:</b> Suggests a lower motor neuron lesion, such as a herniated disc compressing the S1 root, or peripheral neuropathy.</li><li><b>Exaggerated Reflex (Hyperreflexia):</b> Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the S1/S2 level.</li><li><b>USMLE Tip:</b> An absent Achilles reflex is a classic finding in [[71daebd6|Tabes Dorsalis]] and [[lumbosacral_radiculopathy|S1 radiculopathy]].</li></ul>",
      "takeAway": "<p>The <b>Achilles reflex</b> is a simple yet powerful clinical tool that specifically assesses the integrity of the S1 spinal nerve root; its absence or exaggeration can help differentiate between lower and upper motor neuron pathologies.</p>",
      "mermaid": "graph TD; A[Tap Achilles Tendon] --> B(Stretch Gastrocnemius); B --> C(Afferent Signal via Tibial N.); C --> D[S1/S2 Spinal Cord]; D --> E(Efferent Signal via Tibial N.); E --> F(Plantar Flexion);"
    },
    "connections": [
      {
        "type": "tests_nerve_root",
        "to": "s1_nerve_root"
      },
      {
        "type": "is_absent_in",
        "to": "71daebd6"
      },
      {
        "type": "is_a_type_of",
        "to": "deep_tendon_reflex"
      }
    ]
  },
  "fcedc59f": {
    "title": "Neuron Action Potential",
    "primaryType": "physiology",
    "tags": [
      "Neuroscience",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Neurons"
    ],
    "content": {
      "definition": "<p>A <b>neuron action potential</b> is a rapid, all-or-none electrical signal that propagates down an axon, caused by the sequential opening and closing of <i>voltage-gated ion channels</i>, which temporarily reverses the membrane potential and allows for long-distance communication in the nervous system.</p>",
      "atAGlance": "<ul><li><b>Resting Potential (~-70 mV):</b> Maintained by the Na<sup>+</sup>/K<sup>+</sup> pump and high resting permeability to K<sup>+</sup> (K<sup>+</sup> leak channels).</li><li><b>Depolarization:</b> A stimulus reaching threshold potential (~-55 mV) triggers the rapid opening of voltage-gated <mark>Na<sup>+</sup> channels</mark>, causing a massive influx of Na<sup>+</sup> and a sharp rise in membrane potential.</li><li><b>Repolarization:</b> Voltage-gated Na<sup>+</sup> channels inactivate, and voltage-gated <mark>K<sup>+</sup> channels</mark> open, leading to an efflux of K<sup>+</sup> that brings the membrane potential back down.</li><li><b>Hyperpolarization:</b> K<sup>+</sup> channels are slow to close, causing the membrane potential to briefly dip below the resting potential.</li><li><b>USMLE Tip:</b> Many neurotoxins and drugs target these channels. [[tetrodotoxin|Tetrodotoxin]] (pufferfish) and [[lidocaine|local anesthetics]] block voltage-gated Na<sup>+</sup> channels, preventing action potential propagation.</li></ul>",
      "takeAway": "<p>The neuron action potential is fundamentally a precisely orchestrated sequence of ionic movements: a rapid influx of <b>Na<sup>+</sup></b> causes the rising phase (depolarization), and a subsequent efflux of <b>K<sup>+</sup></b> causes the falling phase (repolarization), enabling high-speed signal transmission.</p>",
      "mermaid": "graph TD; A(Resting State) --Stimulus--> B(Threshold); B --Na+ Influx--> C(Depolarization); C --Na+ Inactivation & K+ Efflux--> D(Repolarization); D --Slow K+ Channel Closing--> E(Hyperpolarization); E --> A;"
    },
    "connections": [
      {
        "type": "is_blocked_by",
        "to": "tetrodotoxin"
      },
      {
        "type": "is_blocked_by",
        "to": "local_anesthetics"
      },
      {
        "type": "is_fundamental_to",
        "to": "synaptic_transmission"
      }
    ]
  },
  "67e83e3b": {
    "title": "Acute Disseminated Encephalomyelitis (ADEM)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Immunology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Demyelinating Disorders"
    ],
    "content": {
      "definition": "<p><b>Acute Disseminated Encephalomyelitis (ADEM)</b> is a rare, acute, <i>immune-mediated inflammatory and demyelinating disorder</i> of the central nervous system that typically occurs following a viral infection or, less commonly, a vaccination.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Believed to be caused by <mark>molecular mimicry</mark>, where an immune response against an infectious agent cross-reacts with myelin antigens (e.g., myelin basic protein).</li><li><b>Clinical Presentation:</b> Rapid onset of multifocal neurological symptoms, including encephalopathy (altered mental status, confusion, coma), which is a key feature distinguishing it from a typical [[45dd6d19|Multiple Sclerosis]] flare. Other symptoms include fever, headache, seizures, and focal deficits.</li><li><b>Timing:</b> Symptoms typically appear 1-2 weeks after an antecedent infection (e.g., measles, varicella) or vaccination.</li><li><b>Imaging:</b> MRI shows multiple, bilateral, asymmetric, poorly demarcated white matter lesions of similar age, often involving both the brain and spinal cord.</li><li><b>USMLE Tip:</b> Differentiate ADEM from [[45dd6d19|MS]]: ADEM is <u>monophasic</u> and presents with encephalopathy, whereas MS is typically relapsing-remitting and rarely presents with encephalopathy in its initial flare.</li></ul>",
      "takeAway": "<p><b>Acute Disseminated Encephalomyelitis</b> is a post-infectious autoimmune attack on CNS myelin, distinguished from [[45dd6d19|Multiple Sclerosis]] by its <u>monophasic</u> course and the prominent presence of encephalopathy alongside multifocal neurological deficits.</p>",
      "mermaid": "graph TD; A[Viral Infection/Vaccination] --> B(Immune Response); B --Molecular Mimicry--> C[Attack on Myelin]; C --> D[Perivenous Inflammation & Demyelination]; D --> E[Multifocal Neurologic Deficits + Encephalopathy];"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "demyelinating_disorder"
      },
      {
        "type": "differentiated_from",
        "to": "45dd6d19"
      },
      {
        "type": "is_triggered_by",
        "to": "viral_infection"
      }
    ]
  },
  "ed52e40b": {
    "title": "Acute Inflammatory Demyelinating Polyneuropathy (AIDP)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Immunology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Peripheral Neuropathies"
    ],
    "content": {
      "definition": "<p><b>Acute Inflammatory Demyelinating Polyneuropathy (AIDP)</b> is the most common subtype of <i>Guillain-Barré Syndrome</i>, an autoimmune condition characterized by the rapid onset of symmetric, ascending muscle weakness or paralysis and destruction of myelin sheaths of peripheral nerves by Schwann cells.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Often triggered by an antecedent infection (classically <mark>Campylobacter jejuni</mark>, also CMV, EBV, Zika). It is thought to be due to <mark>molecular mimicry</mark> between microbial antigens and peripheral nerve myelin or axons.</li><li><b>Clinical Presentation:</b> Rapidly progressive, symmetric <mark>ascending weakness/paralysis</mark> starting in the lower extremities. Patients often have absent or depressed deep tendon reflexes.</li><li><b>Key Complications:</b> Respiratory failure due to diaphragmatic weakness is a life-threatening complication. Autonomic dysfunction (tachycardia, arrhythmias, BP instability) is also common.</li><li><b>Diagnosis:</b> CSF analysis shows <mark>albuminocytologic dissociation</mark> (high protein with a normal cell count). Nerve conduction studies show slowed nerve conduction velocity.</li><li><b>USMLE Tip:</b> The combination of recent diarrheal illness (*C. jejuni*) followed by ascending paralysis and high protein in the CSF with normal cell count is a classic vignette for Guillain-Barré Syndrome.</li></ul>",
      "takeAway": "<p><b>AIDP (Guillain-Barré Syndrome)</b> is an acute, post-infectious autoimmune attack on peripheral nerve myelin, leading to a characteristic ascending paralysis; the hallmark diagnostic finding is <mark>albuminocytologic dissociation</mark> in the CSF, reflecting widespread inflammation of nerve roots without direct infection.</p>",
      "mermaid": "graph TD; A[Antecedent Infection e.g., C. jejuni] --> B(Molecular Mimicry); B --> C[Immune Attack on Schwann Cells/Myelin]; C --> D[Peripheral Nerve Demyelination]; D --> E[Ascending Paralysis & Areflexia];"
    },
    "connections": [
      {
        "type": "is_a_subtype_of",
        "to": "e8720ceb"
      },
      {
        "type": "is_associated_with",
        "to": "campylobacter_jejuni"
      },
      {
        "type": "presents_with",
        "to": "a0f3ce4c"
      },
      {
        "type": "damages",
        "to": "schwann_cells"
      }
    ]
  },
  "d268ace0": {
    "title": "Opioid-Induced Acute Pulmonary Edema",
    "primaryType": "finding",
    "tags": [
      "Pharmacology",
      "Toxicology",
      "Pulmonology",
      "USMLE"
    ],
    "classificationPath": [
      "Respiratory",
      "Pathology",
      "Acute Respiratory Distress Syndrome"
    ],
    "content": {
      "definition": "<p><b>Opioid-induced acute pulmonary edema</b> is a form of <i>non-cardiogenic pulmonary edema</i> that can occur as a life-threatening complication of opioid overdose, characterized by increased pulmonary vascular permeability and subsequent alveolar flooding.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> The exact mechanism is multifactorial but is thought to involve direct toxic effects on the pulmonary capillary endothelium, hypoxia-induced vascular injury, and a massive sympathetic surge following transient hypoxia, all leading to <mark>increased vascular permeability</mark>.</li><li><b>Clinical Presentation:</b> Occurs shortly after an opioid overdose. Patients present with severe dyspnea, hypoxia, frothy pink sputum, and diffuse crackles on auscultation, often after being resuscitated with [[naloxone]].</li><li><b>Radiology:</b> Chest X-ray shows bilateral diffuse alveolar infiltrates, consistent with pulmonary edema, but with a normal cardiac silhouette (distinguishing it from cardiogenic pulmonary edema).</li><li><b>Treatment:</b> Management is supportive and includes supplemental oxygen, non-invasive or mechanical ventilation, and addressing the underlying opioid overdose. Diuretics are <u>not effective</u> as the cause is permeability, not fluid overload.</li><li><b>USMLE Tip:</b> Be aware of the patient who is treated for an opioid overdose with [[naloxone]] and subsequently develops severe respiratory distress; this points towards non-cardiogenic pulmonary edema rather than a cardiac cause.</li></ul>",
      "takeAway": "<p>Unlike cardiogenic pulmonary edema which is caused by high hydrostatic pressure, <b>opioid-induced pulmonary edema</b> is a permeability problem where opioid toxicity and hypoxia damage the alveolar-capillary barrier, leading to leaky vessels and flooded lungs that do not respond to diuretics.</p>",
      "mermaid": "graph TD; A[Opioid Overdose] --> B(Hypoxia & Direct Toxicity); B --> C[Pulmonary Capillary Endothelial Damage]; C --> D[Increased Vascular Permeability]; D --> E[Alveolar Flooding]; E --> F[Non-Cardiogenic Pulmonary Edema];"
    },
    "connections": [
      {
        "type": "is_caused_by",
        "to": "opioid_analgesics"
      },
      {
        "type": "is_a_type_of",
        "to": "acute_respiratory_distress_syndrome"
      },
      {
        "type": "is_treated_with",
        "to": "naloxone"
      }
    ]
  },
  "76ba7f2e": {
    "title": "Adenohypophysis (Anterior Pituitary)",
    "primaryType": "anatomy",
    "tags": [
      "Endocrinology",
      "Anatomy",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Endocrine",
      "Anatomy",
      "Pituitary Gland"
    ],
    "content": {
      "definition": "<p>The <b>Adenohypophysis</b>, or anterior pituitary, is the anterior lobe of the pituitary gland, an endocrine gland of ectodermal origin (from <i>Rathke's pouch</i>) that synthesizes and secretes six major peptide hormones in response to releasing and inhibiting hormones from the [[89e86633|hypothalamus]].</p>",
      "atAGlance": "<ul><li><b>Embryology:</b> Arises from an upward evagination of the oral ectoderm called <mark>Rathke's pouch</mark>. Remnants can form a [[7048db1e|craniopharyngioma]].</li><li><b>Hormones Secreted:</b> The anterior pituitary hormones can be remembered with the mnemonic <b>FLAT PiG</b>: <b>F</b>SH, <b>L</b>H, <b>A</b>CTH, <b>T</b>SH (Tropic hormones), and <b>P</b>rolactin, <b>i</b>(ignore), <b>G</b>H (Direct hormones).</li><li><b>Cell Types:</b> Somatotrophs (GH), Lactotrophs (Prolactin), Corticotrophs (ACTH), Thyrotrophs (TSH), and Gonadotrophs (FSH/LH).</li><li><b>Vascular Supply:</b> Receives blood from the superior hypophyseal artery, which forms a portal system (hypothalamic-hypophyseal portal system) that transports hypothalamic releasing/inhibiting hormones directly to the anterior pituitary.</li><li><b>USMLE Tip:</b> The most common tumor of the pituitary is a [[5f3188bd|pituitary adenoma]], which is most frequently a prolactinoma. Its connection to the [[89e86633|hypothalamus]] is vascular, in contrast to the posterior pituitary's neural connection.</li></ul>",
      "takeAway": "<p>The <b>Adenohypophysis</b> is the hormonal powerhouse of the pituitary, controlled by the [[89e86633|hypothalamus]] via a unique portal venous system, and its diverse cell populations are responsible for regulating growth, stress, reproduction, and metabolism throughout the body.</p>",
      "mermaid": "graph TD; A[Hypothalamus] --Releasing/Inhibiting Hormones--> B(Hypophyseal Portal System); B --> C(Adenohypophysis); C --> D[FSH, LH]; C --> E[ACTH]; C --> F[TSH]; C --> G[Prolactin]; C --> H[GH];"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "pituitary_gland"
      },
      {
        "type": "is_regulated_by",
        "to": "89e86633"
      },
      {
        "type": "secretes",
        "to": "growth_hormone"
      },
      {
        "type": "secretes",
        "to": "prolactin"
      },
      {
        "type": "can_develop",
        "to": "5f3188bd"
      }
    ]
  },
  "aaeda12d": {
    "title": "Adenovirus",
    "primaryType": "microbe",
    "tags": [
      "Virology",
      "Infectious Disease",
      "Ophthalmology",
      "Pediatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Infections"
    ],
    "content": {
      "definition": "<p><b>Adenovirus</b> is a non-enveloped, double-stranded DNA virus that is a common cause of various infections, including pharyngitis, pneumonia, hemorrhagic cystitis, and notably, <i>viral conjunctivitis</i> (pink eye).</p>",
      "atAGlance": "<ul><li><b>Structure:</b> Non-enveloped, icosahedral capsid with a linear dsDNA genome.</li><li><b>Transmission:</b> Transmitted via respiratory droplets, fecal-oral route, and direct contact with contaminated surfaces (fomites). Highly stable in the environment.</li><li><b>Ocular Manifestation:</b> The most common cause of viral [[c4d08c09|conjunctivitis]], presenting with a <mark>watery discharge</mark>, red eye, and often a swollen preauricular lymph node.</li><li><b>Other Clinical Syndromes:</b> Causes febrile pharyngitis, acute hemorrhagic cystitis, and pneumonia (especially in military recruits).</li><li><b>USMLE Tip:</b> In a question describing a patient (often a child) with red, watery eyes and a recent history of a cold or attending daycare, Adenovirus is the most likely pathogen. The watery discharge is key to differentiating it from bacterial conjunctivitis.</li></ul>",
      "takeAway": "<p><b>Adenovirus</b> is a highly resilient DNA virus responsible for the majority of viral conjunctivitis cases, characterized by a watery discharge that distinguishes it from the purulent discharge of bacterial causes.</p>",
      "mermaid": "graph TD; A[Adenovirus] --> B{Transmission}; B --> B1[Respiratory Droplets]; B --> B2[Fecal-Oral]; B --> B3[Fomites]; A --> C{Clinical Syndromes}; C --> C1[Conjunctivitis]; C --> C2[Pharyngitis]; C --> C3[Pneumonia]; C --> C4[Hemorrhagic Cystitis];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "c4d08c09"
      },
      {
        "type": "is_a_type_of",
        "to": "dna_virus"
      }
    ]
  },
  "21d4b96a": {
    "title": "Adrenoleukodystrophy",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Endocrinology",
      "Genetics",
      "Biochemistry",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Demyelinating Disorders"
    ],
    "content": {
      "definition": "<p><b>Adrenoleukodystrophy</b> is an <i>X-linked recessive disorder</i> caused by a mutation in the <b>ABCD1</b> gene, leading to impaired β-oxidation of very-long-chain fatty acids (VLCFAs) in peroxisomes. This results in the accumulation of VLCFAs in the adrenal glands, testes, and white matter of the brain, causing adrenal insufficiency and progressive demyelination.</p>",
      "atAGlance": "<ul><li><b>Genetics:</b> X-linked recessive mutation in the <i>ABCD1</i> gene.</li><li><b>Pathophysiology:</b> Defective peroxisomal β-oxidation leads to the accumulation of <mark>very-long-chain fatty acids (VLCFAs)</mark> in various tissues.</li><li><b>Neurologic Manifestations:</b> Progressive demyelination of the central nervous system, leading to cognitive decline, behavioral changes, spasticity, and vision/hearing loss.</li><li><b>Endocrine Manifestations:</b> Adrenal insufficiency ([[addison_disease|Addison disease]]) is a common feature, presenting with fatigue, hyperpigmentation, and electrolyte abnormalities. Testicular atrophy and infertility can also occur.</li><li><b>USMLE Tip:</b> A classic vignette involves a young boy with new-onset behavioral problems or declining school performance who also shows signs of adrenal insufficiency (e.g., hyperpigmentation, low cortisol).</li></ul>",
      "takeAway": "<p><b>Adrenoleukodystrophy</b> is a dual-system disease combining progressive CNS demyelination with adrenal failure, all stemming from a single X-linked genetic defect in peroxisomal fatty acid metabolism.</p>",
      "mermaid": "graph TD; A[ABCD1 Gene Mutation] --> B(Defective Peroxisomal β-oxidation); B --> C[Accumulation of VLCFAs]; C --> D[Adrenal Cortex] --> E(Adrenal Insufficiency); C --> F[CNS White Matter] --> G(Demyelination & Neurodegeneration);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "peroxisomal_disorder"
      },
      {
        "type": "is_a_type_of",
        "to": "demyelinating_disorder"
      },
      {
        "type": "causes",
        "to": "addison_disease"
      },
      {
        "type": "has_inheritance_pattern",
        "to": "x_linked_recessive"
      }
    ]
  },
  "c63255c8": {
    "title": "Age-related Macular Degeneration (AMD)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Geriatrics",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Retinal Disorders"
    ],
    "content": {
      "definition": "<p><b>Age-related Macular Degeneration (AMD)</b> is a progressive neurodegenerative disease of the macula, the central part of the retina, leading to the gradual loss of <i>central vision</i>. It is the leading cause of irreversible blindness in older adults in developed countries.</p>",
      "atAGlance": "<ul><li><b>Dry (Atrophic) AMD:</b> More common (~80%). Characterized by the slow breakdown of photoreceptors in the macula and the deposition of yellowish extracellular material called <mark>drusen</mark> between Bruch's membrane and the retinal pigment epithelium. Causes gradual vision loss.</li><li><b>Wet (Exudative) AMD:</b> Less common but more severe. Characterized by rapid vision loss due to choroidal neovascularization. Abnormal blood vessels grow under the retina, leak fluid and blood, and can cause scarring.</li><li><b>Clinical Presentation:</b> Patients report painless, progressive loss of central vision, leading to scotomas (blind spots). A key early symptom of wet AMD is <mark>metamorphopsia</mark> (straight lines appear wavy).</li><li><b>Diagnosis:</b> Fundoscopy reveals drusen (dry AMD) or hemorrhage/exudates (wet AMD). An Amsler grid is used to detect metamorphopsia.</li><li><b>USMLE Tip:</b> Remember the key difference: <b>Dry AMD = Drusen</b> and gradual loss. <b>Wet AMD = Neovascularization</b> and rapid loss. Central vision loss is the hallmark for both.</li></ul>",
      "takeAway": "<p><b>Age-related Macular Degeneration</b> specifically targets central, high-acuity vision by damaging the macula. The distinction between the slow, drusen-associated 'dry' form and the rapid, neovascular 'wet' form is critical for prognosis and management.</p>",
      "mermaid": "graph TD; A[Aging & Genetic Factors] --> B{Macular Damage}; B --> C[Dry AMD]; C --> D[Drusen Deposition & Atrophy]; D --> E[Gradual Central Vision Loss]; B --> F[Wet AMD]; F --> G[Choroidal Neovascularization]; G --> H[Hemorrhage & Exudate]; H --> I[Rapid Central Vision Loss];"
    },
    "connections": [
      {
        "type": "affects",
        "to": "macula"
      },
      {
        "type": "presents_with",
        "to": "central_scotoma"
      },
      {
        "type": "presents_with",
        "to": "metamorphopsia"
      }
    ]
  },
  "13d6bca7": {
    "title": "Agraphia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Cognitive Deficit",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Brain Lesions"
    ],
    "content": {
      "definition": "<p><b>Agraphia</b> is an acquired neurological disorder characterized by the <i>loss of the ability to communicate through writing</i>, stemming from damage to specific brain areas involved in language processing and motor control of the hand.</p>",
      "atAGlance": "<ul><li><b>Localization:</b> Agraphia is a key localizing sign for a lesion in the <mark>dominant angular gyrus</mark> of the parietal lobe.</li><li><b>Associated Syndrome:</b> It is one of the four classic components of [[38f3ed1f|Gerstmann syndrome]].</li><li><b>Gerstmann Syndrome Tetrad:</b> The full syndrome includes <b>Agraphia</b>, <b>[[8558c64b|Acalculia]]</b> (inability to perform calculations), <b>Finger Agnosia</b> (inability to distinguish fingers), and <b>Left-Right Disorientation</b>.</li><li><b>Alexia with Agraphia:</b> When a patient can neither read nor write, the lesion is typically in the dominant angular gyrus. This is distinct from [[fcf30c1b|alexia without agraphia]].</li><li><b>USMLE Tip:</b> If a question describes a patient who suddenly cannot write but has no other motor deficits in the hand, and also has trouble with math, think of a dominant parietal lobe lesion, likely from an [[143bb23d|MCA stroke]].</li></ul>",
      "takeAway": "<p><b>Agraphia</b> is not simply poor handwriting; it is a specific neurological deficit in the production of written language that, when paired with [[8558c64b|acalculia]], strongly points to a lesion in the dominant angular gyrus, a hallmark of [[38f3ed1f|Gerstmann syndrome]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_component_of",
        "to": "38f3ed1f"
      },
      {
        "type": "is_caused_by_lesion_in",
        "to": "26efa771"
      },
      {
        "type": "is_caused_by_stroke_in",
        "to": "143bb23d"
      }
    ]
  },
  "0d04bf44": {
    "title": "Akathisia",
    "primaryType": "finding",
    "tags": [
      "Psychiatry",
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Psychiatry",
      "Pharmacology",
      "Adverse Effects"
    ],
    "content": {
      "definition": "<p><b>Akathisia</b> is a movement disorder characterized by a subjective feeling of inner restlessness and a compelling urge to be in constant motion, most commonly seen as an <i>extrapyramidal side effect</i> of antipsychotic medications.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Most commonly caused by dopamine receptor antagonists, particularly <mark>first-generation (typical) antipsychotics</mark> (e.g., haloperidol). It can also occur with second-generation antipsychotics and some antidepressants.</li><li><b>Clinical Presentation:</b> Patients describe an inability to sit still, feeling like they need to 'jump out of their skin.' Objective signs include pacing, shuffling feet, and shifting from one foot to another.</li><li><b>Timeline:</b> It is a subacute extrapyramidal symptom, typically developing days to weeks after starting or increasing the dose of an offending agent.</li><li><b>Treatment:</b> Management involves reducing the dose of the antipsychotic, switching to an agent with a lower risk (e.g., quetiapine), or adding medications like <mark>propranolol</mark>, benzodiazepines, or benztropine.</li><li><b>USMLE Tip:</b> Differentiate akathisia from psychotic agitation. Akathisia is a drug side effect causing restlessness, while agitation is a symptom of the underlying psychosis. Mistaking one for the other and increasing the antipsychotic dose will worsen akathisia.</li></ul>",
      "takeAway": "<p><b>Akathisia</b> is a distressing, drug-induced state of motor restlessness that must be distinguished from psychiatric agitation, as the treatment involves reducing or counteracting the offending antipsychotic, not increasing it.</p>",
      "mermaid": "graph TD; A[Dopamine (D2) Receptor Blockade] --> B(Disruption of Nigrostriatal Pathway); B --> C[Subjective Restlessness & Compulsion to Move]; C --> D(Akathisia);"
    },
    "connections": [
      {
        "type": "is_an_adverse_effect_of",
        "to": "antipsychotics"
      },
      {
        "type": "is_a_type_of",
        "to": "extrapyramidal_symptoms"
      },
      {
        "type": "treated_by",
        "to": "propranolol"
      }
    ]
  },
  "43be7a6e": {
    "title": "Alar Plate",
    "primaryType": "anatomy",
    "tags": [
      "Embryology",
      "Neuroscience",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Embryology",
      "Neural Development"
    ],
    "content": {
      "definition": "<p>The <b>Alar Plate</b> is the dorsal part of the neural tube in the developing embryo, which differentiates into <i>sensory neurons</i> of the spinal cord and brainstem under the influence of signaling molecules like bone morphogenetic proteins (BMPs).</p>",
      "atAGlance": "<ul><li><b>Location:</b> Dorsal (posterior) region of the developing spinal cord and brainstem.</li><li><b>Function:</b> Gives rise to <u>sensory</u> components of the central nervous system. Mnemonic: Alar is dorsal, like the dorsal fin of a shark which senses things in the water.</li><li><b>Inducing Signal:</b> Development is induced by signaling molecules from the overlying ectoderm, primarily <mark>Bone Morphogenetic Proteins (BMPs)</mark>.</li><li><b>Counterpart:</b> The ventral counterpart is the [[253e3efb|Basal Plate]], which develops into motor neurons under the influence of Sonic Hedgehog (SHH) from the notochord.</li><li><b>USMLE Tip:</b> Remember the simple orientation: <b>Alar = Sensory = Dorsal</b>, and <b>Basal = Motor = Ventral</b>. This organization persists in the adult spinal cord.</li></ul>",
      "takeAway": "<p>The <b>Alar Plate</b> is the embryonic foundation for the sensory pathways of the CNS, establishing the fundamental dorsal-sensory and ventral-motor organization of the neural tube that is maintained throughout life.</p>",
      "mermaid": "graph TD; A[Neural Tube] --> B(Alar Plate - Dorsal); A --> C(Basal Plate - Ventral); D[Ectoderm] --BMPs--> B; B --> E[Sensory Neurons]; F[Notochord] --SHH--> C; C --> G[Motor Neurons];"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "neural_tube"
      },
      {
        "type": "develops_into",
        "to": "sensory_neurons"
      },
      {
        "type": "is_counterpart_to",
        "to": "253e3efb"
      },
      {
        "type": "is_induced_by",
        "to": "bone_morphogenetic_proteins"
      }
    ]
  },
  "a0f3ce4c": {
    "title": "Albuminocytologic Dissociation",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pathology",
      "Diagnostics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Peripheral Neuropathies"
    ],
    "content": {
      "definition": "<p><b>Albuminocytologic dissociation</b> is the pathognomonic finding in the cerebrospinal fluid (CSF) of patients with [[ed52e40b|Guillain-Barré Syndrome]], characterized by a significantly <i>elevated protein concentration</i> in the presence of a <i>normal or near-normal white blood cell count</i>.</p>",
      "atAGlance": "<ul><li><b>Classic Association:</b> This finding is the hallmark of [[ed52e40b|Guillain-Barré Syndrome (GBS)]], specifically the AIDP subtype.</li><li><b>Pathophysiology:</b> Widespread inflammation of the nerve roots (radiculopathy) disrupts the blood-nerve barrier, allowing protein (mainly albumin) to leak from the plasma into the CSF.</li><li><b>Cell Count:</b> The cell count remains normal (typically <10 cells/mm<sup>3</sup>) because the inflammatory process is primarily in the peripheral nerve roots, not within the CSF space itself (i.e., it is not meningitis).</li><li><b>Timing:</b> The protein level may be normal in the first few days of GBS and typically peaks 1-2 weeks after symptom onset.</li><li><b>USMLE Tip:</b> A patient presenting with ascending paralysis after a recent infection (*C. jejuni* or viral URI) and a CSF report showing high protein but a normal cell count is a classic vignette for [[ed52e40b|Guillain-Barré Syndrome]].</li></ul>",
      "takeAway": "<p><b>Albuminocytologic dissociation</b> is a powerful diagnostic clue for [[ed52e40b|Guillain-Barré Syndrome]], reflecting the unique pathophysiology of nerve root inflammation that increases blood-nerve barrier permeability to proteins without causing a significant cellular infiltrate into the CSF.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_hallmark_of",
        "to": "ed52e40b"
      },
      {
        "type": "is_found_in",
        "to": "cerebrospinal_fluid"
      }
    ]
  },
  "fcf30c1b": {
    "title": "Alexia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Cognitive Deficit",
      "Stroke",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Brain Lesions"
    ],
    "content": {
      "definition": "<p><b>Alexia</b> is an acquired neurological disorder characterized by the <i>inability to read or comprehend written language</i>, resulting from a lesion in the brain's language or visual processing centers.</p>",
      "atAGlance": "<ul><li><b>Alexia without Agraphia (Pure Alexia):</b> A specific syndrome where the patient can write but cannot read what they have just written. This is a classic disconnection syndrome.</li><li><b>Lesion Location:</b> Caused by a lesion in the <mark>dominant (usually left) occipital lobe</mark> that also damages the <mark>splenium of the corpus callosum</mark>.</li><li><b>Mechanism:</b> Visual information from the intact right occipital lobe cannot cross over to the dominant hemisphere's language areas (Wernicke's area, angular gyrus) for interpretation because the connecting fibers in the splenium are damaged. The dominant visual cortex is also damaged, so no visual information can be processed on that side.</li><li><b>Vascular Territory:</b> This specific lesion is classically caused by a stroke in the territory of the [[b6a2cc31|Posterior Cerebral Artery (PCA)]].</li><li><b>USMLE Tip:</b> The vignette of a patient who can write a sentence but is unable to read it back is pathognomonic for alexia without agraphia, pointing directly to a left PCA stroke affecting the occipital lobe and splenium.</li></ul>",
      "takeAway": "<p><b>Alexia without agraphia</b> is a quintessential disconnection syndrome where visual information is stranded in the non-dominant hemisphere, unable to reach the language centers in the dominant hemisphere because the connecting bridge (splenium of the corpus callosum) has been destroyed, typically by a PCA stroke.</p>",
      "mermaid": "graph TD; A[Written Word] --> B(Eyes); B --> C[Right Visual Cortex]; C --x D(Splenium of Corpus Callosum); D --x E[Left Language Areas]; B --> F(Left Visual Cortex); F --x G[Lesion];"
    },
    "connections": [
      {
        "type": "is_caused_by_lesion_in",
        "to": "occipital_lobe"
      },
      {
        "type": "is_caused_by_lesion_in",
        "to": "corpus_callosum"
      },
      {
        "type": "is_caused_by_stroke_in",
        "to": "b6a2cc31"
      },
      {
        "type": "is_distinct_from",
        "to": "13d6bca7"
      }
    ]
  },
  "083094db": {
    "title": "Alprazolam",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Psychiatry",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Psychiatry",
      "Pharmacology",
      "Anxiolytics"
    ],
    "content": {
      "definition": "<p><b>Alprazolam</b> (trade name Xanax) is a potent, short-acting <i>benzodiazepine</i> used primarily for the management of anxiety disorders, especially panic disorder, and for the short-term treatment of anxiety associated with depression.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> A positive allosteric modulator of the [[gaba_a_receptor|GABA<sub>A</sub> receptor]]. It increases the <u>frequency</u> of chloride channel opening in response to GABA binding, leading to enhanced CNS inhibition.</li><li><b>Pharmacokinetics:</b> It is short-acting. Mnemonic for short-acting benzodiazepines: <b>ATOM</b> (<b>A</b>lprazolam, <b>T</b>riazolam, <b>O</b>xazepam, <b>M</b>idazolam).</li><li><b>Clinical Use:</b> Primarily for [[panic_disorder|panic disorder]] and [[generalized_anxiety_disorder|generalized anxiety disorder]].</li><li><b>Adverse Effects:</b> Sedation, dependence, tolerance, and withdrawal symptoms. Additive CNS depression with other depressants like alcohol and barbiturates. Has a higher addictive potential due to its short half-life.</li><li><b>USMLE Tip:</b> Because of its rapid onset and short duration, alprazolam is highly effective for acute panic attacks but also carries a high risk of dependence and severe withdrawal. Overdose is treated with [[flumazenil]].</li></ul>",
      "takeAway": "<p><b>Alprazolam</b> is a high-potency, short-acting benzodiazepine that provides rapid relief for panic and anxiety by enhancing GABAergic inhibition, but its pharmacokinetic profile also contributes to a significant risk of dependence and withdrawal.</p>",
      "mermaid": "graph TD; A[Alprazolam] --> B(Binds to GABA-A Receptor); B --> C(↑ Frequency of Cl- Channel Opening); C --> D(↑ Cl- Influx); D --> E(Hyperpolarization of Neuron); E --> F(CNS Depression/Anxiolysis);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "14464617"
      },
      {
        "type": "treats",
        "to": "panic_disorder"
      },
      {
        "type": "treats",
        "to": "d1c786e9"
      },
      {
        "type": "overdose_treated_by",
        "to": "flumazenil"
      }
    ]
  },
  "77ae6148": {
    "title": "Alzheimer Disease",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Geriatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Dementia"
    ],
    "content": {
      "definition": "<p><b>Alzheimer Disease</b> is the most common cause of <i>dementia</i> in older adults, a progressive neurodegenerative disorder characterized by the extracellular deposition of <b>amyloid-β (Aβ) plaques</b> and the intracellular accumulation of <b>hyperphosphorylated tau tangles</b>, leading to widespread cortical atrophy and a significant cholinergic deficit.</p>",
      "atAGlance": "<ul><li><b>Pathology Hallmarks:</b> Extracellular <mark>senile plaques</mark> (composed of Aβ) and intracellular <mark>neurofibrillary tangles</mark> (composed of hyperphosphorylated tau protein). The number of tangles correlates with disease severity.</li><li><b>Genetics:</b> Risk is increased by the <mark>ApoE4</mark> allele for the sporadic, late-onset form. Early-onset familial forms are associated with mutations in <i>APP</i> (chromosome 21), <i>presenilin-1</i> (chromosome 14), and <i>presenilin-2</i> (chromosome 1).</li><li><b>Clinical Presentation:</b> Insidious onset of progressive short-term memory loss, followed by language deficits (aphasia), visuospatial difficulties, and executive dysfunction. Personality and behavioral changes are common in later stages.</li><li><b>Neurotransmitter Deficit:</b> Marked decrease in [[6a005559|acetylcholine]] due to degeneration of cholinergic neurons in the [[361438f2|Basal nucleus of Meynert]].</li><li><b>USMLE Tip:</b> Patients with <b>Down syndrome (Trisomy 21)</b> have a greatly increased risk of early-onset Alzheimer's because the <i>APP</i> gene is located on chromosome 21, leading to a gene dosage effect and increased Aβ production.</li></ul>",
      "takeAway": "<p>The core pathology of <b>Alzheimer Disease</b> involves a dual-proteinopathy of extracellular amyloid plaques and intracellular tau tangles, which together trigger synaptic dysfunction and neuronal death, manifesting clinically as a progressive decline in memory and cognition due to widespread cortical and hippocampal atrophy.</p>",
      "mermaid": "graph TD; A[APP Gene on Chr 21] --Abnormal Cleavage--> B(Amyloid-β Monomers); B --> C(Oligomers & Plaques); D[Tau Protein] --Hyperphosphorylation--> E(Neurofibrillary Tangles); C & E --> F(Synaptic Dysfunction & Neuronal Death); F --> G(Cortical Atrophy); G --> H(Dementia);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "bb316ca0"
      },
      {
        "type": "is_associated_with",
        "to": "down_syndrome"
      },
      {
        "type": "involves_deficiency_of",
        "to": "6a005559"
      },
      {
        "type": "treated_by",
        "to": "47d0372e"
      },
      {
        "type": "affects",
        "to": "361438f2"
      }
    ]
  },
  "9c9679ea": {
    "title": "Amantadine",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Infectious Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Parkinson Disease Therapy"
    ],
    "content": {
      "definition": "<p><b>Amantadine</b> is a medication with multiple mechanisms of action, used primarily in neurology to treat [[58c8ea03|Parkinson disease]] and drug-induced extrapyramidal symptoms, and historically as an antiviral agent for influenza A.</p>",
      "atAGlance": "<ul><li><b>Mechanism (Parkinson's):</b> Increases dopamine availability by <mark>enhancing dopamine release</mark> and <mark>inhibiting dopamine reuptake</mark> in the CNS. It also has some anticholinergic properties.</li><li><b>Clinical Use (Neurology):</b> Used for mild [[58c8ea03|Parkinson disease]] to improve tremor, rigidity, and bradykinesia. It is particularly useful for reducing levodopa-induced dyskinesias in advanced disease. Also used to treat acute dystonia caused by antipsychotics.</li><li><b>Antiviral Use:</b> Previously used for prophylaxis and treatment of Influenza A by blocking the M2 proton channel, but is no longer recommended due to widespread resistance.</li><li><b>Adverse Effects:</b> CNS effects like confusion, hallucinations, and dizziness. A characteristic side effect is <mark>livedo reticularis</mark> (a mottled, purplish skin discoloration) and peripheral edema.</li><li><b>USMLE Tip:</b> For Parkinson's, amantadine is a 'weaker' drug but can be useful early on or for managing side effects of more potent therapies. The association with livedo reticularis is a classic board question clue.</li></ul>",
      "takeAway": "<p><b>Amantadine</b> serves a niche role in managing [[58c8ea03|Parkinson disease]] by modestly increasing dopamine levels, but its utility is limited by CNS side effects and the unique dermatologic finding of livedo reticularis.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "treats",
        "to": "58c8ea03"
      },
      {
        "type": "causes_adverse_effect",
        "to": "livedo_reticularis"
      },
      {
        "type": "increases_levels_of",
        "to": "90adc821"
      }
    ]
  },
  "f0aac1c3": {
    "title": "Amaurosis Fugax",
    "primaryType": "finding",
    "tags": [
      "Ophthalmology",
      "Neurology",
      "Cardiovascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Retinal Disorders"
    ],
    "content": {
      "definition": "<p><b>Amaurosis fugax</b> (from Greek for 'darkening' and Latin for 'fleeting') is a painless, <i>transient monocular vision loss</i>, classically described by patients as a <mark>\"curtain coming down over one eye.\"</mark> It is a form of [[623ba776|transient ischemic attack (TIA)]] affecting the retina.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Most commonly caused by an embolus to the [[3334840f|central or branch retinal artery]], which temporarily obstructs blood flow.</li><li><b>Source of Emboli:</b> The most frequent source is an atherosclerotic plaque in the <mark>ipsilateral carotid artery</mark>. It can also be cardiogenic (e.g., from atrial fibrillation).</li><li><b>Clinical Significance:</b> It is a critical warning sign of underlying cerebrovascular disease and portends a high risk of a major [[c5da3c57|stroke]].</li><li><b>Workup:</b> Patients require urgent evaluation, including a carotid ultrasound (duplex) to assess for stenosis and an EKG/echocardiogram to rule out cardiac sources.</li><li><b>USMLE Tip:</b> A vignette describing a patient with a history of hypertension and hyperlipidemia who experiences a sudden, painless, temporary \"curtain-like\" vision loss in one eye should immediately point to amaurosis fugax secondary to carotid artery disease.</li></ul>",
      "takeAway": "<p><b>Amaurosis fugax</b> is not just an eye problem but a neurological emergency; this transient 'curtain' of vision loss is a TIA of the retina, most often signaling significant atherosclerotic disease in the ipsilateral carotid artery and a high impending risk of stroke.</p>",
      "mermaid": "graph TD; A[Carotid Artery Plaque] --> B(Embolus); B --> C[Ophthalmic Artery]; C --> D[Retinal Artery Occlusion]; D --> E[Transient Monocular Vision Loss]; E --> F(Amaurosis Fugax);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "623ba776"
      },
      {
        "type": "is_caused_by",
        "to": "carotid_artery_stenosis"
      },
      {
        "type": "is_a_symptom_of",
        "to": "3334840f"
      }
    ]
  },
  "a4a401c7": {
    "title": "Amblyopia",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Pediatrics",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Pediatric Ophthalmology"
    ],
    "content": {
      "definition": "<p><b>Amblyopia</b>, commonly known as \"lazy eye,\" is a neurodevelopmental disorder of vision characterized by <i>decreased visual acuity</i> in one or both eyes that is not correctable by refractive means and is not due to any structural eye pathology. It results from abnormal visual experience during early childhood.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> During a critical period of visual development (birth to ~7 years), the brain suppresses or ignores the input from one eye, leading to maldevelopment of the visual cortex corresponding to that eye.</li><li><b>Common Causes:</b><br>1. <b>[[cdcda821|Strabismus]] (Misalignment):</b> The brain ignores the image from the deviating eye to avoid diplopia.<br>2. <b>Anisometropia (Unequal Refractive Error):</b> The brain favors the eye with better focus.<br>3. <b>Deprivation:</b> An obstruction like a congenital [[85f03b02|cataract]] or ptosis blocks a clear image from forming.</li><li><b>Diagnosis:</b> Detected during pediatric vision screening. The key finding is a difference in visual acuity between the two eyes.</li><li><b>Treatment:</b> Must be initiated early in the critical period. Treatment involves correcting the underlying cause (e.g., glasses for refractive error, surgery for strabismus/cataract) and then forcing the brain to use the amblyopic eye, typically by <mark>patching the good eye</mark> or using atropine drops to blur its vision.</li><li><b>USMLE Tip:</b> Early detection and treatment are crucial. If not treated before the end of the critical period (~age 7-8), amblyopia can result in irreversible vision loss.</li></ul>",
      "takeAway": "<p><b>Amblyopia</b> is a 'brain' problem, not an 'eye' problem; it is the failure of the visual cortex to develop properly due to abnormal input from an eye during a critical developmental window, leading to vision loss that can only be reversed by forcing the brain to pay attention to the 'lazy' eye before that window closes.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_caused_by",
        "to": "cdcda821"
      },
      {
        "type": "is_caused_by",
        "to": "85f03b02"
      },
      {
        "type": "is_treated_by",
        "to": "ocular_patching"
      }
    ]
  },
  "9115b704": {
    "title": "Amino Acids (CNS Context)",
    "primaryType": "molecule",
    "tags": [
      "Biochemistry",
      "Neuroscience",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Blood-Brain Barrier"
    ],
    "content": {
      "definition": "<p><b>Amino acids</b> are organic compounds that serve as the building blocks of proteins and as precursors for many neurotransmitters. In the central nervous system, their passage from the blood into the brain is tightly regulated by the [[dd47b9cc|blood-brain barrier]].</p>",
      "atAGlance": "<ul><li><b>Blood-Brain Barrier Transport:</b> Amino acids are generally lipid-insoluble and cannot diffuse freely across the [[dd47b9cc|blood-brain barrier]]. They require <mark>carrier-mediated transport proteins</mark> to enter the CNS.</li><li><b>Transport Systems:</b> There are specific transporters for different classes of amino acids (e.g., large neutral, basic, acidic). These transporters can become saturated and exhibit competition.</li><li><b>Neurotransmitter Precursors:</b> Many crucial neurotransmitters are synthesized from amino acids that must be transported into the brain. Examples include Tyrosine (precursor to [[90adc821|dopamine]], norepinephrine) and Tryptophan (precursor to [[5d3c2089|serotonin]]).</li><li><b>Clinical Relevance:</b> In disorders like [[phenylketonuria|Phenylketonuria (PKU)]], high levels of one amino acid (phenylalanine) can saturate the large neutral amino acid transporter, impairing the transport of other essential amino acids (like tyrosine and tryptophan) into the brain, contributing to neurological dysfunction.</li><li><b>USMLE Tip:</b> Remember that both glucose and amino acids require specific carrier-mediated transport to cross the [[dd47b9cc|blood-brain barrier]]; they do not diffuse freely.</li></ul>",
      "takeAway": "<p>The brain's supply of essential <b>amino acids</b>, critical for both protein synthesis and neurotransmitter production, is entirely dependent on specialized carrier proteins at the [[dd47b9cc|blood-brain barrier]], a system that can be competitively inhibited in certain metabolic diseases.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "crosses_via_transporters",
        "to": "dd47b9cc"
      },
      {
        "type": "is_precursor_to",
        "to": "90adc821"
      },
      {
        "type": "is_precursor_to",
        "to": "5d3c2089"
      },
      {
        "type": "transport_is_impaired_in",
        "to": "phenylketonuria"
      }
    ]
  },
  "c6814506": {
    "title": "Amitriptyline",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Psychiatry",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Psychiatry",
      "Pharmacology",
      "Antidepressants"
    ],
    "content": {
      "definition": "<p><b>Amitriptyline</b> is a <i>tricyclic antidepressant (TCA)</i> that works by inhibiting the reuptake of serotonin and norepinephrine. Due to its significant side effect profile, its primary use has shifted from depression to treating neuropathic pain and providing prophylaxis for [[c8833bae|migraine headaches]].</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Blocks reuptake of norepinephrine and serotonin. Also has potent antagonistic effects at muscarinic, α1-adrenergic, and H1-histamine receptors, which account for its side effects.</li><li><b>Clinical Use (Neurology):</b> Used for prophylaxis of [[c8833bae|migraine headaches]] and for the management of chronic neuropathic pain (e.g., diabetic neuropathy, postherpetic neuralgia).</li><li><b>Adverse Effects:</b> Strong anticholinergic effects (<mark>dry mouth, constipation, urinary retention, confusion</mark>), orthostatic hypotension (α1 blockade), sedation (H1 blockade), and weight gain.</li><li><b>Cardiotoxicity:</b> Overdose is life-threatening, causing QRS widening and ventricular arrhythmias due to Na<sup>+</sup> channel blockade. Treat with sodium bicarbonate.</li><li><b>USMLE Tip:</b> Remember the 'Tri-C's' for TCA toxicity: <b>C</b>onvulsions, <b>C</b>oma, <b>C</b>ardiotoxicity. Amitriptyline is a tertiary amine TCA, giving it more potent anticholinergic and antihistaminic effects compared to secondary amines like nortriptyline.</li></ul>",
      "takeAway": "<p><b>Amitriptyline</b>, a classic TCA, is now more valued for its role in migraine prevention and neuropathic pain than for depression, but its use is always tempered by a significant burden of anticholinergic, antihistaminic, and anti-adrenergic side effects, with cardiotoxicity being the most dangerous in overdose.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "tricyclic_antidepressant"
      },
      {
        "type": "used_for_prophylaxis_of",
        "to": "c8833bae"
      },
      {
        "type": "treats",
        "to": "neuropathic_pain"
      },
      {
        "type": "has_adverse_effect",
        "to": "cardiotoxicity"
      }
    ]
  },
  "a62c0c9f": {
    "title": "Amnesia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Psychiatry",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Cognitive Disorders"
    ],
    "content": {
      "definition": "<p><b>Amnesia</b> is a deficit in memory caused by brain damage, disease, or psychological trauma. It can be categorized based on the temporal nature of the memory loss relative to the causative event.</p>",
      "atAGlance": "<ul><li><b>Anterograde Amnesia:</b> The inability to form <u>new</u> memories after the event that caused the amnesia. Long-term memories from before the event remain intact.</li><li><b>Anterograde Lesion Site:</b> Classically caused by bilateral damage to the <mark>hippocampus</mark>, a key structure in the medial temporal lobe for memory consolidation. Seen in [[77ae6148|Alzheimer disease]] and [[herpes_simplex_encephalitis|herpes simplex encephalitis]].</li><li><b>Retrograde Amnesia:</b> The loss of memories that were formed <u>before</u> the onset of amnesia.</li><li><b>Korsakoff Syndrome:</b> A classic example of a syndrome causing both anterograde and retrograde amnesia, along with confabulation. It is caused by thiamine (B1) deficiency, often in the context of chronic alcohol use, and involves damage to the <mark>mammillary bodies</mark> and thalamus.</li><li><b>USMLE Tip:</b> Bilateral hippocampal lesions (e.g., from an anoxic brain injury or HSV encephalitis) are the classic cause of profound anterograde amnesia. The patient can remember their childhood but not what they had for breakfast.</li></ul>",
      "takeAway": "<p>The hippocampus is the brain's 'save button' for new memories; therefore, bilateral damage to this structure results in profound <b>anterograde amnesia</b>, leaving the individual unable to consolidate new experiences into long-term memory.</p>",
      "mermaid": "graph TD; A[Brain Injury/Disease] --> B{Amnesia}; B --> C[Anterograde Amnesia]; C --> D(Inability to form new memories); D --> E[Lesion: Hippocampus]; B --> F[Retrograde Amnesia]; F --> G(Loss of past memories); G --> H[Lesion: Widespread Cortex];"
    },
    "connections": [
      {
        "type": "is_caused_by_lesion_in",
        "to": "a0590674"
      },
      {
        "type": "is_caused_by_lesion_in",
        "to": "f02cfaa1"
      },
      {
        "type": "is_a_feature_of",
        "to": "wernicke_korsakoff_syndrome"
      },
      {
        "type": "is_a_feature_of",
        "to": "77ae6148"
      }
    ]
  },
  "d220fc3f": {
    "title": "Amygdala",
    "primaryType": "anatomy",
    "tags": [
      "Neuroscience",
      "Anatomy",
      "Limbic System",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Limbic System"
    ],
    "content": {
      "definition": "<p>The <b>Amygdala</b> is an almond-shaped set of neurons located deep within the medial temporal lobe of the brain. It is a key component of the [[73ace357|limbic system]] and plays a central role in processing emotions, particularly fear, anxiety, and aggression, as well as in memory formation and decision-making.</p>",
      "atAGlance": "<ul><li><b>Function:</b> The amygdala is the brain's emotional center, responsible for processing fear, pleasure, and anger. It links emotions to memories and influences social and sexual behavior.</li><li><b>Location:</b> Situated in the medial temporal lobe, anterior to the [[a0590674|hippocampus]].</li><li><b>Lesion Effects (Bilateral):</b> Bilateral destruction of the amygdala results in <mark>Klüver-Bucy syndrome</mark>.</li><li><b>Klüver-Bucy Syndrome:</b> Characterized by disinhibited behavior, including hyperorality (tendency to examine objects with the mouth), hypersexuality, hyperphagia, and visual agnosia. Patients also exhibit placidity (loss of fear response).</li><li><b>USMLE Tip:</b> The classic cause of bilateral amygdala damage leading to Klüver-Bucy syndrome is [[herpes_simplex_encephalitis|Herpes Simplex Virus-1 (HSV-1) encephalitis]], which has a predilection for the temporal lobes.</li></ul>",
      "takeAway": "<p>The <b>Amygdala</b> acts as the brain's alarm system and emotional processor; its bilateral destruction unleashes primitive behaviors by removing the normal emotional filters, resulting in the dramatic and disinhibited presentation of Klüver-Bucy syndrome.</p>",
      "mermaid": "graph TD; A[Sensory Input] --> B(Amygdala); B --Fear/Emotion Processing--> C[Hypothalamus & Brainstem]; C --> D(Autonomic & Behavioral Response);"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "73ace357"
      },
      {
        "type": "bilateral_lesion_causes",
        "to": "kluver_bucy_syndrome"
      },
      {
        "type": "is_damaged_in",
        "to": "herpes_simplex_encephalitis"
      }
    ]
  },
  "b374ebd6": {
    "title": "Cerebral Amyloid Angiopathy",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Geriatrics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Cerebrovascular Disease"
    ],
    "content": {
      "definition": "<p><b>Cerebral Amyloid Angiopathy (CAA)</b> is a condition in which amyloid-β protein deposits in the walls of small to medium-sized arteries of the cerebral cortex and leptomeninges, weakening the vessels and increasing the risk of spontaneous, recurrent <mark>lobar</mark> intraparenchymal hemorrhages.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Deposition of <mark>amyloid-β</mark> (the same protein found in [[77ae6148|Alzheimer's]] plaques) in the tunica media and adventitia of cortical and leptomeningeal vessels.</li><li><b>Clinical Presentation:</b> Most commonly presents with recurrent, spontaneous lobar hemorrhages in older adults (>65 years). These hemorrhages are typically located in the superficial cortex (lobar) rather than deep structures like the basal ganglia.</li><li><b>Location:</b> Hemorrhages are characteristically <mark>lobar</mark> (frontal, parietal, occipital, temporal lobes), contrasting with hypertensive hemorrhages which are typically deep (basal ganglia, thalamus, pons).</li><li><b>Association:</b> Strongly associated with [[77ae6148|Alzheimer disease]], although it can occur independently.</li><li><b>USMLE Tip:</b> An elderly patient with no history of significant hypertension who presents with a spontaneous, superficial (lobar) intracerebral hemorrhage should raise high suspicion for Cerebral Amyloid Angiopathy. Recurrent hemorrhages in different lobes are a key feature.</li></ul>",
      "takeAway": "<p><b>Cerebral Amyloid Angiopathy</b> is a major cause of lobar intracerebral hemorrhage in the elderly, resulting from amyloid-β deposition that makes cortical blood vessels brittle and prone to rupture, distinct from the deep brain hemorrhages typically caused by hypertension.</p>",
      "mermaid": "graph TD; A[Amyloid-β Deposition] --> B(Vessel Wall Weakening); B --> C[Cortical & Leptomeningeal Arteries]; C --> D(Rupture); D --> E[Recurrent Lobar Hemorrhage];"
    },
    "connections": [
      {
        "type": "causes",
        "to": "70b266c8"
      },
      {
        "type": "is_associated_with",
        "to": "77ae6148"
      },
      {
        "type": "differentiated_from",
        "to": "hypertensive_hemorrhage"
      }
    ]
  },
  "4ed629f9": {
    "title": "Amyotrophic Lateral Sclerosis (ALS)",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Degenerative Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Motor Neuron Diseases"
    ],
    "content": {
      "definition": "<p><b>Amyotrophic Lateral Sclerosis (ALS)</b>, also known as Lou Gehrig's disease, is a relentless and fatal neurodegenerative disorder characterized by the progressive loss of both <u>upper motor neurons</u> (in the motor cortex) and <u>lower motor neurons</u> (in the brainstem and spinal cord).</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Degeneration of corticospinal tracts (lateral sclerosis) and anterior horn cells (amyotrophy). The exact cause is unknown in most cases (sporadic), but some familial cases are linked to a mutation in the <mark>superoxide dismutase 1 (SOD1)</mark> gene.</li><li><b>Clinical Presentation:</b> A hallmark of ALS is the combination of both <b>upper motor neuron (UMN)</b> signs (spasticity, hyperreflexia, Babinski sign) and <b>lower motor neuron (LMN)</b> signs (fasciculations, atrophy, flaccid weakness).</li><li><b>Symptoms:</b> Can present with asymmetric limb weakness (e.g., foot drop, hand weakness), dysarthria (difficulty speaking), and dysphagia (difficulty swallowing). Sensation, cognition, and eye movements are typically spared.</li><li><b>Bulbar Involvement:</b> When LMNs in the brainstem are affected, it leads to [[901f3180|bulbar palsy]], causing dysarthria, dysphagia, and tongue fasciculations.</li><li><b>Treatment:</b> [[riluzole|Riluzole]], a glutamate antagonist, may modestly increase survival. Management is largely supportive, focusing on respiratory support and nutrition.</li><li><b>USMLE Tip:</b> The combination of UMN and LMN signs in the same patient is the key to diagnosing ALS. Look for a patient with weakness and atrophy in one arm (LMN) but hyperreflexia in the legs (UMN).</li></ul>",
      "takeAway": "<p><b>Amyotrophic Lateral Sclerosis</b> is uniquely devastating because it attacks the entire voluntary motor system, from the brain to the muscle, combining the spasticity of UMN lesions with the muscle wasting of LMN lesions, while cruelly sparing the patient's intellect and senses.</p>",
      "mermaid": "graph TD; A[UMN Degeneration - Motor Cortex] --> B(Spasticity, Hyperreflexia); C[LMN Degeneration - Anterior Horn] --> D(Fasciculations, Atrophy); A & C --> E(Progressive Motor Weakness);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "motor_neuron_disease"
      },
      {
        "type": "presents_with",
        "to": "upper_motor_neuron_signs"
      },
      {
        "type": "presents_with",
        "to": "lower_motor_neuron_signs"
      },
      {
        "type": "treated_by",
        "to": "riluzole"
      },
      {
        "type": "is_associated_with_mutation_in",
        "to": "sod1_gene"
      }
    ]
  },
  "ce2052d6": {
    "title": "Anal Wink Reflex",
    "primaryType": "physiology",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Spinal Cord"
    ],
    "content": {
      "definition": "<p>The <b>Anal Wink Reflex</b> is a superficial reflex involving the contraction of the external anal sphincter upon stroking the skin around the anus. It is used to test the integrity of the <mark>S3 and S4</mark> spinal nerve roots and the pudendal nerve.</p>",
      "atAGlance": "<ul><li><b>Nerve Roots:</b> Tests the integrity of the <b>S3-S4</b> spinal cord segments. Mnemonic: S2, 3, 4 keep the penis off the floor (for erection), and S3, 4 are for the anal wink.</li><li><b>Pathway:</b> Stroking the perianal skin stimulates afferent fibers of the pudendal nerve. The signal travels to the S3-S4 spinal segments, synapses, and an efferent signal returns via the pudendal nerve to cause contraction of the external anal sphincter.</li><li><b>Clinical Significance:</b> An absent anal wink reflex is a key sign in <mark>[[2904b5c8|Cauda Equina Syndrome]]</mark>, a neurosurgical emergency. It indicates damage to the S3-S4 nerve roots.</li><li><b>Other Conditions:</b> The reflex may also be absent in other conditions affecting the sacral nerve roots or spinal cord, such as spinal cord injury or spina bifida.</li><li><b>USMLE Tip:</b> In a patient with severe low back pain, saddle anesthesia, and bowel/bladder dysfunction, checking for the anal wink reflex is a critical step. Its absence strongly supports the diagnosis of [[2904b5c8|Cauda Equina Syndrome]].</li></ul>",
      "takeAway": "<p>The <b>Anal Wink Reflex</b> is a simple but vital physical exam maneuver for assessing the function of the lower sacral nerve roots (S3-S4); its absence is a red flag for [[2904b5c8|Cauda Equina Syndrome]].</p>",
      "mermaid": "graph TD; A[Stroke Perianal Skin] --> B(Afferent Signal via Pudendal N.); B --> C[S3-S4 Spinal Cord]; C --> D(Efferent Signal via Pudendal N.); D --> E(External Anal Sphincter Contraction);"
    },
    "connections": [
      {
        "type": "tests_nerve_root",
        "to": "s3_nerve_root"
      },
      {
        "type": "tests_nerve_root",
        "to": "s4_nerve_root"
      },
      {
        "type": "is_absent_in",
        "to": "2904b5c8"
      }
    ]
  },
  "5bcc9894": {
    "title": "Anencephaly",
    "primaryType": "disease",
    "tags": [
      "Embryology",
      "Neurology",
      "Pediatrics",
      "Congenital Malformation",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Embryology",
      "Neural Tube Defects"
    ],
    "content": {
      "definition": "<p><b>Anencephaly</b> is a severe and lethal congenital malformation, classified as an open <i>neural tube defect</i>, resulting from the failure of the rostral (anterior) neuropore to close during the 4th week of embryonic development. This leads to the absence of the forebrain and a large portion of the skull (calvarium).</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Failure of the rostral neuropore to close leads to an open calvarium and absence of the forebrain. The remaining brain tissue is exposed and degenerates.</li><li><b>Clinical Presentation:</b> Incompatible with postnatal life; infants are stillborn or die shortly after birth. The fetus has a characteristic <mark>\"frog-like appearance\"</mark> due to the absent cranial vault.</li><li><b>Maternal Findings:</b> Associated with <mark>polyhydramnios</mark> due to impaired fetal swallowing, as the neural control for swallowing is absent.</li><li><b>Diagnosis:</b> Can be detected prenatally via ultrasound. Maternal serum screening will show markedly <mark>elevated alpha-fetoprotein (AFP)</mark>. Amniotic fluid will also have elevated AFP and acetylcholinesterase (AChE).</li><li><b>Prevention:</b> Risk is significantly reduced by maternal folic acid supplementation before conception and during early pregnancy.</li></ul>",
      "takeAway": "<p><b>Anencephaly</b> represents a catastrophic failure of early neural development, where the absence of the forebrain and skull results in a condition incompatible with life, and is prenatally indicated by elevated maternal AFP and polyhydramnios.</p>",
      "mermaid": "graph TD; A[Failure of Rostral Neuropore Closure] --> B(Absence of Forebrain & Calvarium); B --> C(Polyhydramnios); B --> D(Lethal Outcome);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "neural_tube_defect"
      },
      {
        "type": "is_associated_with",
        "to": "polyhydramnios"
      },
      {
        "type": "is_diagnosed_by",
        "to": "alpha_fetoprotein"
      }
    ]
  },
  "a5295f1a": {
    "title": "Anesthetics",
    "primaryType": "concept",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Anesthetics"
    ],
    "content": {
      "definition": "<p><b>Anesthetics</b> are drugs that induce a reversible loss of sensation. They are broadly classified into <i>general anesthetics</i>, which cause a reversible loss of consciousness, and <i>local anesthetics</i>, which block nerve transmission in a specific region of the body.</p>",
      "atAGlance": "<ul><li><b>General Anesthetics:</b> Induce a state of unconsciousness, analgesia, amnesia, and muscle relaxation. They can be inhaled (e.g., sevoflurane, desflurane) or intravenous (e.g., propofol, ketamine, etomidate). Their potency is measured by the <mark>Minimum Alveolar Concentration (MAC)</mark>.</li><li><b>Local Anesthetics:</b> Block nerve conduction by inhibiting voltage-gated Na<sup>+</sup> channels. They are classified as esters (e.g., procaine, cocaine) or amides (e.g., lidocaine, bupivacaine). They are weak bases and are less effective in infected (acidic) tissue.</li><li><b>Neuromuscular Blockers:</b> Often used with general anesthetics to achieve profound muscle relaxation (paralysis). They can be depolarizing (e.g., succinylcholine) or non-depolarizing (e.g., rocuronium).</li><li><b>Malignant Hyperthermia:</b> A rare, life-threatening hypermetabolic state triggered by inhaled anesthetics (except N<sub>2</sub>O) and succinylcholine in genetically susceptible individuals. Treated with [[dantrolene]].</li><li><b>USMLE Tip:</b> Understand the key pharmacokinetic properties of inhaled anesthetics: low blood solubility (low blood:gas partition coefficient) leads to rapid induction and recovery, while high lipid solubility (high oil:gas partition coefficient) corresponds to high potency (low MAC).</li></ul>",
      "takeAway": "<p>The field of <b>anesthesia</b> relies on a combination of drugs to achieve a balanced state of unconsciousness, analgesia, and muscle relaxation, with general anesthetics acting on the CNS to induce sleep and local anesthetics acting on peripheral nerves to block pain signals.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "general_anesthetics"
      },
      {
        "type": "includes",
        "to": "local_anesthetics"
      },
      {
        "type": "is_associated_with",
        "to": "malignant_hyperthermia"
      }
    ]
  },
  "a7f97d7f": {
    "title": "Cerebral Aneurysms",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Neurosurgery",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Cerebrovascular Disease"
    ],
    "content": {
      "definition": "<p><b>Cerebral aneurysms</b> are localized, abnormal dilations of blood vessels in the brain, which carry a significant risk of rupture, leading to life-threatening intracranial hemorrhage.</p>",
      "atAGlance": "<ul><li><b>Saccular (Berry) Aneurysms:</b> Most common type. Thin-walled outpouchings, typically occurring at arterial branch points in the [[e22300e8|Circle of Willis]]. Most common site is the junction of the [[bd802d22|anterior communicating artery]] and anterior cerebral artery. Rupture causes [[63f8b05f|subarachnoid hemorrhage]].</li><li><b>Associations with Saccular Aneurysms:</b> <mark>Autosomal Dominant Polycystic Kidney Disease (ADPKD)</mark>, Ehlers-Danlos syndrome, Marfan syndrome, hypertension, smoking.</li><li><b>Charcot-Bouchard Microaneurysms:</b> Aneurysms of small, penetrating arteries (e.g., lenticulostriate arteries) associated with chronic hypertension. Rupture causes [[70b266c8|intraparenchymal hemorrhage]], typically in deep brain structures like the basal ganglia or thalamus.</li><li><b>Rupture Presentation:</b> Rupture of a saccular aneurysm classically presents as a sudden, severe <mark>\"worst headache of my life\"</mark> (thunderclap headache), indicating a [[63f8b05f|subarachnoid hemorrhage]].</li><li><b>USMLE Tip:</b> A patient with ADPKD who develops a sudden, severe headache should be immediately evaluated for a ruptured berry aneurysm. A PCom aneurysm can compress CN III, causing a 'down and out' eye with a 'blown' (dilated) pupil.</li></ul>",
      "takeAway": "<p>Cerebral aneurysms are focal weaknesses in brain arteries; the larger <b>saccular (berry) aneurysms</b> at the Circle of Willis rupture into the subarachnoid space, while the smaller <b>Charcot-Bouchard microaneurysms</b> in deep brain structures rupture due to hypertension, causing intraparenchymal bleeds.</p>",
      "mermaid": "graph TD; A[Cerebral Aneurysm] --> B{Types}; B --> C[Saccular/Berry]; C --> D(Circle of Willis); D --> E[Rupture -> Subarachnoid Hemorrhage]; B --> F[Charcot-Bouchard]; F --> G(Small Penetrating Arteries); G --> H[Rupture -> Intraparenchymal Hemorrhage];"
    },
    "connections": [
      {
        "type": "rupture_causes",
        "to": "63f8b05f"
      },
      {
        "type": "rupture_causes",
        "to": "70b266c8"
      },
      {
        "type": "is_associated_with",
        "to": "autosomal_dominant_polycystic_kidney_disease"
      },
      {
        "type": "includes",
        "to": "a9f6d703"
      }
    ]
  },
  "9c80344d": {
    "title": "Angle-Closure Glaucoma",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Emergency Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Glaucoma"
    ],
    "content": {
      "definition": "<p><b>Angle-closure glaucoma</b> is an ophthalmologic emergency characterized by a sudden, severe increase in intraocular pressure (IOP) due to the physical obstruction of aqueous humor outflow through the trabecular meshwork by the peripheral iris.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Occurs in individuals with a pre-existing narrow anterior chamber angle. Pupillary dilation (mydriasis) causes the peripheral iris to bunch up and block the trabecular meshwork, acutely halting aqueous humor drainage.</li><li><b>Triggers:</b> Any event causing mydriasis can trigger an attack, such as entering a dark room, stress, or administration of sympathomimetic or anticholinergic drugs.</li><li><b>Clinical Presentation:</b> <mark>Sudden onset of severe, unilateral eye pain</mark>, headache, nausea/vomiting, and blurred vision with <mark>halos around lights</mark>.</li><li><b>Physical Exam:</b> The eye is red and hard to palpation ('rock hard'). The pupil is typically <mark>mid-dilated and nonreactive</mark> to light. The cornea may appear hazy or steamy.</li><li><b>USMLE Tip:</b> This is a true ophthalmic emergency. The classic presentation of a painful, red eye with a fixed, mid-dilated pupil and halos around lights is pathognomonic.</li></ul>",
      "takeAway": "<p><b>Angle-closure glaucoma</b> is a mechanical plumbing problem of the eye where pupillary dilation in a predisposed individual causes the iris to act like a drain plug, leading to a rapid and painful spike in intraocular pressure that threatens vision.</p>",
      "mermaid": "graph TD; A[Predisposing Narrow Angle] --Pupillary Dilation--> B(Iris bunches at periphery); B --> C(Blocks Trabecular Meshwork); C --> D(↓ Aqueous Outflow); D --> E(↑↑ Intraocular Pressure); E --> F(Acute Pain, Vision Loss, Red Eye);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "3ce6c035"
      },
      {
        "type": "is_triggered_by",
        "to": "mydriasis"
      },
      {
        "type": "differentiated_from",
        "to": "5ea7b741"
      }
    ]
  },
  "ed8c1c37": {
    "title": "Anhidrosis in Horner Syndrome",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Autonomic",
      "Dermatology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Autonomic Disorders"
    ],
    "content": {
      "definition": "<p><b>Anhidrosis</b>, the inability to sweat normally, is one of the three classic signs of [[c19010a3|Horner syndrome]], resulting from the disruption of sympathetic innervation to the sweat glands of the face.</p>",
      "atAGlance": "<ul><li><b>Horner Syndrome Triad:</b> The full triad is <b>Ptosis</b> (mild eyelid droop), <b>Miosis</b> (constricted pupil), and <b>Anhidrosis</b> (decreased sweating).</li><li><b>Mechanism:</b> Disruption of the oculosympathetic pathway prevents the release of acetylcholine from postganglionic sympathetic neurons that innervate sweat glands (a sympathetic exception).</li><li><b>Localization Value:</b> The distribution of anhidrosis can help localize the lesion in the three-neuron sympathetic chain.</li><li><b>Lesion Localization:</b><br> - <b>1st Order (Central):</b> Lesion in hypothalamus or brainstem/spinal cord. Anhidrosis affects the entire ipsilateral half of the body.<br> - <b>2nd Order (Preganglionic):</b> Lesion in the chest (e.g., Pancoast tumor). Anhidrosis affects the ipsilateral face and neck.<br> - <b>3rd Order (Postganglionic):</b> Lesion above the superior cervical ganglion (e.g., carotid dissection). Anhidrosis is often minimal or absent, affecting only a small patch on the forehead, because fibers to most facial sweat glands travel with the external carotid artery.</li><li><b>USMLE Tip:</b> A painful Horner syndrome (especially with neck pain) should raise suspicion for a carotid artery dissection, a 3rd order neuron lesion where anhidrosis is often absent.</li></ul>",
      "takeAway": "<p>While part of the classic triad, the presence and distribution of <b>anhidrosis</b> in [[c19010a3|Horner syndrome]] is a subtle but powerful clue for localizing the lesion along the long oculosympathetic pathway, with widespread anhidrosis suggesting a central lesion and absent anhidrosis pointing towards a postganglionic (3rd order) problem.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_sign_of",
        "to": "c19010a3"
      },
      {
        "type": "is_caused_by",
        "to": "sympathetic_pathway_disruption"
      }
    ]
  },
  "830c856c": {
    "title": "Anterior Cerebral Artery (ACA)",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Cerebrovascular",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Cerebral Vasculature"
    ],
    "content": {
      "definition": "<p>The <b>Anterior Cerebral Artery (ACA)</b> is a major artery of the brain that branches from the internal carotid artery and supplies the medial portion of the frontal and parietal lobes, as well as the corpus callosum.</p>",
      "atAGlance": "<ul><li><b>Origin:</b> Arises from the bifurcation of the internal carotid artery. The left and right ACAs are connected by the [[bd802d22|anterior communicating artery]].</li><li><b>Territory Supplied:</b> Supplies the medial surface of the cerebral hemispheres. Based on the motor and sensory homunculus, this corresponds to the <mark>lower extremities</mark>.</li><li><b>Stroke Syndrome:</b> Occlusion of the ACA results in a characteristic stroke syndrome with <mark>contralateral motor and sensory deficits predominantly affecting the lower limb</mark> (leg > arm/face).</li><li><b>Other Stroke Signs:</b> May also cause urinary incontinence due to damage to the paracentral lobule. Frontal lobe signs like abulia (lack of will/initiative) or personality changes can occur.</li><li><b>USMLE Tip:</b> The key to identifying an ACA stroke is the disproportionate weakness and sensory loss in the contralateral leg compared to the arm and face. This contrasts sharply with an [[143bb23d|MCA stroke]].</li></ul>",
      "takeAway": "<p>The <b>Anterior Cerebral Artery</b> is responsible for the medial brain territory, meaning its occlusion uniquely manifests as a stroke that 'kicks the leg out' from under the patient, with motor and sensory deficits primarily affecting the contralateral lower extremity.</p>",
      "mermaid": "graph TD; A[Internal Carotid Artery] --> B(Anterior Cerebral Artery); B --> C(Supplies Medial Cortex); C --> D(Motor/Sensory Homunculus for Leg); B --Connects via AComA--> E(Contralateral ACA);"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "e22300e8"
      },
      {
        "type": "occlusion_causes",
        "to": "anterior_cerebral_artery_stroke"
      },
      {
        "type": "is_connected_to_contralateral_by",
        "to": "bd802d22"
      }
    ]
  },
  "3c4b0ef7": {
    "title": "Anterior Circulation Strokes",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Cerebrovascular",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Cerebrovascular Disease"
    ],
    "content": {
      "definition": "<p><b>Anterior circulation strokes</b> are ischemic events caused by occlusion of the internal carotid artery or its major branches, the [[830c856c|anterior cerebral artery (ACA)]] and the [[143bb23d|middle cerebral artery (MCA)]], leading to deficits related to the cerebral hemispheres.</p>",
      "atAGlance": "<ul><li><b>Vessels Involved:</b> Internal carotid artery (ICA), [[143bb23d|Middle Cerebral Artery (MCA)]], [[830c856c|Anterior Cerebral Artery (ACA)]].</li><li><b>MCA Stroke:</b> The most common type of ischemic stroke. Presents with <mark>contralateral hemiparesis and sensory loss affecting the face and upper limb more than the lower limb</mark>. If the dominant (usually left) hemisphere is affected, it causes [[6bc9a567|aphasia]] (Broca's or Wernicke's). If the non-dominant hemisphere is affected, it causes hemineglect.</li><li><b>ACA Stroke:</b> Presents with <mark>contralateral hemiparesis and sensory loss affecting the lower limb more than the upper limb</mark>. May also cause urinary incontinence and frontal lobe signs (e.g., personality changes, abulia).</li><li><b>Distinction:</b> The key differentiator is the distribution of weakness based on the homunculus: MCA strokes affect the face/arm, while ACA strokes affect the leg.</li><li><b>USMLE Tip:</b> Aphasia is a 'cortical sign' that strongly points to an MCA stroke in the dominant hemisphere. Leg weakness greater than arm weakness is the classic sign of an ACA stroke.</li></ul>",
      "takeAway": "<p><b>Anterior circulation strokes</b> produce deficits that can be precisely localized by understanding the functional anatomy of the cerebral cortex and the homunculus; MCA strokes paralyze the contralateral face and arm, while ACA strokes paralyze the contralateral leg.</p>",
      "mermaid": "graph TD; A[Internal Carotid Artery] --> B(MCA); B --> C(Contralateral Face/Arm Deficits, Aphasia/Neglect); A --> D(ACA); D --> E(Contralateral Leg Deficits, Incontinence);"
    },
    "connections": [
      {
        "type": "includes",
        "to": "middle_cerebral_artery_stroke"
      },
      {
        "type": "includes",
        "to": "anterior_cerebral_artery_stroke"
      },
      {
        "type": "differentiated_from",
        "to": "276cefbc"
      }
    ]
  },
  "bd802d22": {
    "title": "Anterior Communicating Artery (AComA)",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Cerebrovascular",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Cerebral Vasculature"
    ],
    "content": {
      "definition": "<p>The <b>Anterior Communicating Artery (AComA)</b> is a short blood vessel that connects the left and right [[830c856c|anterior cerebral arteries]], forming the anterior aspect of the [[e22300e8|Circle of Willis]].</p>",
      "atAGlance": "<ul><li><b>Function:</b> Provides collateral blood flow between the two anterior cerebral circulations.</li><li><b>Clinical Significance:</b> It is the <mark>most common site</mark> for the formation of saccular (berry) aneurysms in the brain.</li><li><b>Aneurysm Complications:</b><br>1. <b>Rupture:</b> Leads to [[63f8b05f|subarachnoid hemorrhage]], presenting as a \"worst headache of my life.\"<br>2. <b>Compression:</b> A large, unruptured aneurysm can compress the adjacent <mark>optic chiasm</mark>, causing a [[6c3a980e|bitemporal hemianopia]] (tunnel vision).</li><li><b>USMLE Tip:</b> When a question mentions a saccular aneurysm, the AComA should be the first location you consider. If the patient has visual field defects, especially bitemporal hemianopia, an AComA aneurysm is a very likely cause.</li></ul>",
      "takeAway": "<p>The <b>Anterior Communicating Artery</b>, while small, is clinically significant as the number one location for berry aneurysms, which can either rupture catastrophically into the subarachnoid space or compress the optic chiasm, causing tunnel vision.</p>",
      "mermaid": "graph TD; A[Left ACA] -- AComA --> B[Right ACA]; C(AComA Aneurysm) --> D(Rupture -> SAH); C --> E(Compression -> Bitemporal Hemianopia);"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "e22300e8"
      },
      {
        "type": "connects",
        "to": "830c856c"
      },
      {
        "type": "is_common_site_for",
        "to": "a9f6d703"
      },
      {
        "type": "aneurysm_can_cause",
        "to": "6c3a980e"
      }
    ]
  },
  "b7b67074": {
    "title": "Arachnoid Granulations",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Meninges"
    ],
    "content": {
      "definition": "<p><b>Arachnoid granulations</b> (or arachnoid villi) are microscopic protrusions of the [[46e279b9|arachnoid mater]] through the dura mater into the superior sagittal sinus and other [[21f1c955|dural venous sinuses]], functioning as one-way valves for the drainage of cerebrospinal fluid (CSF) from the subarachnoid space into the venous circulation.</p>",
      "atAGlance": "<ul><li><b>Function:</b> The primary site for <mark>CSF reabsorption</mark> into the bloodstream.</li><li><b>Mechanism:</b> CSF flows from the subarachnoid space into the venous sinus down a pressure gradient. The structure acts as a one-way valve, preventing venous blood from entering the subarachnoid space.</li><li><b>Location:</b> Most numerous along the <mark>superior sagittal sinus</mark>.</li><li><b>Pathology:</b> Impaired function or obstruction of arachnoid granulations (e.g., from scarring after meningitis or subarachnoid hemorrhage) can lead to <mark>[[aa4115c7|communicating hydrocephalus]]</mark>.</li><li><b>USMLE Tip:</b> Remember that CSF is produced by the choroid plexus and reabsorbed by the arachnoid granulations. A problem with reabsorption (communicating hydrocephalus) is distinct from a blockage of flow within the ventricles (non-communicating hydrocephalus).</li></ul>",
      "takeAway": "<p><b>Arachnoid granulations</b> are the critical drainage ports for cerebrospinal fluid, acting as sophisticated one-way valves that allow CSF to exit the subarachnoid space and return to the venous system, thereby maintaining intracranial pressure homeostasis.</p>",
      "mermaid": "graph TD; A[Choroid Plexus] --Produces--> B(CSF); B --> C(Ventricular System); C --> D(Subarachnoid Space); D --> E(Arachnoid Granulations); E --Reabsorption--> F[Dural Venous Sinuses];"
    },
    "connections": [
      {
        "type": "is_involved_in_reabsorption_of",
        "to": "7109d8b6"
      },
      {
        "type": "is_a_protrusion_of",
        "to": "46e279b9"
      },
      {
        "type": "dysfunction_causes",
        "to": "aa4115c7"
      },
      {
        "type": "drains_into",
        "to": "21f1c955"
      }
    ]
  },
  "46e279b9": {
    "title": "Arachnoid Mater",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Meninges"
    ],
    "content": {
      "definition": "<p>The <b>Arachnoid Mater</b> is the middle layer of the three meninges that surround the brain and spinal cord. It is a delicate, avascular membrane located between the outer [[5bbe3597|dura mater]] and the inner [[pia_mater|pia mater]].</p>",
      "atAGlance": "<ul><li><b>Structure:</b> Composed of a web-like network of collagen and elastic fibers, from which it gets its name (from Greek 'arachne' for spider).</li><li><b>Embryologic Origin:</b> Derived from the [[14c6f2a7|neural crest]].</li><li><b>Subarachnoid Space:</b> The space between the arachnoid mater and the pia mater is the <mark>subarachnoid space</mark>, which contains cerebrospinal fluid (CSF) and major cerebral blood vessels.</li><li><b>Arachnoid Granulations:</b> Protrusions of the arachnoid mater through the dura into the superior sagittal sinus, responsible for CSF reabsorption.</li><li><b>Clinical Relevance:</b> Rupture of an artery in the subarachnoid space (e.g., from a berry aneurysm) causes a [[63f8b05f|subarachnoid hemorrhage]]. A [[e98ea0ba|meningioma]], a common benign brain tumor, arises from arachnoid cap cells.</li></ul>",
      "takeAway": "<p>The <b>Arachnoid Mater</b> forms a crucial boundary, creating the subarachnoid space that houses the CSF and cerebral vasculature, and its specialized granulations are essential for CSF drainage.</p>",
      "mermaid": "graph TD; A[Skull] --> B[Dura Mater]; B --> C(Arachnoid Mater); C --> D[Subarachnoid Space - CSF]; D --> E[Pia Mater]; E --> F[Brain];"
    },
    "connections": [
      {
        "type": "is_a_layer_of",
        "to": "meninges"
      },
      {
        "type": "is_located_between",
        "to": "5bbe3597"
      },
      {
        "type": "is_located_between",
        "to": "pia_mater"
      },
      {
        "type": "gives_rise_to",
        "to": "e98ea0ba"
      }
    ]
  },
  "5dd343d3": {
    "title": "Area Postrema",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Physiology",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Brainstem"
    ],
    "content": {
      "definition": "<p>The <b>Area Postrema</b> is a highly vascularized structure in the medulla oblongata, located on the floor of the fourth ventricle, that functions as the <mark>chemoreceptor trigger zone (CTZ)</mark> for vomiting. It is one of the circumventricular organs, meaning it lacks a complete [[dd47b9cc|blood-brain barrier]].</p>",
      "atAGlance": "<ul><li><b>Location:</b> Dorsal surface of the medulla oblongata at the caudal end of the fourth ventricle.</li><li><b>Function:</b> Detects emetogenic toxins in the blood and CSF and sends signals to the [[74b651ab|vomiting center]] (nucleus tractus solitarius) to induce emesis (vomiting).</li><li><b>Blood-Brain Barrier:</b> Its fenestrated capillaries allow it to directly sample the chemical composition of the blood.</li><li><b>Receptors:</b> Rich in various receptors, including dopamine D<sub>2</sub>, serotonin 5-HT<sub>3</sub>, and neurokinin-1 (NK-1) receptors.</li><li><b>Clinical Relevance:</b> This is the site of action for many antiemetic drugs. For example, [[ondansetron]] is a 5-HT<sub>3</sub> antagonist, and [[metoclopramide]] is a D<sub>2</sub> antagonist. It is also the area stimulated by toxins during chemotherapy, leading to chemotherapy-induced nausea and vomiting.</li></ul>",
      "takeAway": "<p>The <b>Area Postrema</b> serves as the brain's chemical surveillance system for the blood; its lack of a blood-brain barrier allows it to detect toxins and trigger the protective reflex of vomiting, making it a key target for antiemetic medications.</p>",
      "mermaid": "graph TD; A[Emetogenic Toxins in Blood] --> B(Area Postrema/CTZ); B --> C(Vomiting Center - NTS); C --> D(Vomiting Reflex);"
    },
    "connections": [
      {
        "type": "is_a",
        "to": "circumventricular_organ"
      },
      {
        "type": "is_also_known_as",
        "to": "chemoreceptor_trigger_zone"
      },
      {
        "type": "sends_signals_to",
        "to": "74b651ab"
      },
      {
        "type": "is_target_of",
        "to": "ondansetron"
      }
    ]
  },
  "08cb577f": {
    "title": "Argyll Robertson Pupil",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Infectious Disease",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Cranial Nerves"
    ],
    "content": {
      "definition": "<p>The <b>Argyll Robertson Pupil</b> is a specific type of pupillary abnormality characterized by bilateral small pupils that constrict when the patient focuses on a near object (accommodation reflex) but do <u>not</u> constrict when exposed to bright light (light reflex). This phenomenon is known as <mark>light-near dissociation</mark>.</p>",
      "atAGlance": "<ul><li><b>Classic Mnemonic:</b> Often called the \"prostitute's pupil\" because it \"accommodates but does not react.\"</li><li><b>Pathophysiology:</b> The lesion is thought to be in the <mark>pretectal nucleus</mark> in the superior colliculus of the midbrain, which interrupts the afferent limb of the pupillary light reflex pathway before it reaches the Edinger-Westphal nuclei bilaterally. The pathway for accommodation, which is more complex and involves the cerebral cortex, is spared.</li><li><b>Classic Association:</b> It is a highly specific sign of late-stage, or tertiary, <mark>neurosyphilis</mark>, particularly [[71daebd6|tabes dorsalis]].</li><li><b>Other Causes:</b> While classic for syphilis, it can also be seen in other conditions causing midbrain lesions, such as diabetes mellitus or Parinaud syndrome.</li><li><b>USMLE Tip:</b> A patient with ataxia, a positive Romberg sign, and pupils that accommodate but don't react to light is a classic presentation of [[71daebd6|tabes dorsalis]] due to neurosyphilis.</li></ul>",
      "takeAway": "<p>The <b>Argyll Robertson Pupil</b> is a pathognomonic sign of neurosyphilis, representing a selective lesion in the midbrain that disconnects the pupillary light reflex pathway while preserving the separate, cortically-driven accommodation pathway, resulting in the classic light-near dissociation.</p>",
      "mermaid": "graph TD; A[Light] --> B(Optic Nerve); B --> C(Pretectal Nucleus); C --x Lesion; C --x D(Edinger-Westphal Nucleus); E[Near Object] --> F(Visual Cortex); F --> G(Accommodation Pathway); G --> D; D --> H(Pupillary Constriction);"
    },
    "connections": [
      {
        "type": "is_a_sign_of",
        "to": "neurosyphilis"
      },
      {
        "type": "is_a_sign_of",
        "to": "71daebd6"
      },
      {
        "type": "is_caused_by_lesion_in",
        "to": "pretectal_nucleus"
      },
      {
        "type": "is_an_example_of",
        "to": "light_near_dissociation"
      }
    ]
  },
  "09db7b12": {
    "title": "Aspirin",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Cardiology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Stroke Therapy"
    ],
    "content": {
      "definition": "<p><b>Aspirin</b> (acetylsalicylic acid) is a nonsteroidal anti-inflammatory drug (NSAID) that irreversibly inhibits cyclooxygenase (COX) enzymes, primarily used at low doses for its antiplatelet effects in the prevention of cardiovascular and cerebrovascular events.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> <u>Irreversibly</u> acetylates and inhibits both COX-1 and COX-2. Its antiplatelet effect is due to inhibition of COX-1 in platelets, which blocks the synthesis of <mark>Thromboxane A<sub>2</sub> (TXA<sub>2</sub>)</mark>, a potent promoter of platelet aggregation.</li><li><b>Clinical Use (Neurology):</b> Used for secondary prevention of [[c5da3c57|ischemic stroke]] and [[623ba776|transient ischemic attacks (TIAs)]]. It is a cornerstone of antiplatelet therapy.</li><li><b>Adverse Effects:</b> GI distress (gastritis, ulcers), bleeding, tinnitus (a sign of toxicity), and Reye syndrome in children with viral illness.</li><li><b>Reye Syndrome:</b> A rare but severe condition of acute encephalopathy and fatty liver failure in children given aspirin for a viral infection (e.g., influenza, varicella). <u>Aspirin is contraindicated in children</u> for this reason (except in Kawasaki disease).</li><li><b>USMLE Tip:</b> The irreversibility of aspirin's effect on platelets is key. Since platelets lack a nucleus, they cannot synthesize new COX enzyme, so the antiplatelet effect lasts for the life of the platelet (~7-10 days).</li></ul>",
      "takeAway": "<p><b>Aspirin's</b> primary role in stroke prevention stems from its unique ability to <u>irreversibly</u> inhibit platelet COX-1, effectively silencing thromboxane A<sub>2</sub> production for the platelet's entire lifespan and thus reducing the risk of thrombotic occlusion.</p>",
      "mermaid": "graph TD; A[Aspirin] --Irreversibly Inhibits--> B(Platelet COX-1); B --x C(Arachidonic Acid -> Thromboxane A2); C --x D(Platelet Aggregation); D --x E(Thrombus Formation);"
    },
    "connections": [
      {
        "type": "prevents",
        "to": "c5da3c57"
      },
      {
        "type": "prevents",
        "to": "623ba776"
      },
      {
        "type": "inhibits",
        "to": "cyclooxygenase"
      },
      {
        "type": "causes_adverse_effect",
        "to": "reye_syndrome"
      }
    ]
  },
  "b564ac97": {
    "title": "Asterixis",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Gastroenterology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Movement Disorders"
    ],
    "content": {
      "definition": "<p><b>Asterixis</b> is a type of negative myoclonus characterized by a brief, flapping tremor of the hands, typically elicited by having the patient extend their arms and dorsiflex their wrists. It is a classic sign of metabolic encephalopathy.</p>",
      "atAGlance": "<ul><li><b>Elicitation:</b> The patient holds their arms out with wrists extended ('stop traffic' pose). The 'flap' is a sudden, brief loss of postural tone, causing the hands to drop, followed by a rapid, jerky return to the original position.</li><li><b>Pathophysiology:</b> It is not a true tremor but a failure of the brain to maintain a sustained posture, thought to be due to abnormal function of the diencephalic motor centers that regulate posture and tone.</li><li><b>Classic Association:</b> Most commonly associated with <mark>hepatic encephalopathy</mark> due to liver failure, where high ammonia levels are neurotoxic.</li><li><b>Other Causes:</b> Can also be seen in other metabolic encephalopathies, including uremia (renal failure), CO<sub>2</sub> narcosis (hypercapnia), and drug intoxication. It is also a feature of [[wilson_disease|Wilson disease]].</li><li><b>USMLE Tip:</b> A patient with a history of cirrhosis who presents with confusion and a 'flapping tremor' of the hands has hepatic encephalopathy. The tremor is asterixis.</li></ul>",
      "takeAway": "<p><b>Asterixis</b> is a 'negative' movement disorder—a brief lapse in muscle tone rather than an active contraction—that serves as a crucial physical exam finding for metabolic encephalopathies, most classically hepatic encephalopathy from hyperammonemia.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_sign_of",
        "to": "hepatic_encephalopathy"
      },
      {
        "type": "is_a_sign_of",
        "to": "uremia"
      },
      {
        "type": "is_a_sign_of",
        "to": "wilson_disease"
      },
      {
        "type": "is_a_type_of",
        "to": "myoclonus"
      }
    ]
  },
  "18cff34e": {
    "title": "Astigmatism",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Refractive Errors"
    ],
    "content": {
      "definition": "<p><b>Astigmatism</b> is a common refractive error of the eye where vision is blurred or distorted at all distances. It occurs when the cornea or lens has an irregular, non-spherical curvature, causing light rays to focus at multiple points rather than a single point on the retina.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> The cornea, which should be shaped like a sphere, is instead shaped more like a football (toric). This causes light entering the eye to have different focal points in different planes (e.g., vertical vs. horizontal).</li><li><b>Symptoms:</b> Blurred or distorted vision, eye strain, and headaches.</li><li><b>Diagnosis:</b> Diagnosed during a standard eye exam using a phoropter and keratometer.</li><li><b>Correction:</b> Corrected with eyeglasses or contact lenses that have a <mark>cylindrical lens</mark> to compensate for the irregular curvature. It can also be corrected with refractive surgery (e.g., LASIK).</li><li><b>USMLE Tip:</b> Differentiate from other refractive errors: [[myopia|myopia]] (nearsightedness) and [[hyperopia|hyperopia]] (farsightedness) are caused by the length of the eyeball relative to its focusing power, while astigmatism is caused by an irregularly shaped cornea or lens.</li></ul>",
      "takeAway": "<p><b>Astigmatism</b> is a refractive error caused by an asymmetrically shaped cornea or lens, which acts like a warped mirror, scattering light to multiple focal points and resulting in blurred vision that requires a cylindrical lens for correction.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "refractive_error"
      },
      {
        "type": "differentiated_from",
        "to": "myopia"
      },
      {
        "type": "differentiated_from",
        "to": "hyperopia"
      }
    ]
  },
  "8192f595": {
    "title": "Astrocytes",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Histology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Glial Cells"
    ],
    "content": {
      "definition": "<p><b>Astrocytes</b> are the most abundant type of glial cell in the central nervous system. These star-shaped cells perform a wide variety of essential supportive and homeostatic functions for neurons, and are the origin of the most common primary brain tumor in adults, [[b6bbd0bc|glioblastoma]].</p>",
      "atAGlance": "<ul><li><b>Functions:</b> Physical support for neurons, repair (gliosis/scar formation), component of the [[dd47b9cc|blood-brain barrier]] (via foot processes), removal of excess neurotransmitters (especially glutamate), and maintenance of the ionic environment.</li><li><b>Histological Marker:</b> They are identified by their expression of <mark>Glial Fibrillary Acidic Protein (GFAP)</mark>, an intermediate filament protein.</li><li><b>Reactive Gliosis:</b> In response to CNS injury (e.g., stroke, trauma), astrocytes proliferate and hypertrophy to form a <mark>glial scar</mark>, which walls off the damaged area but can also impede axonal regeneration.</li><li><b>Tumor Origin:</b> Astrocytes are the cell of origin for astrocytomas, including the highly malignant [[b6bbd0bc|glioblastoma]].</li><li><b>USMLE Tip:</b> Remember GFAP as the key marker for astrocytes and astrocytic tumors. The formation of a glial scar by astrocytes is the CNS equivalent of fibrosis in other tissues.</li></ul>",
      "takeAway": "<p><b>Astrocytes</b> are the indispensable 'housekeepers' of the CNS, providing structural, metabolic, and homeostatic support to neurons, forming the blood-brain barrier, and orchestrating the glial scar response to injury, but they can also give rise to the most aggressive brain tumors.</p>",
      "mermaid": "graph TD; A[Astrocyte]; A --> B(Physical Support); A --> C(Blood-Brain Barrier); A --> D(Neurotransmitter Uptake); A --> E(Ion Buffering); A --> F(Repair/Gliosis); A --Neoplastic Transformation--> G(Astrocytoma/Glioblastoma);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "glial_cell"
      },
      {
        "type": "expresses_marker",
        "to": "fb50d450"
      },
      {
        "type": "is_cell_of_origin_for",
        "to": "b6bbd0bc"
      },
      {
        "type": "forms",
        "to": "glial_scar"
      }
    ]
  },
  "9767fd6b": {
    "title": "Ataxia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Movement Disorders"
    ],
    "content": {
      "definition": "<p><b>Ataxia</b> is a neurological sign consisting of a lack of voluntary coordination of muscle movements, leading to a clumsy, unsteady gait and impaired balance. It can be caused by damage to the cerebellum, the vestibular system, or sensory pathways.</p>",
      "atAGlance": "<ul><li><b>Cerebellar Ataxia:</b> Caused by damage to the cerebellum. <br> - <b>Truncal Ataxia:</b> Affects the midline, causing an unsteady, wide-based ('drunken sailor') gait. Associated with lesions of the cerebellar vermis.<br> - <b>Limb Ataxia:</b> Affects the extremities, causing dysmetria (overshooting/undershooting targets) and intention tremor. Associated with lesions of the cerebellar hemispheres.</li><li><b>Sensory Ataxia:</b> Caused by loss of proprioception, typically from damage to the [[e7f5cbbe|dorsal columns]] of the spinal cord or peripheral nerves. Patients have a positive [[47a0f3d1|Romberg sign]] (worsening of balance with eyes closed) and a stomping gait. Seen in [[71daebd6|tabes dorsalis]] and [[6f5bea90|subacute combined degeneration]].</li><li><b>Vestibular Ataxia:</b> Caused by dysfunction of the vestibular system. Associated with vertigo, nystagmus, and nausea.</li><li><b>USMLE Tip:</b> Differentiating the type of ataxia is key. A positive [[47a0f3d1|Romberg sign]] points to a sensory (dorsal column) cause, not a cerebellar cause. Patients with cerebellar ataxia are unsteady with their eyes open or closed.</li></ul>",
      "takeAway": "<p><b>Ataxia</b> is a sign of discoordination that can be localized by its characteristics: truncal and limb incoordination points to the cerebellum, a positive Romberg sign points to sensory loss in the dorsal columns, and associated vertigo points to the vestibular system.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_sign_of",
        "to": "cerebellar_lesion"
      },
      {
        "type": "is_a_sign_of",
        "to": "dorsal_column_lesion"
      },
      {
        "type": "is_a_sign_of",
        "to": "vestibular_dysfunction"
      },
      {
        "type": "is_a_symptom_of",
        "to": "71daebd6"
      }
    ]
  },
  "19272e70": {
    "title": "Athetosis",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Movement Disorders",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Movement Disorders"
    ],
    "content": {
      "definition": "<p><b>Athetosis</b> is a type of involuntary movement disorder characterized by slow, writhing, snake-like movements, particularly affecting the distal extremities (fingers and hands). It is a symptom of damage to the [[ed462927|basal ganglia]].</p>",
      "atAGlance": "<ul><li><b>Description:</b> Slow, twisting, and writhing movements that are continuous and non-rhythmic. It is often described as being 'snake-like.'</li><li><b>Lesion Location:</b> Caused by lesions in the [[ed462927|basal ganglia]], particularly the striatum (caudate and putamen).</li><li><b>Classic Association:</b> Athetosis is a characteristic feature of [[ffd7e743|Huntington disease]], where it often co-occurs with chorea (termed choreoathetosis).</li><li><b>Other Causes:</b> Can also be seen in conditions like cerebral palsy.</li><li><b>USMLE Tip:</b> When you see a description of slow, writhing, 'snake-like' movements of the fingers in a patient with other signs of a basal ganglia disorder (like chorea or dementia), think of athetosis, especially in the context of [[ffd7e743|Huntington disease]].</li></ul>",
      "takeAway": "<p><b>Athetosis</b> is a specific and visually distinct sign of basal ganglia dysfunction, representing a failure of motor control that manifests as slow, ceaseless, writhing movements, most classically seen in [[ffd7e743|Huntington disease]].</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_symptom_of",
        "to": "ffd7e743"
      },
      {
        "type": "is_caused_by_lesion_in",
        "to": "ed462927"
      },
      {
        "type": "is_a_type_of",
        "to": "dyskinesia"
      }
    ]
  },
  "ed7a236f": {
    "title": "Atonic Seizures",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pediatrics",
      "Epilepsy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Seizures"
    ],
    "content": {
      "definition": "<p><b>Atonic seizures</b>, also known as \"drop attacks\" or \"drop seizures,\" are a type of generalized seizure characterized by a sudden loss of muscle tone, causing the individual to collapse to the ground. The loss of consciousness is typically very brief.</p>",
      "atAGlance": "<ul><li><b>Clinical Presentation:</b> A sudden, complete loss of postural muscle tone lasting 1-2 seconds. This can cause the head to drop, the jaw to slacken, or the entire body to fall limply to the floor.</li><li><b>Risk of Injury:</b> There is a high risk of head and facial injuries from the sudden falls. Patients may need to wear protective helmets.</li><li><b>Associated Syndromes:</b> While they can occur in various epilepsy syndromes, atonic seizures are a hallmark feature of <mark>Lennox-Gastaut syndrome</mark>, a severe form of childhood epilepsy.</li><li><b>EEG Findings:</b> The EEG may show brief, generalized spike-and-wave discharges followed by diffuse slow waves.</li><li><b>USMLE Tip:</b> A vignette describing a child with developmental delay who has multiple seizure types, including sudden falls leading to injury, is highly suggestive of Lennox-Gastaut syndrome, with atonic seizures being a key component.</li></ul>",
      "takeAway": "<p><b>Atonic seizures</b> are dramatic 'drop attacks' caused by a sudden, global loss of muscle tone, posing a significant risk of injury and often signaling a severe underlying epilepsy syndrome like Lennox-Gastaut.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "64c08e92"
      },
      {
        "type": "is_a_feature_of",
        "to": "lennox_gastaut_syndrome"
      }
    ]
  },
  "52194edb": {
    "title": "Atracurium",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Neuromuscular Blockers"
    ],
    "content": {
      "definition": "<p><b>Atracurium</b> is a non-depolarizing <i>neuromuscular blocking agent</i> used in anesthesia to induce skeletal muscle relaxation and paralysis, facilitating endotracheal intubation and surgical procedures.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction, preventing [[6a005559|acetylcholine]] from binding and causing muscle contraction.</li><li><b>Metabolism:</b> Undergoes <mark>Hoffmann elimination</mark>, a spontaneous, non-enzymatic degradation at physiological pH and temperature. This makes its metabolism independent of liver or kidney function.</li><li><b>Clinical Use:</b> Ideal for patients with <mark>renal or hepatic failure</mark> because its elimination does not depend on these organs.</li><li><b>Adverse Effects:</b> Can cause histamine release, leading to hypotension, flushing, and bronchoconstriction. Its metabolite, laudanosine, can lower the seizure threshold, but this is rarely clinically significant.</li><li><b>Reversal:</b> The neuromuscular blockade can be reversed by [[acetylcholinesterase_inhibitors|acetylcholinesterase inhibitors]] (e.g., neostigmine), which increase the concentration of acetylcholine in the synaptic cleft to outcompete the blocker.</li><li><b>USMLE Tip:</b> The key feature of atracurium (and its stereoisomer, cisatracurium) is its Hoffmann elimination, making it the neuromuscular blocker of choice for patients with organ dysfunction.</li></ul>",
      "takeAway": "<p><b>Atracurium</b> is a non-depolarizing neuromuscular blocker distinguished by its unique Hoffmann elimination pathway, a spontaneous chemical breakdown that makes it a safe and predictable choice for inducing paralysis in patients with kidney or liver disease.</p>",
      "mermaid": "graph TD; A[Atracurium] --Competitively Antagonizes--> B(Nicotinic ACh Receptors); B --x C(ACh Binding); C --x D(Muscle Contraction); A --Hoffmann Elimination--> E(Inactive Metabolites);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "nondepolarizing_neuromuscular_blocker"
      },
      {
        "type": "undergoes",
        "to": "hoffmann_elimination"
      },
      {
        "type": "is_reversed_by",
        "to": "acetylcholinesterase_inhibitors"
      }
    ]
  },
  "0c2b4642": {
    "title": "Atrophy",
    "primaryType": "pathology",
    "tags": [
      "Pathology",
      "Cell Biology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Cellular Adaptations"
    ],
    "content": {
      "definition": "<p><b>Atrophy</b> is a cellular adaptation characterized by a decrease in the size of a cell, organ, or tissue after it has reached its normal mature size. It results from a decrease in cell substance and can be either physiologic or pathologic.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> Atrophy occurs via a decrease in protein synthesis and an increase in protein degradation. The main pathway for protein degradation is the <mark>ubiquitin-proteasome pathway</mark>. It can also involve autophagy, where the cell digests its own components.</li><li><b>Causes:</b> Common causes include disuse, denervation, loss of endocrine stimulation, inadequate nutrition, and ischemia.</li><li><b>Neurologic Relevance (Denervation Atrophy):</b> When a muscle loses its nerve supply (denervation), it undergoes rapid and profound atrophy. This is a key sign of a <mark>lower motor neuron (LMN) lesion</mark>.</li><li><b>UMN vs. LMN Lesions:</b> Significant muscle atrophy is a hallmark of LMN lesions (e.g., polio, [[4ed629f9|ALS]], peripheral nerve injury). In contrast, upper motor neuron (UMN) lesions cause only mild disuse atrophy.</li><li><b>USMLE Tip:</b> In a clinical vignette, the presence of marked muscle wasting (atrophy) and fasciculations strongly points towards an LMN component of a disease process.</li></ul>",
      "takeAway": "<p><b>Atrophy</b> is a reduction in cell size and substance, most often driven by the ubiquitin-proteasome pathway. In neurology, denervation atrophy is a critical sign that localizes a lesion to the lower motor neuron, distinguishing it from upper motor neuron pathology.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "cellular_adaptation"
      },
      {
        "type": "is_a_sign_of",
        "to": "lower_motor_neuron_lesion"
      },
      {
        "type": "is_mediated_by",
        "to": "ubiquitin_proteasome_pathway"
      }
    ]
  },
  "b1873d5b": {
    "title": "Auditory Anatomy and Physiology",
    "primaryType": "concept",
    "tags": [
      "Otology",
      "Neuroscience",
      "Anatomy",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Otology",
      "Anatomy and Physiology"
    ],
    "content": {
      "definition": "<p><b>Auditory anatomy and physiology</b> describes the structures and mechanisms by which sound waves are collected, transmitted, transduced into neural signals, and processed by the brain to produce the sensation of hearing.</p>",
      "atAGlance": "<ul><li><b>Outer Ear:</b> The pinna and external auditory canal collect sound waves and funnel them to the tympanic membrane (eardrum).</li><li><b>Middle Ear:</b> An air-filled cavity containing the ossicles (malleus, incus, stapes). The ossicles amplify the vibrations from the tympanic membrane and transmit them to the oval window of the inner ear.</li><li><b>Inner Ear:</b> The [[001c359f|cochlea]], a fluid-filled, snail-shaped structure, contains the organ of Corti. Vibrations from the stapes create pressure waves in the cochlear fluid.</li><li><b>Transduction:</b> These pressure waves cause the basilar membrane to vibrate at specific locations depending on the frequency (tonotopy). High frequencies vibrate the base, low frequencies vibrate the apex. This vibration bends the stereocilia of hair cells in the organ of Corti, opening ion channels and generating a neural signal.</li><li><b>Neural Pathway:</b> The signal travels from the hair cells via the cochlear nerve (part of CN VIII) to the cochlear nuclei in the brainstem, then through a complex pathway (superior olive, lateral lemniscus, inferior colliculus, medial geniculate nucleus of the thalamus) to the [[d24b6af6|auditory cortex]] in the temporal lobe.</li></ul>",
      "takeAway": "<p>The auditory system is a remarkable transducer, converting mechanical energy (sound waves) into mechanical vibration (ossicles), then into hydraulic waves (cochlear fluid), and finally into electrical signals (hair cells) that the brain interprets as sound.</p>",
      "mermaid": "graph TD; A[Sound Waves] --> B(Outer Ear); B --> C(Tympanic Membrane); C --> D(Middle Ear Ossicles); D --> E(Oval Window); E --> F(Cochlear Fluid); F --> G(Basilar Membrane Vibration); G --> H(Hair Cell Transduction); H --> I(CN VIII); I --> J(Brain); "
    },
    "connections": [
      {
        "type": "involves_structure",
        "to": "001c359f"
      },
      {
        "type": "involves_structure",
        "to": "vestibulocochlear_nerve"
      },
      {
        "type": "culminates_in",
        "to": "d24b6af6"
      }
    ]
  },
  "d24b6af6": {
    "title": "Auditory Cortex",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Cerebral Cortex"
    ],
    "content": {
      "definition": "<p>The <b>Auditory Cortex</b> is the region of the cerebral cortex responsible for processing auditory information. It is located in the superior temporal gyrus of the temporal lobe and includes the primary auditory cortex (Brodmann areas 41 and 42) and surrounding auditory association areas.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Superior temporal gyrus in the temporal lobe.</li><li><b>Function:</b> The primary auditory cortex is responsible for the perception of basic sound characteristics like pitch and volume. The surrounding association areas, including [[wernicke_area|Wernicke's area]] in the dominant hemisphere, are involved in the interpretation and comprehension of complex sounds, particularly speech.</li><li><b>Thalamic Relay:</b> It receives its primary input from the <mark>medial geniculate nucleus (MGN)</mark> of the [[afc0a64b|thalamus]]. Mnemonic: <b>M</b>edial = <b>M</b>usic (hearing).</li><li><b>Tonotopic Organization:</b> The auditory cortex is organized tonotopically, meaning that different frequencies of sound are processed in different, specific areas of the cortex, mirroring the organization of the [[001c359f|cochlea]].</li><li><b>USMLE Tip:</b> A lesion in the primary auditory cortex does not typically cause complete deafness in one ear, as auditory information from each ear is processed bilaterally in the brain. However, a lesion in [[wernicke_area|Wernicke's area]] (an auditory association cortex) will cause receptive aphasia.</li></ul>",
      "takeAway": "<p>The <b>Auditory Cortex</b> is the final destination for sound processing in the brain, receiving signals from the medial geniculate nucleus and interpreting them, with specialized areas like Wernicke's area in the dominant hemisphere being crucial for language comprehension.</p>",
      "mermaid": "graph TD; A[Cochlea] --> B(CN VIII); B --> C(Brainstem Nuclei); C --> D(Medial Geniculate Nucleus); D --> E(Auditory Cortex);"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "temporal_lobe"
      },
      {
        "type": "receives_input_from",
        "to": "medial_geniculate_nucleus"
      },
      {
        "type": "includes",
        "to": "wernicke_area"
      }
    ]
  },
  "4f0ade90": {
    "title": "Autonomic Nervous System",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Autonomic Nervous System"
    ],
    "content": {
      "definition": "<p>The <b>Autonomic Nervous System (ANS)</b> is the division of the peripheral nervous system that controls involuntary bodily functions, such as heart rate, digestion, respiratory rate, and pupillary response. It is subdivided into the sympathetic, parasympathetic, and enteric systems.</p>",
      "atAGlance": "<ul><li><b>Sympathetic Division:</b> Mediates the \"fight or flight\" response. Preganglionic neurons are short and release [[6a005559|acetylcholine]] onto nicotinic receptors in the paravertebral ganglia. Postganglionic neurons are long and primarily release norepinephrine onto adrenergic receptors.</li><li><b>Parasympathetic Division:</b> Mediates the \"rest and digest\" response. Preganglionic neurons are long and release [[6a005559|acetylcholine]] onto nicotinic receptors in ganglia near or within target organs. Postganglionic neurons are short and release [[6a005559|acetylcholine]] onto muscarinic receptors.</li><li><b>CNS Control:</b> The ANS is regulated by higher centers in the CNS, including the [[89e86633|hypothalamus]] and the [[73ace357|limbic system]], which modulate autonomic outflow in response to emotional and environmental stimuli.</li><li><b>Clinical Relevance:</b> Autonomic dysregulation is a feature of many neurological disorders, including [[ed52e40b|Guillain-Barré syndrome]] (acute inflammatory demyelinating polyneuropathy), which can cause life-threatening cardiac irregularities and blood pressure instability.</li><li><b>USMLE Tip:</b> Understand the neurotransmitter/receptor pairings: All preganglionic neurons use ACh (nicotinic). Parasympathetic postganglionic neurons use ACh (muscarinic). Most sympathetic postganglionic neurons use norepinephrine (adrenergic), with the key exception being sweat glands (ACh, muscarinic).</li></ul>",
      "takeAway": "<p>The <b>Autonomic Nervous System</b> maintains homeostasis through a balance of its sympathetic ('gas pedal') and parasympathetic ('brake pedal') divisions, utilizing a two-neuron chain with distinct neurotransmitters and receptor targets to exert involuntary control over virtually every organ system.</p>",
      "mermaid": "graph TD; A[CNS] --> B(Preganglionic Neuron); B --ACh--> C(Autonomic Ganglion); C --NE/ACh--> D(Target Organ);"
    },
    "connections": [
      {
        "type": "is_regulated_by",
        "to": "89e86633"
      },
      {
        "type": "is_regulated_by",
        "to": "73ace357"
      },
      {
        "type": "is_dysregulated_in",
        "to": "ed52e40b"
      }
    ]
  },
  "174cf2c0": {
    "title": "Axonal Injury",
    "primaryType": "pathology",
    "tags": [
      "Neurology",
      "Pathology",
      "Trauma",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Trauma"
    ],
    "content": {
      "definition": "<p><b>Axonal injury</b> refers to damage to the axons of neurons, which can occur from trauma, ischemia, or neurodegenerative processes. The neuronal response to injury and the potential for regeneration depend on whether the injury is in the central or peripheral nervous system.</p>",
      "atAGlance": "<ul><li><b>Wallerian Degeneration:</b> The process of degeneration of the axon <u>distal</u> to the site of injury. The axon disintegrates and its myelin sheath breaks down, cleared by Schwann cells (PNS) or microglia (CNS).</li><li><b>Axonal Reaction (Central Chromatolysis):</b> Changes occurring in the neuronal cell body <u>proximal</u> to the injury. The cell body swells, the nucleus is displaced to the periphery, and Nissl bodies disperse. This reflects an increase in protein synthesis for repair.</li><li><b>Diffuse Axonal Injury (DAI):</b> A severe form of traumatic brain injury caused by shearing forces from rapid acceleration/deceleration. It involves widespread damage to axons in the white matter tracts. MRI shows multiple punctate hemorrhages. Often results in coma or persistent vegetative state.</li><li><b>Regeneration:</b> Axonal regeneration is limited in the CNS due to inhibitory factors from oligodendrocytes and glial scar formation by astrocytes. Regeneration is more successful in the PNS, guided by the remaining Schwann cells and endoneurial tube.</li><li><b>USMLE Tip:</b> Remember the key difference in response to injury: Wallerian degeneration occurs distal to the cut, while axonal reaction (chromatolysis) occurs in the proximal cell body.</li></ul>",
      "takeAway": "<p><b>Axonal injury</b> triggers a cascade of degenerative and regenerative processes, with the outcome largely determined by the location; peripheral nerves have a significant capacity for regeneration guided by Schwann cells, whereas central nervous system axons are largely unable to regenerate due to an inhibitory environment.</p>",
      "mermaid": "graph TD; A[Axon Injury] --> B(Proximal Segment); B --> C(Axonal Reaction/Chromatolysis); A --> D(Distal Segment); D --> E(Wallerian Degeneration);"
    },
    "connections": [
      {
        "type": "includes",
        "to": "22b22e08"
      },
      {
        "type": "involves_process",
        "to": "wallerian_degeneration"
      },
      {
        "type": "involves_process",
        "to": "central_chromatolysis"
      }
    ]
  },
  "8947da55": {
    "title": "Babinski Reflex (Plantar Reflex)",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Physical Exam",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Spinal Cord"
    ],
    "content": {
      "definition": "<p>The <b>Babinski reflex</b> (or sign) is the dorsiflexion of the great toe and fanning of the other toes in response to stroking the plantar surface of the foot. While a normal primitive reflex in infants, its presence in an adult is a pathognomonic sign of an <u>upper motor neuron (UMN) lesion</u>.</p>",
      "atAGlance": "<ul><li><b>Technique:</b> The sole of the foot is stroked with a blunt object from the heel along the lateral aspect to the ball of the foot.</li><li><b>Normal Response (Adult):</b> Plantar flexion (downward curling) of the toes.</li><li><b>Abnormal Response (Babinski Sign):</b> Extension (dorsiflexion) of the great toe and fanning of the other toes.</li><li><b>Pathophysiology:</b> The sign indicates damage to the corticospinal tract, which normally suppresses this primitive reflex after infancy.</li><li><b>Clinical Significance:</b> A positive Babinski sign is a key physical exam finding that helps differentiate UMN lesions from LMN lesions. It is a sign of <mark>upper motor neuron damage</mark>.</li><li><b>USMLE Tip:</b> In an adult, a positive Babinski sign is <u>always</u> abnormal. It points to a lesion anywhere along the corticospinal tract, from the motor cortex down to the spinal cord.</li></ul>",
      "takeAway": "<p>The <b>Babinski sign</b> is a clinical indicator of corticospinal tract dysfunction, representing the re-emergence of a primitive reflex that is normally suppressed by mature upper motor neurons; its presence in an adult is a definitive sign of a UMN lesion.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_sign_of",
        "to": "upper_motor_neuron_lesion"
      },
      {
        "type": "is_a_type_of",
        "to": "primitive_reflex"
      },
      {
        "type": "is_absent_in",
        "to": "lower_motor_neuron_lesion"
      }
    ]
  },
  "1ddc3f08": {
    "title": "Baclofen",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Skeletal Muscle Relaxants"
    ],
    "content": {
      "definition": "<p><b>Baclofen</b> is a centrally acting skeletal muscle relaxant (antispasmodic) that functions as a GABA<sub>B</sub> receptor agonist, primarily used to treat muscle spasticity.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Acts as an agonist at <mark>GABA<sub>B</sub> receptors</gmark> in the spinal cord. This activation leads to hyperpolarization of motor neurons by increasing K<sup>+</sup> conductance, which reduces the release of excitatory neurotransmitters.</li><li><b>Clinical Use:</b> Treatment of spasticity associated with [[45dd6d19|multiple sclerosis]], spinal cord injuries, and [[171ca00b|cerebral palsy]]. It is not typically used for acute muscle spasms from injury.</li><li><b>Administration:</b> Can be administered orally or intrathecally (directly into the CSF) via a pump for severe spasticity.</li><li><b>Adverse Effects:</b> Sedation, drowsiness, dizziness, and muscle weakness. Abrupt withdrawal of intrathecal baclofen can be life-threatening, causing high fever, rebound spasticity, and seizures.</li><li><b>USMLE Tip:</b> Remember that baclofen acts on the '<b>bac</b>k' (spinal cord) at GABA<b><sub>B</sub></b> receptors. Differentiate its use for chronic spasticity from drugs like cyclobenzaprine used for acute muscle spasms.</li></ul>",
      "takeAway": "<p><b>Baclofen</b> effectively reduces chronic muscle spasticity by mimicking GABA's inhibitory effects at GABA<sub>B</sub> receptors specifically within the spinal cord, thereby dampening the hyperactive reflexes that cause stiffness and spasms.</p>",
      "mermaid": "graph TD; A[Baclofen] --> B(Activates GABA-B Receptors in Spinal Cord); B --> C(↑ K+ Conductance); C --> D(Hyperpolarization of Motor Neurons); D --> E(↓ Spasticity);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "af72aab5"
      },
      {
        "type": "treats",
        "to": "45dd6d19"
      },
      {
        "type": "treats",
        "to": "171ca00b"
      },
      {
        "type": "acts_as_agonist_at",
        "to": "gaba_b_receptor"
      }
    ]
  },
  "52564aea": {
    "title": "Barbiturates",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Sedative-Hypnotics"
    ],
    "content": {
      "definition": "<p><b>Barbiturates</b> (e.g., phenobarbital, pentobarbital, thiopental) are a class of sedative-hypnotic drugs that act as central nervous system depressants by enhancing the effects of the neurotransmitter GABA.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Bind to the GABA<sub>A</sub> receptor at a different site than GABA or benzodiazepines. They increase the <mark><u>duration</u></mark> of chloride channel opening. Mnemonic: Barbi<b>durates</b> increase the <b>duration</b>.</li><li><b>Clinical Use:</b> Formerly used for anxiety and insomnia but now largely replaced by benzodiazepines due to a worse safety profile. Current uses include: <br> - <b>Anticonvulsant:</b> [[phenobarbital]] for seizures.<br> - <b>Anesthesia:</b> Thiopental for induction of anesthesia.</li><li><b>Adverse Effects:</b> Significant CNS and respiratory depression, which can be fatal in overdose and is potentiated by alcohol. High potential for dependence and abuse. Induces cytochrome P450 enzymes, leading to numerous drug interactions.</li><li><b>Contraindication:</b> <u>Absolutely contraindicated</u> in patients with porphyria, as they induce δ-ALA synthase.</li><li><b>USMLE Tip:</b> The key difference from benzodiazepines is the mechanism (duration vs. frequency) and the lack of a ceiling effect on CNS depression, making overdose much more dangerous. There is no specific antidote for barbiturate overdose; treatment is supportive.</li></ul>",
      "takeAway": "<p><b>Barbiturates</b> are potent CNS depressants that enhance GABAergic inhibition by prolonging the opening of chloride channels, but their narrow therapeutic index and high risk of fatal respiratory depression have relegated them to niche uses like seizure control and anesthesia induction.</p>",
      "mermaid": "graph TD; A[Barbiturate] --> B(Binds to GABA-A Receptor); B --> C(↑ Duration of Cl- Channel Opening); C --> D(↑ Cl- Influx); D --> E(Hyperpolarization of Neuron); E --> F(CNS Depression);"
    },
    "connections": [
      {
        "type": "acts_on",
        "to": "gaba_a_receptor"
      },
      {
        "type": "is_contraindicated_in",
        "to": "porphyria"
      },
      {
        "type": "induces",
        "to": "cytochrome_p450"
      },
      {
        "type": "differentiated_from",
        "to": "14464617"
      }
    ]
  },
  "ed462927": {
    "title": "Basal Ganglia",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Physiology",
      "Movement Disorders",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Basal Ganglia"
    ],
    "content": {
      "definition": "<p>The <b>Basal Ganglia</b> are a group of subcortical nuclei in the forebrain that are crucial for motor control, particularly in selecting and initiating voluntary movements, while suppressing unwanted movements. They also play a role in procedural learning, habit formation, and emotion.</p>",
      "atAGlance": "<ul><li><b>Components:</b> The main components are the <b>Striatum</b> (caudate nucleus + putamen), <b>Globus Pallidus</b> (internal and external segments), <b>Subthalamic Nucleus</b>, and <b>Substantia Nigra</b> (pars compacta and pars reticulata).</li><li><b>Function:</b> The basal ganglia modulate motor output from the cortex via feedback loops. They do not directly connect to the spinal cord.</li><li><b>Direct Pathway:</b> Facilitates movement. Cortical activation stimulates the striatum, which inhibits the globus pallidus internus (GPi), thereby disinhibiting the [[afc0a64b|thalamus]] and allowing it to excite the motor cortex.</li><li><b>Indirect Pathway:</b> Inhibits movement. This more complex loop ultimately results in stimulation of the GPi, which increases inhibition of the [[afc0a64b|thalamus]], thus suppressing cortical activity.</li><li><b>Pathology:</b> Lesions in the basal ganglia lead to movement disorders. <br> - [[58c8ea03|Parkinson disease]]: Loss of dopaminergic neurons in the substantia nigra pars compacta leads to bradykinesia and tremor (hypokinetic).<br> - [[ffd7e743|Huntington disease]]: Degeneration of the striatum leads to chorea (hyperkinetic).<br> - Hemiballismus: Lesion of the subthalamic nucleus leads to wild, flinging movements.</li></ul>",
      "takeAway": "<p>The <b>Basal Ganglia</b> function as a sophisticated 'gatekeeper' for motor commands, using a balance between a 'go' (direct) pathway and a 'no-go' (indirect) pathway to fine-tune voluntary movement; disruption of this balance is the fundamental cause of movement disorders like Parkinson's and Huntington's disease.</p>",
      "mermaid": "graph LR; A[Cortex] --> B(Striatum); B --|Direct Pathway (Go)|--> C(↓ GPi/SNr Inhibition); C --> D(↑ Thalamic Excitation); D --> A; B --|Indirect Pathway (No-Go)|--> E(↑ GPi/SNr Inhibition); E --> F(↓ Thalamic Excitation); F --> A;"
    },
    "connections": [
      {
        "type": "is_implicated_in",
        "to": "58c8ea03"
      },
      {
        "type": "is_implicated_in",
        "to": "ffd7e743"
      },
      {
        "type": "is_implicated_in",
        "to": "hemiballismus"
      },
      {
        "type": "sends_output_to",
        "to": "afc0a64b"
      }
    ]
  },
  "361438f2": {
    "title": "Basal Nucleus of Meynert",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Brain Nuclei"
    ],
    "content": {
      "definition": "<p>The <b>Basal Nucleus of Meynert</b> is a group of neurons located in the substantia innominata of the basal forebrain. It is the primary source of cholinergic ([[6a005559|acetylcholine]]) innervation to the entire cerebral cortex, playing a vital role in cognitive functions like memory and attention.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Basal forebrain, part of the substantia innominata.</li><li><b>Neurotransmitter:</b> Synthesizes and releases [[6a005559|acetylcholine (ACh)]].</li><li><b>Projections:</b> Provides widespread cholinergic projections to the neocortex and hippocampus.</li><li><b>Function:</b> Modulates cortical excitability, arousal, attention, and is critical for learning and memory formation.</li><li><b>Clinical Relevance:</b> There is significant degeneration and loss of cholinergic neurons in the Basal Nucleus of Meynert in <mark>[[77ae6148|Alzheimer disease]]</mark>. This loss of cortical ACh is a major contributor to the cognitive and memory deficits seen in the disease.</li><li><b>USMLE Tip:</b> The degeneration of the Basal Nucleus of Meynert and the resulting cholinergic deficit is a key pathophysiological feature of [[77ae6148|Alzheimer disease]] and is the rationale for using [[acetylcholinesterase_inhibitors|acetylcholinesterase inhibitors]] (e.g., [[47d0372e|donepezil]]) as a symptomatic treatment.</li></ul>",
      "takeAway": "<p>The <b>Basal Nucleus of Meynert</b> is the brain's main cholinergic hub for the cortex; its profound degeneration in [[77ae6148|Alzheimer disease]] leads to a cortical acetylcholine deficit that underlies the hallmark cognitive decline of the disease.</p>",
      "mermaid": "graph TD; A[Basal Nucleus of Meynert] --ACh Projections--> B(Cerebral Cortex & Hippocampus); B --> C(Arousal, Memory, Attention); A --x Degeneration in Alzheimer's; "
    },
    "connections": [
      {
        "type": "produces",
        "to": "6a005559"
      },
      {
        "type": "degenerates_in",
        "to": "77ae6148"
      },
      {
        "type": "is_part_of",
        "to": "basal_forebrain"
      }
    ]
  },
  "253e3efb": {
    "title": "Basal Plate",
    "primaryType": "anatomy",
    "tags": [
      "Embryology",
      "Neuroscience",
      "Anatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Embryology",
      "Neural Development"
    ],
    "content": {
      "definition": "<p>The <b>Basal Plate</b> is the ventral part of the neural tube in the developing embryo, which differentiates into <i>motor neurons</i> of the spinal cord and brainstem under the influence of the signaling molecule Sonic Hedgehog (SHH).</p>",
      "atAGlance": "<ul><li><b>Location:</b> Ventral (anterior) region of the developing spinal cord and brainstem.</li><li><b>Function:</b> Gives rise to <u>motor</u> components of the central nervous system, including the anterior horn of the spinal cord and the motor nuclei of the cranial nerves.</li><li><b>Inducing Signal:</b> Development is induced by <mark>Sonic Hedgehog (SHH)</mark>, a signaling molecule secreted by the underlying notochord.</li><li><b>Counterpart:</b> The dorsal counterpart is the [[43be7a6e|Alar Plate]], which develops into sensory neurons under the influence of Bone Morphogenetic Proteins (BMPs).</li><li><b>USMLE Tip:</b> Remember the simple orientation: <b>Basal = Motor = Ventral</b>, and <b>Alar = Sensory = Dorsal</b>. This fundamental organization persists into the adult CNS.</li></ul>",
      "takeAway": "<p>The <b>Basal Plate</b> is the embryonic blueprint for the motor output of the CNS, established by Sonic Hedgehog signaling from the notochord, which sets up the ventral-motor organization of the neural tube that is conserved throughout the nervous system.</p>",
      "mermaid": "graph TD; A[Neural Tube] --> B(Alar Plate - Dorsal); A --> C(Basal Plate - Ventral); D[Ectoderm] --BMPs--> B; B --> E[Sensory Neurons]; F[Notochord] --SHH--> C; C --> G[Motor Neurons];"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "neural_tube"
      },
      {
        "type": "develops_into",
        "to": "motor_neurons"
      },
      {
        "type": "is_counterpart_to",
        "to": "43be7a6e"
      },
      {
        "type": "is_induced_by",
        "to": "sonic_hedgehog"
      }
    ]
  },
  "c335e16d": {
    "title": "Basement Membrane (CNS)",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Histology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Blood-Brain Barrier"
    ],
    "content": {
      "definition": "<p>In the central nervous system, the <b>basement membrane</b> is a thin, specialized layer of the extracellular matrix that surrounds cerebral capillaries and, along with astrocyte foot processes and endothelial tight junctions, forms a critical component of the [[dd47b9cc|blood-brain barrier]].</p>",
      "atAGlance": "<ul><li><b>Composition:</b> Primarily composed of Type IV collagen, laminin, and proteoglycans.</li><li><b>Function:</b> Provides structural support to the capillary endothelium and acts as a selective filter, regulating the passage of molecules from the blood into the brain parenchyma.</li><li><b>Role in Blood-Brain Barrier:</b> The basement membrane, together with endothelial [[tight_junctions|tight junctions]] and astrocyte end-feet, creates the highly restrictive [[dd47b9cc|blood-brain barrier]].</li><li><b>Pathology:</b> Thickening of the basement membrane is a feature of chronic hyperglycemia in diabetes, contributing to microvascular complications like [[73b00ab0|diabetic retinopathy]]. In [[goodpasture_syndrome|Goodpasture syndrome]], autoantibodies target Type IV collagen in the basement membranes of the kidneys and lungs.</li><li><b>USMLE Tip:</b> The three key components of the blood-brain barrier are: 1) Tight junctions between non-fenestrated endothelial cells, 2) The basement membrane, and 3) Astrocyte foot processes.</li></ul>",
      "takeAway": "<p>The <b>basement membrane</b> of CNS capillaries is a crucial structural and functional element of the [[dd47b9cc|blood-brain barrier]], acting as both scaffolding and a selective filter to maintain the tightly controlled environment of the brain.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_component_of",
        "to": "dd47b9cc"
      },
      {
        "type": "is_composed_of",
        "to": "type_iv_collagen"
      },
      {
        "type": "is_thickened_in",
        "to": "diabetes_mellitus"
      }
    ]
  },
  "e7a90cd9": {
    "title": "Basilar Artery",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Cerebrovascular",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Cerebral Vasculature"
    ],
    "content": {
      "definition": "<p>The <b>Basilar Artery</b> is a critical artery at the base of the brain, formed by the union of the two vertebral arteries. It ascends along the anterior surface of the pons and is a key component of the posterior circulation, supplying the brainstem, cerebellum, and occipital lobes.</p>",
      "atAGlance": "<ul><li><b>Formation:</b> Formed by the confluence of the left and right vertebral arteries at the pontomedullary junction.</li><li><b>Branches:</b> Gives rise to the [[3c075343|anterior inferior cerebellar artery (AICA)]], superior cerebellar artery (SCA), and numerous small pontine arteries. It terminates by bifurcating into the two [[b6a2cc31|posterior cerebral arteries (PCAs)]].</li><li><b>Territory Supplied:</b> Brainstem (pons, midbrain), cerebellum, and via its terminal branches (PCAs), the occipital and inferior temporal lobes.</li><li><b>Stroke Syndromes:</b><br> - <b>Basilar Artery Occlusion:</b> Can be catastrophic, leading to <mark>\"locked-in syndrome\"</mark> if the ventral pons is infarcted bilaterally. This causes quadriplegia and mutism, with preserved consciousness and vertical eye movements.<br> - <b>Top of the Basilar Syndrome:</b> Embolic occlusion of the distal basilar artery affects the midbrain, thalamus, and temporal/occipital lobes, causing visual and behavioral disturbances with minimal motor deficits.</li><li><b>USMLE Tip:</b> A stroke causing quadriplegia but sparing consciousness and vertical eye movements is pathognomonic for basilar artery occlusion leading to locked-in syndrome.</li></ul>",
      "takeAway": "<p>The <b>Basilar Artery</b> is the central trunk of the posterior circulation; its occlusion can lead to devastating brainstem strokes, most notably the 'locked-in syndrome,' which severs the brain's motor output while leaving consciousness intact.</p>",
      "mermaid": "graph TD; A[Vertebral Arteries] --> B(Basilar Artery); B --> C(Pontine Arteries); B --> D(AICA); B --> E(SCA); B --> F(PCAs);"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "posterior_circulation"
      },
      {
        "type": "is_formed_by",
        "to": "vertebral_arteries"
      },
      {
        "type": "occlusion_causes",
        "to": "locked_in_syndrome"
      },
      {
        "type": "bifurcates_into",
        "to": "b6a2cc31"
      }
    ]
  },
  "91fcdbc5": {
    "title": "REM Sleep Behavior Disorder",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Sleep Medicine",
      "Psychiatry",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Sleep Disorders"
    ],
    "content": {
      "definition": "<p><b>REM Sleep Behavior Disorder (RBD)</b> is a parasomnia characterized by the loss of normal muscle atonia during REM sleep, leading to the physical enactment of vivid, often violent or action-filled dreams.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Failure of the brainstem mechanisms (particularly in the pons) that normally induce muscle paralysis during REM sleep.</li><li><b>Clinical Presentation:</b> Patients may shout, punch, kick, or jump out of bed during sleep, corresponding to the content of their dreams. This can result in injury to the patient or their bed partner.</li><li><b>Classic Association:</b> RBD is a very strong predictor of future neurodegenerative disease, particularly <mark>α-synucleinopathies</mark>.</li><li><b>Associated Diseases:</b> A majority of patients with idiopathic RBD will eventually develop [[58c8ea03|Parkinson disease]], [[db2f16e5|Lewy body dementia]], or multiple system atrophy, often years or decades after the onset of RBD.</li><li><b>USMLE Tip:</b> An older male patient who reports acting out violent dreams and has injured his spouse during sleep should raise immediate suspicion for REM Sleep Behavior Disorder, which should be considered a prodromal sign of Parkinson disease or Lewy body dementia.</li></ul>",
      "takeAway": "<p><b>REM Sleep Behavior Disorder</b> is more than just a sleep disturbance; it is a critical early warning sign of an underlying α-synucleinopathy, where the failure to paralyze muscles during dreaming precedes the onset of motor and cognitive symptoms of diseases like Parkinson's by many years.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "parasomnia"
      },
      {
        "type": "is_a_prodromal_sign_of",
        "to": "58c8ea03"
      },
      {
        "type": "is_a_prodromal_sign_of",
        "to": "db2f16e5"
      },
      {
        "type": "is_associated_with",
        "to": "alpha_synucleinopathies"
      }
    ]
  },
  "b0a6f66e": {
    "title": "Behavior Modulation",
    "primaryType": "physiology",
    "tags": [
      "Neuroscience",
      "Psychiatry",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Limbic System"
    ],
    "content": {
      "definition": "<p><b>Behavior modulation</b> refers to the complex neural processes by which the brain regulates and controls behavior, integrating emotional, cognitive, and homeostatic inputs to produce appropriate responses. This function is primarily orchestrated by the [[73ace357|limbic system]] and its connections with the prefrontal cortex and [[89e86633|hypothalamus]].</p>",
      "atAGlance": "<ul><li><b>Limbic System's Role:</b> The [[73ace357|limbic system]] (including the [[d220fc3f|amygdala]], [[a0590674|hippocampus]], and cingulate gyrus) is central to emotion, memory, and motivation, which are the core drivers of behavior.</li><li><b>Amygdala:</b> Processes fear, aggression, and reward. Lesions can lead to placidity or disinhibited behavior (e.g., [[kluver_bucy_syndrome|Klüver-Bucy syndrome]]).</li><li><b>Hypothalamus:</b> Integrates autonomic and endocrine responses with behavior, governing fundamental drives like hunger, thirst, and sexual behavior (the 'Four Fs': Feeding, Fleeing, Fighting, and sexual Functioning).</li><li><b>Prefrontal Cortex:</b> Provides top-down executive control, inhibiting impulsive behaviors and guiding actions based on goals and social context. Lesions can cause disinhibition and impaired judgment.</li><li><b>USMLE Tip:</b> The mnemonic for limbic system functions, the '5 F's' (Feeding, Fleeing, Fighting, Feeling, and Sex), highlights its role in modulating fundamental behaviors.</li></ul>",
      "takeAway": "<p><b>Behavior modulation</b> is a dynamic interplay between the primitive drives of the [[73ace357|limbic system]] and [[89e86633|hypothalamus]] and the executive oversight of the prefrontal cortex, with the final behavioral output reflecting the balance of these competing influences.</p>",
      "mermaid": "graph TD; A[Limbic System - Emotion/Drives] --> C{Behavioral Output}; B[Prefrontal Cortex - Executive Control] --> C;"
    },
    "connections": [
      {
        "type": "is_a_function_of",
        "to": "73ace357"
      },
      {
        "type": "is_a_function_of",
        "to": "89e86633"
      },
      {
        "type": "is_a_function_of",
        "to": "prefrontal_cortex"
      }
    ]
  },
  "c7ce09b2": {
    "title": "Benzocaine",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "Toxicology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Anesthetics"
    ],
    "content": {
      "definition": "<p><b>Benzocaine</b> is an ester-type <i>local anesthetic</i> used topically to numb surfaces such as the skin, mouth, and throat. It works by blocking voltage-gated sodium channels in nerve membranes, thereby preventing the propagation of action potentials.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Blocks voltage-gated Na<sup>+</sup> channels, preventing nerve depolarization.</li><li><b>Class:</b> Ester local anesthetic. Patients with allergies to esters (e.g., procaine) may also react to benzocaine.</li><li><b>Clinical Use:</b> Commonly found in over-the-counter products for teething pain, sore throats (sprays), and sunburn relief. Used in medical settings as a topical anesthetic for procedures like endoscopy.</li><li><b>Adverse Effect:</b> A well-known cause of acquired <mark>methemoglobinemia</mark>, especially in infants and young children.</li><li><b>Methemoglobinemia:</b> Benzocaine oxidizes the iron in hemoglobin from the ferrous (Fe<sup>2+</sup>) to the ferric (Fe<sup>3+</sup>) state. Methemoglobin cannot bind oxygen, leading to functional anemia and cyanosis that does not improve with supplemental oxygen. Blood appears 'chocolate brown'. Treated with methylene blue.</li><li><b>USMLE Tip:</b> A vignette describing a patient who develops cyanosis and shortness of breath shortly after an endoscopic procedure (where a topical anesthetic spray was used) should immediately raise suspicion for benzocaine-induced methemoglobinemia.</li></ul>",
      "takeAway": "<p><b>Benzocaine</b> is a widely used topical anesthetic that carries the rare but life-threatening risk of inducing methemoglobinemia, a condition where hemoglobin's iron is oxidized, rendering it unable to transport oxygen and causing a characteristic 'chocolate brown' blood appearance and cyanosis.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "local_anesthetics"
      },
      {
        "type": "causes_adverse_effect",
        "to": "methemoglobinemia"
      },
      {
        "type": "blocks_channel",
        "to": "voltage_gated_sodium_channel"
      }
    ]
  },
  "14464617": {
    "title": "Benzodiazepines",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Psychiatry",
      "Neurology",
      "Anesthesiology",
      "USMLE"
    ],
    "classificationPath": [
      "Psychiatry",
      "Pharmacology",
      "Anxiolytics"
    ],
    "content": {
      "definition": "<p><b>Benzodiazepines</b> are a class of psychoactive drugs that act as positive allosteric modulators of the GABA<sub>A</sub> receptor, resulting in sedative, hypnotic, anxiolytic, anticonvulsant, and muscle relaxant properties.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Bind to an allosteric site on the GABA<sub>A</sub> receptor, increasing the <mark><u>frequency</u></mark> of chloride channel opening in response to GABA. Mnemonic: <b>Fre</b>nzodiazepines increase <b>fre</b>quency.</li><li><b>Clinical Uses:</b> Anxiety disorders, panic attacks, status epilepticus (lorazepam, diazepam), alcohol withdrawal, insomnia, and procedural sedation/anesthesia (midazolam).</li><li><b>Pharmacokinetics:</b> Classified by duration of action. Short-acting (e.g., [[083094db|alprazolam]], midazolam) have higher abuse potential. Long-acting (e.g., diazepam, chlordiazepoxide) are preferred for alcohol withdrawal. Those not metabolized by the liver (<b>O</b>xazepam, <b>T</b>emazepam, <b>L</b>orazepam - 'Outside The Liver') are safer in patients with hepatic dysfunction.</li><li><b>Adverse Effects:</b> Sedation, dependence, tolerance, withdrawal symptoms. Additive CNS depression with other depressants like alcohol and barbiturates.</li><li><b>Antidote:</b> Overdose can be treated with <mark>flumazenil</mark>, a competitive antagonist at the benzodiazepine binding site on the GABA<sub>A</sub> receptor.</li><li><b>USMLE Tip:</b> Differentiate from [[52564aea|barbiturates]], which increase the <u>duration</u> of channel opening and have a higher risk of fatal respiratory depression.</li></ul>",
      "takeAway": "<p><b>Benzodiazepines</b> are versatile CNS depressants that enhance GABA's inhibitory effects by increasing the frequency of chloride channel opening, but their use is tempered by the significant risks of dependence and additive depression with other substances.</p>",
      "mermaid": "graph TD; A[Benzodiazepine] --> B(Binds to GABA-A Receptor); B --> C(↑ Frequency of Cl- Channel Opening); C --> D(↑ Cl- Influx); D --> E(Hyperpolarization of Neuron); E --> F(CNS Depression/Anxiolysis);"
    },
    "connections": [
      {
        "type": "acts_on",
        "to": "gaba_a_receptor"
      },
      {
        "type": "treats",
        "to": "d1c786e9"
      },
      {
        "type": "treats",
        "to": "status_epilepticus"
      },
      {
        "type": "overdose_treated_by",
        "to": "flumazenil"
      },
      {
        "type": "differentiated_from",
        "to": "52564aea"
      }
    ]
  },
  "383f6fbe": {
    "title": "Benztropine",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Psychiatry",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Parkinson Disease Therapy"
    ],
    "content": {
      "definition": "<p><b>Benztropine</b> is a centrally acting <i>antimuscarinic (anticholinergic) drug</i> used primarily to treat the symptoms of [[58c8ea03|Parkinson disease]] and to manage extrapyramidal side effects (EPS) caused by antipsychotic medications.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Acts as a competitive antagonist at central muscarinic receptors, helping to restore the dopaminergic-cholinergic balance in the [[ed462927|basal ganglia]] that is disrupted in Parkinson's disease.</li><li><b>Clinical Use (Parkinson's):</b> Primarily effective for treating <mark>tremor and rigidity</mark>. It has little effect on bradykinesia. Mnemonic: '<b>Tri</b> to <b>Park</b> my Mercedes-<b>Benz</b>' (<b>Tri</b>hexyphenidyl and <b>Benz</b>tropine for <b>Park</b>inson's).</li><li><b>Clinical Use (EPS):</b> Effective for treating <mark>acute dystonia</mark> and drug-induced parkinsonism caused by dopamine antagonists (antipsychotics).</li><li><b>Adverse Effects:</b> Classic anticholinergic side effects: dry mouth, blurred vision, constipation, urinary retention, tachycardia, and confusion/delirium, especially in the elderly.</li><li><b>USMLE Tip:</b> Benztropine is the go-to drug for treating a patient who develops an acute dystonic reaction (e.g., torticollis, oculogyric crisis) after starting an antipsychotic like haloperidol.</li></ul>",
      "takeAway": "<p><b>Benztropine</b> combats the motor symptoms of Parkinson's and antipsychotic side effects by blocking central acetylcholine activity, thereby counteracting the relative cholinergic overactivity that results from dopamine deficiency or blockade in the basal ganglia.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "96e8bf39"
      },
      {
        "type": "treats",
        "to": "58c8ea03"
      },
      {
        "type": "treats",
        "to": "extrapyramidal_symptoms"
      },
      {
        "type": "treats",
        "to": "acute_dystonia"
      }
    ]
  },
  "a9f6d703": {
    "title": "Berry Aneurysm",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Neurosurgery",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Cerebrovascular Disease"
    ],
    "content": {
      "definition": "<p>A <b>Berry Aneurysm</b>, also known as a saccular aneurysm, is a thin-walled, sac-like outpouching of a cerebral artery, typically located at arterial branch points within the [[e22300e8|Circle of Willis]]. Its rupture is the most common cause of non-traumatic [[63f8b05f|subarachnoid hemorrhage]].</p>",
      "atAGlance": "<ul><li><b>Location:</b> Most commonly found at the junction of the [[bd802d22|anterior communicating artery (AComA)]] with the anterior cerebral artery. The second most common site is the junction of the posterior communicating artery (PComA) with the internal carotid artery.</li><li><b>Pathophysiology:</b> Believed to form due to a congenital weakness in the vessel wall (lack of tunica media) at arterial bifurcations, which is exacerbated over time by hemodynamic stress from hypertension.</li><li><b>Associated Conditions:</b> Increased incidence in patients with <mark>Autosomal Dominant Polycystic Kidney Disease (ADPKD)</mark>, Ehlers-Danlos syndrome, and Marfan syndrome.</li><li><b>Clinical Presentation:</b> Usually asymptomatic until rupture. Rupture causes a [[63f8b05f|subarachnoid hemorrhage]], presenting with a sudden, explosive <mark>\"worst headache of my life.\"</mark></li><li><b>USMLE Tip:</b> A PComA aneurysm can compress the ipsilateral [[68c66997|oculomotor nerve (CN III)]], causing a painful third nerve palsy with a dilated, nonreactive pupil ('blown pupil'). This is a neurosurgical emergency.</li></ul>",
      "takeAway": "<p><b>Berry aneurysms</b> are silent vascular time bombs located at the branch points of the Circle of Willis; their rupture leads to a devastating subarachnoid hemorrhage, classically presenting as a 'thunderclap headache'.</p>",
      "mermaid": "graph TD; A[Arterial Bifurcation in Circle of Willis] --> B(Congenital Wall Weakness); B --Hypertension--> C(Berry Aneurysm Formation); C --> D{Rupture}; D --> E[Subarachnoid Hemorrhage];"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "a7f97d7f"
      },
      {
        "type": "rupture_causes",
        "to": "63f8b05f"
      },
      {
        "type": "is_associated_with",
        "to": "autosomal_dominant_polycystic_kidney_disease"
      },
      {
        "type": "most_common_location_is",
        "to": "bd802d22"
      }
    ]
  },
  "43508d57": {
    "title": "Betaxolol",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "Cardiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Glaucoma Therapy"
    ],
    "content": {
      "definition": "<p><b>Betaxolol</b> is a <i>β<sub>1</sub>-selective adrenergic antagonist</i> (beta-blocker) used primarily in ophthalmology as eye drops to treat [[3ce6c035|glaucoma]] and ocular hypertension. It is also available in oral form for the treatment of systemic hypertension.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action (Glaucoma):</b> When applied topically to the eye, it blocks β-adrenergic receptors on the ciliary epithelium, leading to a <mark>decrease in aqueous humor production</mark> and thus lowering intraocular pressure.</li><li><b>Selectivity:</b> As a β<sub>1</sub>-selective blocker, it has less of an effect on β<sub>2</sub> receptors in the lungs compared to non-selective beta-blockers like timolol.</li><li><b>Clinical Use:</b> Used to treat [[5ea7b741|open-angle glaucoma]]. Its β<sub>1</sub>-selectivity makes it a safer option for patients with asthma or COPD compared to non-selective beta-blockers.</li><li><b>Adverse Effects:</b> Ocular effects can include stinging and burning. Although it is β<sub>1</sub>-selective, systemic absorption can still occur and may cause bradycardia, hypotension, and fatigue. Caution is still advised in patients with respiratory conditions.</li><li><b>USMLE Tip:</b> For a glaucoma patient with a history of asthma, a β<sub>1</sub>-selective blocker like betaxolol is a more appropriate choice than a non-selective one like timolol to minimize the risk of bronchoconstriction.</li></ul>",
      "takeAway": "<p><b>Betaxolol</b> lowers intraocular pressure in glaucoma by reducing aqueous humor production, and its key feature is its β<sub>1</sub>-selectivity, which offers a safer profile for patients with underlying pulmonary disease compared to non-selective beta-blockers.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "beta_blocker"
      },
      {
        "type": "treats",
        "to": "3ce6c035"
      },
      {
        "type": "acts_on",
        "to": "beta_1_adrenergic_receptor"
      }
    ]
  },
  "f36cfe18": {
    "title": "Biceps Reflex",
    "primaryType": "physiology",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Spinal Cord"
    ],
    "content": {
      "definition": "<p>The <b>Biceps reflex</b> is a deep tendon reflex that causes flexion of the elbow when the biceps brachii tendon is tapped. It is used to test the integrity of the <mark>C5 and C6</mark> spinal nerve roots and the musculocutaneous nerve.</p>",
      "atAGlance": "<ul><li><b>Nerve Roots:</b> Primarily tests the <b>C5</b> nerve root, with a contribution from C6. Mnemonic: C<b>5</b>, 6, pick up sticks.</li><li><b>Pathway:</b> Tapping the biceps tendon stretches the muscle spindle in the biceps muscle. The afferent signal travels via the musculocutaneous nerve to the C5/C6 spinal cord segments. It synapses with a motor neuron, and the efferent signal returns via the musculocutaneous nerve to cause contraction of the biceps muscle and elbow flexion.</li><li><b>Diminished/Absent Reflex:</b> Suggests a lower motor neuron lesion, such as a herniated disc compressing the C5 root or a peripheral neuropathy affecting the musculocutaneous nerve.</li><li><b>Exaggerated Reflex (Hyperreflexia):</b> Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the C5 level.</li><li><b>USMLE Tip:</b> The biceps reflex, along with sensation over the lateral arm and deltoid/biceps strength, is a key part of the C5 neurological exam.</li></ul>",
      "takeAway": "<p>The <b>Biceps reflex</b> is a fundamental component of the neurological exam, providing a quick and reliable assessment of the C5 and C6 nerve roots and the integrity of the reflex arc through the cervical spinal cord.</p>",
      "mermaid": "graph TD; A[Tap Biceps Tendon] --> B(Stretch Biceps Muscle); B --> C(Afferent Signal via Musculocutaneous N.); C --> D[C5/C6 Spinal Cord]; D --> E(Efferent Signal via Musculocutaneous N.); E --> F(Biceps Contraction/Elbow Flexion);"
    },
    "connections": [
      {
        "type": "tests_nerve_root",
        "to": "c5_nerve_root"
      },
      {
        "type": "tests_nerve_root",
        "to": "c6_nerve_root"
      },
      {
        "type": "is_a_type_of",
        "to": "deep_tendon_reflex"
      }
    ]
  },
  "188b4a47": {
    "title": "Bimatoprost",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Glaucoma Therapy"
    ],
    "content": {
      "definition": "<p><b>Bimatoprost</b> is a <i>prostaglandin analog</i> used topically as an eye drop to reduce intraocular pressure (IOP) in patients with [[5ea7b741|open-angle glaucoma]] or ocular hypertension.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> It is a synthetic prostamide analog that mimics the action of prostaglandins (specifically PGF<sub>2α</sub>). It lowers IOP by <mark>increasing the outflow of aqueous humor</mark> through the secondary, or <mark>uveoscleral pathway</mark>.</li><li><b>Clinical Use:</b> A first-line agent for the treatment of [[5ea7b741|open-angle glaucoma]] due to its high efficacy and once-daily dosing.</li><li><b>Adverse Effects:</b> The most common side effects are ocular hyperemia (redness), stinging, and a notable cosmetic side effect of <mark>increased eyelash growth</mark> (length and darkness). A permanent side effect can be darkening of the iris color (browning).</li><li><b>Comparison:</b> Other prostaglandin analogs include latanoprost and travoprost, all sharing a similar mechanism and side effect profile.</li><li><b>USMLE Tip:</b> The unique side effect of eyelash growth has been exploited for cosmetic use (Latisse). Remember that prostaglandin analogs work by increasing outflow, whereas beta-blockers decrease production of aqueous humor.</li></ul>",
      "takeAway": "<p><b>Bimatoprost</b> is a highly effective first-line glaucoma medication that lowers eye pressure by enhancing the uveoscleral outflow of aqueous humor, with the well-known and cosmetically exploited side effect of promoting eyelash growth.</p>",
      "mermaid": "graph TD; A[Bimatoprost] --> B(Acts on Prostaglandin Receptors); B --> C(↑ Uveoscleral Outflow); C --> D(↓ Intraocular Pressure);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "prostaglandin_analog"
      },
      {
        "type": "treats",
        "to": "3ce6c035"
      },
      {
        "type": "increases",
        "to": "uveoscleral_outflow"
      }
    ]
  },
  "6c3a980e": {
    "title": "Bitemporal Hemianopia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Endocrinology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Visual Field Defects"
    ],
    "content": {
      "definition": "<p><b>Bitemporal hemianopia</b> is a specific type of partial blindness characterized by the loss of vision in the outer (temporal) halves of the visual fields of both eyes. It is classically caused by a lesion compressing the central part of the <mark>optic chiasm</mark>.</p>",
      "atAGlance": "<ul><li><b>Description:</b> Loss of the temporal (lateral) visual fields in both eyes, often described as \"tunnel vision.\"</li><li><b>Pathophysiology:</b> The optic chiasm is where the nasal retinal fibers from each eye decussate (cross over). These nasal fibers are responsible for perceiving the temporal visual fields. A midline lesion at the chiasm selectively damages these crossing fibers.</li><li><b>Classic Cause:</b> The most common cause is a <mark>[[5f3188bd|pituitary adenoma]]</mark> growing upward from the sella turcica and compressing the chiasm from below.</li><li><b>Other Causes:</b> Other suprasellar masses like a [[7048db1e|craniopharyngioma]] or an aneurysm of the [[bd802d22|anterior communicating artery]] can also cause this defect.</li><li><b>USMLE Tip:</b> A patient presenting with \"tunnel vision\" or complaining of bumping into things on either side, especially if accompanied by endocrine symptoms (e.g., galactorrhea, acromegaly), is a classic vignette for a [[5f3188bd|pituitary adenoma]] causing bitemporal hemianopia.</li></ul>",
      "takeAway": "<p><b>Bitemporal hemianopia</b> is the quintessential sign of optic chiasm compression, resulting from the selective damage to the crossing nasal retinal fibers and creating a characteristic 'tunnel vision' that points directly to a midline suprasellar pathology like a pituitary adenoma.</p>",
      "mermaid": "graph TD; A[Lesion at Optic Chiasm] --Compresses--> B(Crossing Nasal Retinal Fibers); B --> C(Loss of Temporal Visual Fields); C --> D(Bitemporal Hemianopia);"
    },
    "connections": [
      {
        "type": "is_caused_by_lesion_at",
        "to": "optic_chiasm"
      },
      {
        "type": "is_caused_by",
        "to": "5f3188bd"
      },
      {
        "type": "is_caused_by",
        "to": "7048db1e"
      },
      {
        "type": "is_caused_by",
        "to": "bd802d22"
      }
    ]
  },
  "8056ce48": {
    "title": "Blepharitis",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Dermatology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Eyelid Disorders"
    ],
    "content": {
      "definition": "<p><b>Blepharitis</b> is a common inflammatory condition of the eyelids, typically involving the part of the eyelid where the eyelashes grow. It is characterized by inflammation, irritation, itching, and crusting of the eyelid margins.</p>",
      "atAGlance": "<ul><li><b>Anterior Blepharitis:</b> Affects the outside front of the eyelid, where the eyelashes are attached. Often caused by bacteria (<i>Staphylococcus</i>) or seborrheic dermatitis.</li><li><b>Posterior Blepharitis:</b> Affects the inner eyelid (the moist part that makes contact with the eye). Caused by dysfunction of the meibomian glands (Meibomian Gland Dysfunction - MGD). Associated with skin conditions like rosacea.</li><li><b>Symptoms:</b> Red, swollen, or itchy eyelids; gritty or burning sensation in the eyes; crusty debris at the base of the eyelashes upon waking; flaking of skin around the eyes.</li><li><b>Complications:</b> Can lead to [[hordeolum|hordeola (styes)]], [[193c24ec|chalazia]], dry eyes, or chronic conjunctivitis.</li><li><b>Treatment:</b> The cornerstone of treatment is <mark>eyelid hygiene</mark>, including warm compresses and gentle scrubbing of the eyelid margins. Topical antibiotics or steroids may be used in some cases.</li><li><b>USMLE Tip:</b> Look for a patient complaining of chronic eye irritation with crusting on the eyelashes, especially in the morning. This is a classic description of blepharitis.</li></ul>",
      "takeAway": "<p><b>Blepharitis</b> is a chronic inflammation of the eyelid margins, akin to dandruff of the eyelashes, which is managed primarily through diligent eyelid hygiene to control symptoms and prevent complications like styes and chalazia.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "eyelid_disorder"
      },
      {
        "type": "can_lead_to",
        "to": "hordeolum"
      },
      {
        "type": "can_lead_to",
        "to": "193c24ec"
      }
    ]
  },
  "dd47b9cc": {
    "title": "Blood-Brain Barrier (BBB)",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Physiology",
      "Pharmacology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Blood-Brain Barrier"
    ],
    "content": {
      "definition": "<p>The <b>Blood-Brain Barrier (BBB)</b> is a highly selective semipermeable border of endothelial cells that prevents solutes in the circulating blood from non-selectively crossing into the extracellular fluid of the central nervous system where neurons reside.</p>",
      "atAGlance": "<ul><li><b>Key Components:</b><br>1. <b>[[5206aa83|Tight junctions]]</b> between non-fenestrated capillary endothelial cells.<br>2. A thick <b>[[c335e16d|Basement Membrane]]</b>.<br>3. <b>Astrocyte foot processes</b> that surround the capillary.</li><li><b>Function:</b> Protects the brain from circulating toxins, pathogens, and fluctuations in plasma composition. It maintains a stable CNS environment.</li><li><b>Transport Across BBB:</b><br> - <b>Lipid-soluble</b> substances (e.g., O<sub>2</sub>, CO<sub>2</sub>, anesthetics) can diffuse freely.<br> - <b>Water-soluble</b> substances (e.g., glucose, [[9115b704|amino acids]]) require specific <mark>carrier-mediated transport</mark>.</li><li><b>Circumventricular Organs:</b> Areas of the brain that lack a BBB, allowing them to monitor the chemical composition of the blood. These include the [[5dd343d3|area postrema]] (chemoreceptor trigger zone for vomiting) and parts of the [[89e86633|hypothalamus]].</li><li><b>USMLE Tip:</b> Breakdown of the BBB leads to vasogenic edema. Some antibiotics (e.g., penicillins) have poor CNS penetration but can cross an inflamed BBB during meningitis.</li></ul>",
      "takeAway": "<p>The <b>Blood-Brain Barrier</b> is a sophisticated neurovascular unit, not just a simple wall, that uses tight junctions, a robust basement membrane, and astrocyte support to create a highly regulated interface, ensuring the brain's chemical environment remains pristine and protected.</p>",
      "mermaid": "graph TD; A[Capillary Lumen] --> B(Endothelial Cell); B --Tight Junctions--> B; B --> C(Basement Membrane); C --> D(Astrocyte Foot Processes); D --> E[Brain Parenchyma];"
    },
    "connections": [
      {
        "type": "is_composed_of",
        "to": "5206aa83"
      },
      {
        "type": "is_composed_of",
        "to": "c335e16d"
      },
      {
        "type": "is_composed_of",
        "to": "8192f595"
      },
      {
        "type": "is_absent_in",
        "to": "5dd343d3"
      }
    ]
  },
  "03ba9967": {
    "title": "Blood-Nerve Barrier",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Histology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Peripheral Nervous System"
    ],
    "content": {
      "definition": "<p>The <b>Blood-Nerve Barrier</b> is a physiological barrier in the peripheral nervous system that regulates the passage of substances from the blood into the endoneurial space, maintaining a stable microenvironment for peripheral nerve fibers.</p>",
      "atAGlance": "<ul><li><b>Structure:</b> The main cellular component is the <mark>perineurium</mark>, which consists of layers of flattened perineurial cells joined by tight junctions. Tight junctions between endothelial cells of the endoneurial capillaries also contribute.</li><li><b>Function:</b> Protects peripheral nerves from toxins, pathogens, and inflammatory cells, similar to the role of the [[dd47b9cc|blood-brain barrier]] in the CNS.</li><li><b>Comparison to BBB:</b> While analogous to the BBB, the blood-nerve barrier is generally considered less restrictive.</li><li><b>Pathology:</b> Breakdown of the blood-nerve barrier is a key feature of inflammatory neuropathies like [[ed52e40b|Guillain-Barré syndrome]]. This breakdown allows inflammatory cells and proteins to enter the endoneurial space, leading to demyelination and axonal damage.</li><li><b>USMLE Tip:</b> The breakdown of the blood-nerve barrier in [[ed52e40b|Guillain-Barré syndrome]] explains the classic CSF finding of [[a0f3ce4c|albuminocytologic dissociation]]—high protein (leaking from the blood) with a normal cell count.</li></ul>",
      "takeAway": "<p>The <b>Blood-Nerve Barrier</b>, formed primarily by the tight junctions of the perineurium, serves as the protective gatekeeper for peripheral nerves; its disruption in inflammatory conditions like Guillain-Barré syndrome allows an autoimmune assault on the nerves.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_analogous_to",
        "to": "dd47b9cc"
      },
      {
        "type": "is_disrupted_in",
        "to": "ed52e40b"
      },
      {
        "type": "is_formed_by",
        "to": "perineurium"
      }
    ]
  },
  "6ab4b0f2": {
    "title": "Blown Pupil",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Emergency Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Cranial Nerves"
    ],
    "content": {
      "definition": "<p>A <b>\"blown pupil\"</b> is a clinical term for a fixed, dilated pupil (mydriasis) that is nonreactive to light. It is a critical sign of compression of the [[68c66997|oculomotor nerve (CN III)]], often indicating a life-threatening increase in intracranial pressure.</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> The parasympathetic fibers that control pupillary constriction run along the superficial, peripheral aspect of the [[68c66997|oculomotor nerve]]. These fibers are highly susceptible to external compression.</li><li><b>Classic Cause:</b> <mark>Uncal herniation</mark>, where the uncus of the temporal lobe herniates over the tentorium cerebelli and compresses the ipsilateral CN III.</li><li><b>Other Causes:</b> Aneurysm of the <mark>posterior communicating artery (PComA)</mark>, which is anatomically close to CN III, can also cause compression and a blown pupil.</li><li><b>Clinical Significance:</b> A unilateral blown pupil is an ominous sign of rapidly increasing intracranial pressure and impending brainstem compression. It is a neurosurgical emergency.</li><li><b>Associated Signs:</b> Often accompanied by other signs of a CN III palsy, such as ptosis and a \"down and out\" deviation of the eye.</li><li><b>USMLE Tip:</b> In a patient with head trauma and a deteriorating level of consciousness, the sudden appearance of a unilateral fixed and dilated pupil indicates uncal herniation and requires immediate intervention.</li></ul>",
      "takeAway": "<p>A <b>blown pupil</b> is a neurological red flag, signaling compression of the parasympathetic fibers on the outside of the oculomotor nerve, most often by uncal herniation or a PComA aneurysm, and indicates a dire, time-sensitive emergency.</p>",
      "mermaid": "graph TD; A[↑ Intracranial Pressure] --> B(Uncal Herniation); B --Compresses--> C(CN III Parasympathetic Fibers); C --> D(Loss of Pupillary Constriction); D --> E(Fixed, Dilated Pupil);"
    },
    "connections": [
      {
        "type": "is_a_sign_of",
        "to": "oculomotor_nerve_compression"
      },
      {
        "type": "is_caused_by",
        "to": "uncal_herniation"
      },
      {
        "type": "is_caused_by",
        "to": "posterior_communicating_artery_aneurysm"
      }
    ]
  },
  "aebb10eb": {
    "title": "Blowout Fracture",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Trauma",
      "Emergency Medicine",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Trauma"
    ],
    "content": {
      "definition": "<p>A <b>blowout fracture</b> is a traumatic fracture of the walls of the orbit, most commonly the orbital floor, caused by a sudden increase in intraorbital pressure from a direct blow to the globe (e.g., from a fist or a ball).</p>",
      "atAGlance": "<ul><li><b>Mechanism:</b> A blunt, non-penetrating force strikes the globe, transmitting pressure throughout the orbit. The thin orbital floor (roof of the maxillary sinus) and/or medial wall (lamina papyracea of the ethmoid sinus) fracture, or 'blow out.'</li><li><b>Clinical Presentation:</b> Patients present with periorbital pain, swelling, and ecchymosis. Key signs include <mark>diplopia on upward gaze</mark> and numbness of the cheek and upper teeth.</li><li><b>Muscle Entrapment:</b> The fracture can entrap the <mark>inferior rectus muscle</mark> and/or orbital fat. This entrapment restricts upward movement of the eye, causing vertical diplopia, especially on upgaze.</li><li><b>Nerve Injury:</b> The fracture of the orbital floor can damage the <mark>infraorbital nerve</mark> (a branch of CN V<sub>2</sub>), leading to paresthesia or numbness of the ipsilateral cheek, upper lip, and upper gingiva.</li><li><b>USMLE Tip:</b> The combination of a history of blunt eye trauma, diplopia on upward gaze, and numbness of the cheek is classic for an orbital blowout fracture with inferior rectus entrapment and infraorbital nerve injury.</li></ul>",
      "takeAway": "<p>A <b>blowout fracture</b> is a hydraulic fracture of the thin orbital floor, where the force of a blow to the eye is transmitted to the surrounding bone, leading to entrapment of the inferior rectus muscle and injury to the infraorbital nerve, manifesting as an inability to look up and a numb cheek.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "can_cause_entrapment_of",
        "to": "inferior_rectus_muscle"
      },
      {
        "type": "can_cause_injury_to",
        "to": "infraorbital_nerve"
      },
      {
        "type": "presents_with",
        "to": "9914d433"
      }
    ]
  },
  "869535a9": {
    "title": "Bone Morphogenetic Protein (BMP)",
    "primaryType": "molecule",
    "tags": [
      "Embryology",
      "Neuroscience",
      "Developmental Biology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Embryology",
      "Neural Development"
    ],
    "content": {
      "definition": "<p><b>Bone Morphogenetic Proteins (BMPs)</b> are a group of growth factors belonging to the transforming growth factor-beta (TGF-β) superfamily. In neuroembryology, they play a crucial role in establishing the dorsal-ventral axis of the neural tube by inducing the development of the dorsal structures.</p>",
      "atAGlance": "<ul><li><b>Function in Neurodevelopment:</b> Secreted by the overlying ectoderm, BMPs act as a signaling molecule that patterns the dorsal neural tube.</li><li><b>Dorsalization:</b> High concentrations of BMPs induce the formation of the <mark>[[43be7a6e|alar plate]]</mark>, which gives rise to sensory neurons in the dorsal horn of the spinal cord and sensory nuclei of the brainstem.</li><li><b>Counterpart Signal:</b> The ventralizing signal is <mark>Sonic Hedgehog (SHH)</mark>, which is secreted by the notochord and induces the formation of the [[253e3efb|basal plate]] (motor neurons).</li><li><b>Gradient Effect:</b> The opposing gradients of BMP (high dorsally) and SHH (high ventrally) establish the distinct sensory (dorsal) and motor (ventral) domains of the developing central nervous system.</li><li><b>USMLE Tip:</b> Remember the source and effect: BMP from the ectoderm (roof) induces the dorsal/sensory alar plate. SHH from the notochord (floor) induces the ventral/motor basal plate.</li></ul>",
      "takeAway": "<p><b>Bone Morphogenetic Protein</b> acts as the key 'dorsalizing' signal in the developing neural tube, instructing the dorsal region to become the sensory [[43be7a6e|alar plate]], thereby establishing the fundamental sensory-motor polarity of the central nervous system in opposition to the ventralizing signal, Sonic Hedgehog.</p>",
      "mermaid": "graph TD; A[Ectoderm] --Secretes--> B(BMPs); B --Induces--> C(Dorsal Neural Tube); C --> D(Alar Plate); D --> E(Sensory Neurons);"
    },
    "connections": [
      {
        "type": "induces_development_of",
        "to": "43be7a6e"
      },
      {
        "type": "is_counteracted_by",
        "to": "sonic_hedgehog"
      },
      {
        "type": "is_secreted_by",
        "to": "ectoderm"
      }
    ]
  },
  "84b10400": {
    "title": "Botulinum Toxin",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Microbiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Skeletal Muscle Relaxants"
    ],
    "content": {
      "definition": "<p><b>Botulinum toxin</b> is a potent neurotoxin produced by the bacterium <i>Clostridium botulinum</i>. It causes flaccid paralysis by inhibiting the presynaptic release of [[6a005559|acetylcholine]] at the neuromuscular junction. In small, purified doses, it is used therapeutically for a variety of medical and cosmetic purposes.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> The toxin is a protease that cleaves <mark>SNARE proteins</mark> (e.g., SNAP-25, synaptobrevin), which are essential for the fusion of acetylcholine-containing vesicles with the presynaptic membrane. This prevents ACh release.</li><li><b>Medical Uses:</b><br> - <b>Spasticity/Dystonia:</b> Treats focal dystonias (e.g., torticollis, blepharospasm), spasticity in [[171ca00b|cerebral palsy]] and [[45dd6d19|multiple sclerosis]].<br> - <b>Pain:</b> Prophylaxis for chronic [[c8833bae|migraine headaches]].<br> - <b>Other:</b> Hyperhidrosis (excessive sweating), strabismus.</li><li><b>Cosmetic Use:</b> Injected to reduce facial wrinkles by temporarily paralyzing underlying muscles (Botox).</li><li><b>Toxicity (Botulism):</b> Ingestion of the toxin (e.g., from improperly canned foods) causes botulism, a life-threatening illness characterized by descending flaccid paralysis, diplopia, dysphagia, and respiratory failure.</li><li><b>USMLE Tip:</b> Remember that botulinum toxin causes a <u>presynaptic</u> blockade of ACh release, which contrasts with myasthenia gravis (postsynaptic receptor blockade) and Lambert-Eaton syndrome (presynaptic Ca<sup>2+</sup> channel blockade).</li></ul>",
      "takeAway": "<p><b>Botulinum toxin</b> induces paralysis by enzymatically snipping the SNARE proteins required for acetylcholine release at the neuromuscular junction; this potent biological mechanism is harnessed in medicine to selectively weaken overactive muscles in conditions from dystonia to cosmetic wrinkles.</p>",
      "mermaid": "graph TD; A[Botulinum Toxin] --> B(Cleaves SNARE Proteins); B --x C(Vesicle Fusion); C --x D(ACh Release); D --x E(Muscle Contraction); E --> F(Flaccid Paralysis);"
    },
    "connections": [
      {
        "type": "inhibits_release_of",
        "to": "6a005559"
      },
      {
        "type": "treats",
        "to": "dystonia"
      },
      {
        "type": "treats",
        "to": "c8833bae"
      },
      {
        "type": "treats",
        "to": "171ca00b"
      },
      {
        "type": "is_produced_by",
        "to": "clostridium_botulinum"
      }
    ]
  },
  "ac55d026": {
    "title": "Brachioradialis Reflex",
    "primaryType": "physiology",
    "tags": [
      "Neurology",
      "Physical Exam",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Spinal Cord"
    ],
    "content": {
      "definition": "<p>The <b>Brachioradialis reflex</b> is a deep tendon reflex that causes flexion of the elbow and supination of the forearm when the brachioradialis tendon is tapped at the styloid process of the radius. It is used to test the integrity of the <mark>C5 and C6</mark> spinal nerve roots and the radial nerve.</p>",
      "atAGlance": "<ul><li><b>Nerve Roots:</b> Primarily tests the <b>C6</b> nerve root, with a contribution from C5. Mnemonic: C5, <b>6</b>, pick up sticks.</li><li><b>Pathway:</b> Tapping the tendon stretches the brachioradialis muscle. The afferent signal travels via the radial nerve to the C5/C6 spinal cord segments, synapses with a motor neuron, and the efferent signal returns via the radial nerve to cause muscle contraction.</li><li><b>Diminished/Absent Reflex:</b> Suggests a lower motor neuron lesion, such as a herniated disc compressing the C6 root or a peripheral neuropathy affecting the radial nerve.</li><li><b>Exaggerated Reflex (Hyperreflexia):</b> Suggests an upper motor neuron lesion, such as a stroke or spinal cord injury above the C5/C6 level.</li><li><b>USMLE Tip:</b> The brachioradialis reflex, along with the biceps reflex, is a key part of assessing the C5 and C6 nerve roots.</li></ul>",
      "takeAway": "<p>The <b>Brachioradialis reflex</b> is a specific test for the C5-C6 nerve roots, elicited by tapping the distal radius, which provides valuable information for localizing lesions within the cervical spine and brachial plexus.</p>",
      "mermaid": "graph TD; A[Tap Brachioradialis Tendon] --> B(Stretch Muscle); B --> C(Afferent Signal via Radial N.); C --> D[C5/C6 Spinal Cord]; D --> E(Efferent Signal via Radial N.); E --> F(Elbow Flexion/Forearm Supination);"
    },
    "connections": [
      {
        "type": "tests_nerve_root",
        "to": "c5_nerve_root"
      },
      {
        "type": "tests_nerve_root",
        "to": "c6_nerve_root"
      },
      {
        "type": "is_a_type_of",
        "to": "deep_tendon_reflex"
      }
    ]
  },
  "a584135d": {
    "title": "Brain",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Central Nervous System"
    ],
    "content": {
      "definition": "<p>The <b>Brain</b> is the central organ of the human nervous system, responsible for thought, memory, emotion, touch, motor skills, vision, breathing, temperature, hunger, and every process that regulates our body. It is composed of the cerebrum, cerebellum, and brainstem.</p>",
      "atAGlance": "<ul><li><b>Embryology:</b> Develops from the rostral part of the neural tube, which differentiates into the forebrain (prosencephalon), midbrain (mesencephalon), and hindbrain (rhombencephalon).</li><li><b>Major Parts:</b><br> - <b>Cerebrum:</b> The largest part, divided into two hemispheres, responsible for higher cognitive functions.<br> - <b>Cerebellum:</b> Located under the cerebrum, coordinates muscle movements and balance.<br> - <b>Brainstem:</b> Connects the cerebrum and cerebellum to the spinal cord, controlling many automatic functions like breathing and heart rate.</li><li><b>Vascular Supply:</b> Supplied by the anterior circulation (from internal carotid arteries) and posterior circulation (from vertebral arteries), which connect via the [[e22300e8|Circle of Willis]].</li><li><b>Pathology:</b> Can be affected by a wide range of pathologies including [[c5da3c57|ischemic]] and [[hemorrhagic_stroke|hemorrhagic strokes]], [[be057cfc|tumors]], trauma, infection, and neurodegenerative diseases.</li><li><b>USMLE Tip:</b> Understanding the functional localization within the brain (e.g., motor/sensory homunculus, language areas) and the vascular territories is crucial for solving clinical neurology questions.</li></ul>",
      "takeAway": "<p>The <b>Brain</b> is the command center of the body, where intricate networks of neurons process information and control function, with specific regions highly specialized for distinct tasks, making the clinical presentation of brain lesions highly predictable based on their location.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "central_nervous_system"
      },
      {
        "type": "develops_from",
        "to": "neural_tube"
      },
      {
        "type": "can_be_affected_by",
        "to": "c5da3c57"
      },
      {
        "type": "can_be_affected_by",
        "to": "be057cfc"
      }
    ]
  },
  "1777e176": {
    "title": "Brain Death",
    "primaryType": "concept",
    "tags": [
      "Neurology",
      "Critical Care",
      "Medical Ethics",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Coma"
    ],
    "content": {
      "definition": "<p><b>Brain death</b> is the irreversible cessation of all functions of the entire brain, including the brainstem. It is a legal and clinical definition of death, distinct from a persistent vegetative state where brainstem functions may be intact.</p>",
      "atAGlance": "<ul><li><b>Criteria:</b> Diagnosis requires evidence of an irreversible cause of coma, absence of confounding factors (e.g., hypothermia, drug intoxication), and the absence of all brainstem reflexes.</li><li><b>Brainstem Reflexes Tested:</b> Pupillary light reflex, corneal reflex, oculocephalic reflex (doll's eyes), oculovestibular reflex (cold caloric), gag reflex, and cough reflex must all be absent.</li><li><b>Apnea Test:</b> A definitive test where the patient is disconnected from the ventilator to see if a rise in PaCO<sub>2</sub> stimulates a spontaneous respiratory effort. Absence of breathing despite a high PaCO<sub>2</sub> confirms apnea.</li><li><b>Cerebral Perfusion:</b> In brain death, [[3eca3f19|cerebral perfusion pressure (CPP)]] is zero, meaning there is no cerebral blood flow.</li><li><b>Ethical/Legal Status:</b> A patient who meets the criteria for brain death is legally and medically deceased, even if their heart continues to beat with mechanical ventilation. This allows for the cessation of life support and consideration of organ donation.</li></ul>",
      "takeAway": "<p><b>Brain death</b> signifies the irreversible loss of function of the entire brain, including the brainstem, which is confirmed by the absence of all brainstem reflexes and a positive apnea test, establishing legal death despite ongoing cardiac activity on life support.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_defined_by",
        "to": "absence_of_brainstem_reflexes"
      },
      {
        "type": "is_confirmed_by",
        "to": "apnea_test"
      },
      {
        "type": "is_distinct_from",
        "to": "persistent_vegetative_state"
      }
    ]
  },
  "e9a47751": {
    "title": "Brain Injury",
    "primaryType": "pathology",
    "tags": [
      "Neurology",
      "Trauma",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Trauma"
    ],
    "content": {
      "definition": "<p><b>Brain injury</b> is damage to the brain that can result from a traumatic force (Traumatic Brain Injury, TBI) or a non-traumatic event (e.g., stroke, anoxia). The clinical effects depend on the mechanism, location, and severity of the injury.</p>",
      "atAGlance": "<ul><li><b>Traumatic Brain Injury (TBI):</b> Includes concussions, contusions, [[22b22e08|diffuse axonal injury]], and intracranial hemorrhages (epidural, subdural). Caused by external forces.</li><li><b>Non-Traumatic Brain Injury:</b> Includes [[c5da3c57|ischemic]] and [[hemorrhagic_stroke|hemorrhagic strokes]], anoxic brain injury (e.g., from cardiac arrest), infections, and tumors.</li><li><b>Primary vs. Secondary Injury:</b><br> - <b>Primary Injury:</b> The initial damage that occurs at the moment of impact or insult (e.g., shearing of axons, laceration of vessels).<br> - <b>Secondary Injury:</b> A cascade of molecular and inflammatory events that occur in the hours and days following the primary injury (e.g., cerebral edema, excitotoxicity, inflammation), which often worsens the overall outcome.</li><li><b>Stroke Effects:</b> The neurological deficits from a stroke are highly predictable based on the affected [[105efab1|arterial supply]] and the function of the brain region it perfuses (e.g., [[143bb23d|MCA stroke]] causing contralateral face/arm weakness).</li><li><b>USMLE Tip:</b> Understanding the vascular territories of the major cerebral arteries ([[830c856c|ACA]], [[143bb23d|MCA]], [[b6a2cc31|PCA]]) is essential for localizing stroke lesions based on clinical symptoms.</li></ul>",
      "takeAway": "<p><b>Brain injury</b> encompasses a spectrum of damage from various causes, with the final clinical outcome determined not only by the initial insult but also by the subsequent cascade of secondary injury processes like edema and inflammation, which are major targets for neuroprotective therapies.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "c5da3c57"
      },
      {
        "type": "includes",
        "to": "hemorrhagic_stroke"
      },
      {
        "type": "includes",
        "to": "22b22e08"
      },
      {
        "type": "can_be_localized_by",
        "to": "105efab1"
      }
    ]
  },
  "582d8572": {
    "title": "Brainstem",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Brainstem"
    ],
    "content": {
      "definition": "<p>The <b>Brainstem</b> is the posterior part of the brain that is structurally continuous with the spinal cord. It is composed of three parts from superior to inferior: the midbrain, the pons, and the medulla oblongata. It is responsible for vital life functions and serves as a conduit for nerve tracts.</p>",
      "atAGlance": "<ul><li><b>Components:</b> Midbrain, Pons, and Medulla.</li><li><b>Functions:</b><br> 1. <b>Conduit:</b> Contains ascending (sensory) and descending (motor) tracts connecting the cerebrum and cerebellum to the spinal cord.<br> 2. <b>Cranial Nerve Nuclei:</b> Houses the nuclei for cranial nerves III through XII.<br> 3. <b>Integrative Functions:</b> Contains the reticular formation, which is crucial for consciousness, sleep-wake cycles, and vital autonomic functions (e.g., cardiovascular and respiratory control in the medulla).</li><li><b>Ventral View:</b> Shows the cerebral peduncles (midbrain), the bulging pons, and the pyramids (medulla). Cranial nerves can be seen exiting.</li><li><b>Dorsal View:</b> Shows the superior and inferior colliculi (midbrain) and the floor of the fourth ventricle.</li><li><b>USMLE Tip:</b> The 'Rule of 4s' is a helpful mnemonic for localizing brainstem lesions: 4 CNs above the pons (I-IV), 4 in the pons (V-VIII), 4 in the medulla (IX-XII); and 4 midline motor structures (Motor nucleus, Motor pathway, MLF, Medial lemniscus).</li></ul>",
      "takeAway": "<p>The <b>Brainstem</b> is the critical, compact hub connecting the higher brain centers to the body, housing essential cranial nerve nuclei and autonomic centers for survival, making even small lesions within it profoundly debilitating.</p>",
      "mermaid": "graph TD; A[Brainstem] --> B(Midbrain); A --> C(Pons); A --> D(Medulla);"
    },
    "connections": [
      {
        "type": "is_composed_of",
        "to": "midbrain"
      },
      {
        "type": "is_composed_of",
        "to": "pons"
      },
      {
        "type": "is_composed_of",
        "to": "medulla_oblongata"
      },
      {
        "type": "contains_nuclei_for",
        "to": "cranial_nerves"
      }
    ]
  },
  "32ba61d1": {
    "title": "Brainstem and Cerebellar Syndromes",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pathology",
      "Stroke",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Brainstem Syndromes"
    ],
    "content": {
      "definition": "<p><b>Brainstem and Cerebellar Syndromes</b> are collections of neurological signs and symptoms that result from lesions (typically strokes or tumors) affecting specific anatomical locations within the brainstem or cerebellum. Their presentations are highly predictable based on the structures involved.</p>",
      "atAGlance": "<ul><li><b>Lateral Medullary (Wallenberg) Syndrome:</b> Caused by a PICA stroke. Presents with vertigo, nystagmus, ipsilateral ataxia, dysphagia, hoarseness, ipsilateral Horner syndrome, ipsilateral facial pain/temp loss, and contralateral body pain/temp loss.</li><li><b>Lateral Pontine Syndrome:</b> Caused by an AICA stroke. Similar to Wallenberg but includes ipsilateral facial paralysis (CN VII) and deafness (CN VIII), and lacks dysphagia/hoarseness.</li><li><b>Medial Medullary Syndrome:</b> Caused by an ASA stroke. Presents with contralateral hemiparesis, contralateral loss of proprioception/vibration, and ipsilateral tongue deviation (CN XII).</li><li><b>Multiple Sclerosis:</b> Can cause various brainstem and cerebellar syndromes due to its demyelinating plaques. A classic MS-related syndrome is <mark>[[58c684bd|internuclear ophthalmoplegia (INO)]]</mark> from a lesion in the medial longitudinal fasciculus.</li><li><b>USMLE Tip:</b> Learn to differentiate the lateral syndromes: PICA (medulla) involves CN IX/X (dysphagia/hoarseness), while AICA (pons) involves CN VII/VIII (facial palsy/deafness).</li></ul>",
      "takeAway": "<p>The clinical diagnosis of <b>brainstem and cerebellar syndromes</b> is a classic exercise in neuroanatomical localization, where a specific constellation of cranial nerve deficits, long tract signs, and cerebellar findings can pinpoint a lesion to a precise vascular territory or location.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "lateral_medullary_syndrome"
      },
      {
        "type": "includes",
        "to": "lateral_pontine_syndrome"
      },
      {
        "type": "includes",
        "to": "medial_medullary_syndrome"
      },
      {
        "type": "can_be_caused_by",
        "to": "45dd6d19"
      }
    ]
  },
  "be057cfc": {
    "title": "Brain Tumors",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Oncology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Brain Tumors"
    ],
    "content": {
      "definition": "<p><b>Brain tumors</b> are neoplasms originating in the intracranial tissues. They can be primary (arising from brain cells) or metastatic (spreading from cancers elsewhere in the body). Their clinical presentation depends on their location, size, and growth rate.</p>",
      "atAGlance": "<ul><li><b>Adult Primary Tumors:</b> Most are supratentorial. In order of frequency: [[b6bbd0bc|Glioblastoma]], [[e98ea0ba|Meningioma]], [[03ecb69e|Schwannoma]], Oligodendroglioma.</li><li><b>Childhood Primary Tumors:</b> Most are infratentorial. In order of frequency: Pilocytic astrocytoma, [[16d613bb|Medulloblastoma]], [[14365ef4|Ependymoma]].</li><li><b>Metastatic Tumors:</b> More common than primary tumors. Often present as multiple, well-circumscribed lesions at the gray-white junction. Common primary sources are <mark>Lung, Breast, Kidney, Melanoma, and Colon</mark>.</li><li><b>General Symptoms:</b> Headaches (often worse in the morning), seizures, and focal neurological deficits corresponding to the tumor's location.</li><li><b>USMLE Tip:</b> A ring-enhancing lesion on MRI with contrast is a key finding. The differential includes [[b6bbd0bc|glioblastoma]], metastasis, and abscess. A 'butterfly' appearance crossing the corpus callosum is classic for glioblastoma.</li></ul>",
      "takeAway": "<p>The classification and prognosis of <b>brain tumors</b> differ significantly between adults and children, with adults more commonly developing aggressive supratentorial gliomas and children typically having more benign infratentorial tumors.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "includes",
        "to": "b6bbd0bc"
      },
      {
        "type": "includes",
        "to": "e98ea0ba"
      },
      {
        "type": "includes",
        "to": "03ecb69e"
      },
      {
        "type": "includes",
        "to": "16d613bb"
      },
      {
        "type": "includes",
        "to": "14365ef4"
      }
    ]
  },
  "af9d783c": {
    "title": "Brainstem",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Brainstem"
    ],
    "content": {
      "definition": "<p>The <b>Brainstem</b> is the posterior part of the brain that is structurally continuous with the spinal cord. It is composed of three parts from superior to inferior: the midbrain, the pons, and the medulla oblongata. It is responsible for vital life functions and serves as a conduit for nerve tracts.</p>",
      "atAGlance": "<ul><li><b>Components:</b> Midbrain, Pons, and Medulla.</li><li><b>Functions:</b><br> 1. <b>Conduit:</b> Contains ascending (sensory) and descending (motor) tracts connecting the cerebrum and cerebellum to the spinal cord.<br> 2. <b>Cranial Nerve Nuclei:</b> Houses the nuclei for cranial nerves III through XII.<br> 3. <b>Integrative Functions:</b> Contains the reticular formation, which is crucial for consciousness, sleep-wake cycles, and vital autonomic functions (e.g., cardiovascular and respiratory control in the medulla).</li><li><b>Cross Sections:</b> Recognizing the key structures in cross sections of the midbrain, pons, and medulla is essential for localizing brainstem strokes.</li><li><b>Herniation Syndromes:</b> The brainstem is vulnerable to compression during [[8c0728b7|herniation syndromes]], which can lead to coma and death (e.g., Duret hemorrhages from central herniation).</li><li><b>USMLE Tip:</b> The 'Rule of 4s' is a helpful mnemonic for localizing brainstem lesions: 4 CNs above the pons (I-IV), 4 in the pons (V-VIII), 4 in the medulla (IX-XII); and 4 midline motor structures (Motor nucleus, Motor pathway, MLF, Medial lemniscus).</li></ul>",
      "takeAway": "<p>The <b>Brainstem</b> is the critical, compact hub connecting the higher brain centers to the body, housing essential cranial nerve nuclei and autonomic centers for survival, making even small lesions within it profoundly debilitating.</p>",
      "mermaid": "graph TD; A[Brainstem] --> B(Midbrain); A --> C(Pons); A --> D(Medulla);"
    },
    "connections": [
      {
        "type": "is_composed_of",
        "to": "midbrain"
      },
      {
        "type": "is_composed_of",
        "to": "pons"
      },
      {
        "type": "is_composed_of",
        "to": "medulla_oblongata"
      },
      {
        "type": "is_compressed_in",
        "to": "8c0728b7"
      }
    ]
  },
  "0f0fbfa0": {
    "title": "Branch Retinal Vein Occlusion (BRVO)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Retinal Disorders"
    ],
    "content": {
      "definition": "<p>A <b>Branch Retinal Vein Occlusion (BRVO)</b> is the blockage of a small vein in the retina, leading to hemorrhage, edema, and potential vision loss in the quadrant of the retina drained by that vein.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Most commonly occurs at an <mark>arteriovenous (AV) crossing</mark>, where a hardened, atherosclerotic retinal arteriole compresses the adjacent, thinner-walled venule, leading to turbulent flow and thrombus formation.</li><li><b>Risk Factors:</b> Strongly associated with systemic vascular diseases like <mark>hypertension</mark>, diabetes mellitus, and hyperlipidemia.</li><li><b>Clinical Presentation:</b> Sudden, painless, unilateral vision loss, which may be described as a scotoma (blind spot) or blurry vision in a specific part of the visual field.</li><li><b>Fundoscopy:</b> Fundoscopic exam reveals <mark>sectoral (quadrantic) retinal hemorrhages</mark>, venous engorgement, and cotton-wool spots confined to the area drained by the occluded vein.</li><li><b>USMLE Tip:</b> Differentiate from Central Retinal Vein Occlusion (CRVO), which involves the entire retina and has a more dramatic \"blood and thunder\" appearance. BRVO is localized to a quadrant. The key association is hypertension causing AV nicking.</li></ul>",
      "takeAway": "<p>A <b>Branch Retinal Vein Occlusion</b> is a consequence of systemic vascular disease playing out in the eye, where a stiff arteriole compresses a venule at a crossing point, causing a localized 'traffic jam' of blood that results in a sectoral retinal hemorrhage.</p>",
      "mermaid": "graph TD; A[Hypertension/Atherosclerosis] --> B(Arteriolar Sclerosis); B --> C(Compression of Vein at AV Crossing); C --> D(Thrombus Formation); D --> E(Branch Retinal Vein Occlusion); E --> F(Sectoral Hemorrhage & Edema);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "b69e35b5"
      },
      {
        "type": "is_associated_with",
        "to": "hypertension"
      },
      {
        "type": "differentiated_from",
        "to": "b69e35b5"
      }
    ]
  },
  "2fcee185": {
    "title": "Brimonidine",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "Autonomic",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Glaucoma Therapy"
    ],
    "content": {
      "definition": "<p><b>Brimonidine</b> is a highly selective <i>α<sub>2</sub>-adrenergic agonist</i> used as a topical eye drop to lower intraocular pressure (IOP) in the treatment of [[5ea7b741|open-angle glaucoma]] and ocular hypertension.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Has a dual mechanism. It primarily <mark>decreases aqueous humor synthesis</mark> by stimulating α<sub>2</sub> receptors on the ciliary body. It also <mark>increases uveoscleral outflow</mark>.</li><li><b>Clinical Use:</b> A common agent for the long-term management of [[5ea7b741|open-angle glaucoma]].</li><li><b>Adverse Effects:</b> Ocular side effects include allergic conjunctivitis, hyperemia (redness), and pruritus (itching). Systemic side effects are possible due to absorption and include dry mouth, sedation, and fatigue. Unlike apraclonidine, it does not cause mydriasis and can be used in angle-closure glaucoma.</li><li><b>Comparison:</b> Similar to [[c1f67280|apraclonidine]] but is more selective for the α<sub>2</sub> receptor and has a lower incidence of allergic reactions and tachyphylaxis, making it more suitable for long-term use.</li><li><b>USMLE Tip:</b> Remember that α<sub>2</sub> agonists like brimonidine and clonidine act as sympatholytics, reducing sympathetic outflow. In the eye, this leads to decreased aqueous humor production.</li></ul>",
      "takeAway": "<p><b>Brimonidine</b> is an effective glaucoma medication that lowers intraocular pressure through a dual mechanism of decreasing aqueous humor production and increasing its outflow, all mediated by its selective α<sub>2</sub>-adrenergic agonism.</p>",
      "mermaid": "graph TD; A[Brimonidine] --> B(Stimulates α2 Receptors); B --> C(↓ Aqueous Humor Synthesis); B --> D(↑ Uveoscleral Outflow); C & D --> E(↓ Intraocular Pressure);"
    },
    "connections": [
      {
        "type": "treats",
        "to": "3ce6c035"
      },
      {
        "type": "is_a_type_of",
        "to": "alpha_2_agonist"
      },
      {
        "type": "has_similar_mechanism_to",
        "to": "c1f67280"
      }
    ]
  },
  "4dff096f": {
    "title": "Broad-Spectrum Anticonvulsants",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Epilepsy",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Anticonvulsants"
    ],
    "content": {
      "definition": "<p><b>Broad-spectrum anticonvulsants</b> are antiepileptic drugs (AEDs) that are effective against a wide variety of seizure types, including both focal and generalized seizures (e.g., tonic-clonic, absence, myoclonic).</p>",
      "atAGlance": "<ul><li><b>Key Agents:</b> The main broad-spectrum agents are <mark>[[valproic_acid|Valproic acid]]</mark>, <mark>[[08d19a8f|Lamotrigine]]</mark>, <mark>[[2341f9c0|Levetiracetam]]</mark>, and <mark>[[e1f5066c|Topiramate]]</mark>.</li><li><b>Clinical Use:</b> They are the drugs of choice when the seizure type is unclear or when a patient has multiple seizure types (e.g., Lennox-Gastaut syndrome).</li><li><b>Valproic Acid:</b> Very broad spectrum, effective for almost all seizure types. Mechanism involves Na<sup>+</sup> channel blockade, T-type Ca<sup>2+</sup> channel blockade, and increasing GABA levels. Highly teratogenic (neural tube defects).</li><li><b>Lamotrigine:</b> Broad spectrum, but must be titrated slowly to reduce the risk of Stevens-Johnson syndrome (SJS).</li><li><b>Levetiracetam:</b> Very commonly used due to its favorable side effect profile and broad efficacy. Unique mechanism involving synaptic vesicle protein 2A (SV2A).</li><li><b>USMLE Tip:</b> If a question asks for the best initial treatment for a patient with generalized tonic-clonic seizures, a broad-spectrum agent like valproic acid or levetiracetam is a strong choice. Valproic acid is also a first-line option for myoclonic seizures.</li></ul>",
      "takeAway": "<p><b>Broad-spectrum anticonvulsants</b> are the versatile workhorses of epilepsy treatment, effective against both focal and generalized seizures, making them ideal for initial empirical therapy or for patients with complex epilepsy syndromes.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_class_of",
        "to": "f91a0cfa"
      },
      {
        "type": "includes",
        "to": "valproic_acid"
      },
      {
        "type": "includes",
        "to": "08d19a8f"
      },
      {
        "type": "includes",
        "to": "2341f9c0"
      },
      {
        "type": "includes",
        "to": "e1f5066c"
      }
    ]
  },
  "7f6ed344": {
    "title": "Broca's Aphasia",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pathology",
      "Stroke",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Aphasia"
    ],
    "content": {
      "definition": "<p><b>Broca's aphasia</b>, also known as expressive aphasia, is a language disorder characterized by difficulty in producing fluent, grammatical speech, while comprehension remains relatively intact. It is caused by a lesion in [[a3bbace2|Broca's area]].</p>",
      "atAGlance": "<ul><li><b>Lesion Location:</b> <mark>Inferior frontal gyrus</mark> of the dominant (usually left) hemisphere.</li><li><b>Vascular Supply:</b> Supplied by the superior division of the [[143bb23d|Middle Cerebral Artery (MCA)]].</li><li><b>Clinical Presentation:</b> Speech is <mark>nonfluent, telegraphic, and effortful</mark>. Patients use short phrases and omit functional words (e.g., \"Walk dog\"). Repetition is impaired.</li><li><b>Comprehension:</b> Auditory and reading comprehension are relatively preserved, although complex grammar may be difficult.</li><li><b>Patient Awareness:</b> Patients are typically aware of their deficits and become very frustrated by their inability to communicate effectively.</li><li><b>USMLE Tip:</b> Mnemonic: <b>B</b>roca's is <b>B</b>roken <b>B</b>oca (mouth). Look for a patient with a right hemiparesis (especially face and arm) who can follow commands but struggles to speak in complete sentences.</li></ul>",
      "takeAway": "<p><b>Broca's aphasia</b> is a disorder of language production, not comprehension, resulting from damage to the brain's motor-speech planning center. The resulting speech is broken and effortful, leaving the patient frustratingly aware of their inability to express their intact thoughts.</p>",
      "mermaid": "graph TD; A[Lesion in Broca's Area] --> B(Impaired Speech Production); B --> C(Nonfluent, Telegraphic Speech); A --Spares--> D(Wernicke's Area); D --> E(Intact Comprehension);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "6bc9a567"
      },
      {
        "type": "is_caused_by_lesion_in",
        "to": "a3bbace2"
      },
      {
        "type": "is_caused_by_stroke_in",
        "to": "143bb23d"
      },
      {
        "type": "is_contrasted_with",
        "to": "2c4a6130"
      }
    ]
  },
  "a3bbace2": {
    "title": "Broca's Area",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Cerebral Cortex"
    ],
    "content": {
      "definition": "<p><b>Broca's area</b> is a region in the frontal lobe of the dominant hemisphere (usually the left) of the brain with functions linked to speech production.</p>",
      "atAGlance": "<ul><li><b>Location:</b> Located in the <mark>inferior frontal gyrus</mark> of the dominant hemisphere (Brodmann areas 44 and 45).</li><li><b>Function:</b> Responsible for the motor planning and execution of speech. It coordinates the movements of the larynx, tongue, and lips necessary for articulation.</li><li><b>Vascular Supply:</b> Supplied by the superior division of the [[143bb23d|Middle Cerebral Artery (MCA)]].</li><li><b>Lesion Effect:</b> Damage to this area results in [[7f6ed344|Broca's aphasia]] (expressive aphasia), characterized by nonfluent, agrammatical speech with intact comprehension.</li><li><b>Connection:</b> It is connected to [[wernicke_area|Wernicke's area]] (language comprehension) by a bundle of nerve fibers called the arcuate fasciculus.</li><li><b>USMLE Tip:</b> A stroke affecting the left MCA is the most common cause of damage to Broca's area. Because of its proximity to the primary motor cortex, [[7f6ed344|Broca's aphasia]] is often accompanied by contralateral weakness of the face and arm.</li></ul>",
      "takeAway": "<p><b>Broca's area</b> is the brain's 'speech production factory,' translating thoughts and concepts from Wernicke's area into the precise motor commands needed for fluent articulation; a lesion here breaks the production line, resulting in expressive aphasia.</p>",
      "mermaid": "graph TD; A[Wernicke's Area - Comprehension] --Arcuate Fasciculus--> B(Broca's Area); B --Motor Plan--> C(Primary Motor Cortex); C --> D(Speech Articulation);"
    },
    "connections": [
      {
        "type": "is_located_in",
        "to": "frontal_lobe"
      },
      {
        "type": "lesion_causes",
        "to": "7f6ed344"
      },
      {
        "type": "is_supplied_by",
        "to": "143bb23d"
      },
      {
        "type": "is_connected_to",
        "to": "wernicke_area"
      }
    ]
  },
  "d24a5ff0": {
    "title": "Bromocriptine",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Endocrinology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Parkinson Disease Therapy"
    ],
    "content": {
      "definition": "<p><b>Bromocriptine</b> is an ergot derivative that acts as a <i>dopamine D<sub>2</sub> receptor agonist</i>. It is used to treat conditions associated with hyperprolactinemia and [[58c8ea03|Parkinson disease]].</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Stimulates dopamine D<sub>2</sub> receptors in the CNS and periphery.</li><li><b>Clinical Use (Endocrinology):</b> Treats hyperprolactinemia and prolactinomas by stimulating D<sub>2</sub> receptors on lactotrophs in the anterior pituitary, which inhibits prolactin secretion. Also used for acromegaly as it can suppress GH secretion.</li><li><b>Clinical Use (Neurology):</b> Used as an adjunctive therapy in [[58c8ea03|Parkinson disease]] to stimulate dopamine receptors in the striatum. It is an ergot derivative and is less commonly used now than non-ergot agonists (e.g., pramipexole, ropinirole) due to its side effect profile.</li><li><b>Adverse Effects:</b> Nausea, vomiting, postural hypotension, and headache. As an ergot derivative, it can cause pulmonary fibrosis and vasospasm.</li><li><b>USMLE Tip:</b> Bromocriptine is a classic treatment for prolactinomas. Remember that dopamine tonically inhibits prolactin release, so a dopamine agonist will lower prolactin levels.</li></ul>",
      "takeAway": "<p><b>Bromocriptine</b> is a dopamine D<sub>2</sub> agonist that leverages dopamine's inhibitory control over prolactin to treat hyperprolactinemia and supplements dopamine signaling in the basal ganglia to treat Parkinson disease, though its use is limited by its ergot-related side effects.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "dopamine_agonist"
      },
      {
        "type": "treats",
        "to": "hyperprolactinemia"
      },
      {
        "type": "treats",
        "to": "58c8ea03"
      },
      {
        "type": "treats",
        "to": "acromegaly"
      }
    ]
  },
  "4792bc68": {
    "title": "Brown-Séquard Syndrome",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Trauma",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Spinal Cord Lesions"
    ],
    "content": {
      "definition": "<p><b>Brown-Séquard syndrome</b> is a rare neurological condition caused by <i>hemisection of the spinal cord</i>, resulting in a characteristic pattern of ipsilateral motor and proprioceptive loss, and contralateral pain and temperature sensory loss below the level of the lesion.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Typically caused by trauma, such as a penetrating injury (e.g., stab wound) or a tumor compressing one half of the spinal cord.</li><li><b>Ipsilateral Deficits (at and below lesion):</b><br> - <b>Motor:</b> Ipsilateral spastic paralysis below the lesion (corticospinal tract damage).<br> - <b>Sensation:</b> Ipsilateral loss of proprioception, vibration, and fine touch below the lesion ([[e7f5cbbe|dorsal column]] damage).</li><li><b>Contralateral Deficits (below lesion):</b><br> - <b>Sensation:</b> Contralateral loss of pain and temperature sensation, typically beginning 1-2 segments below the lesion (spinothalamic tract damage, as fibers decussate in the spinal cord).</li><li><b>Deficits at the Level of the Lesion:</b><br> - Ipsilateral flaccid paralysis (LMN damage at that level).<br> - Ipsilateral complete loss of all sensation.</li><li><b>USMLE Tip:</b> This syndrome is a classic test of spinal cord tract anatomy. The key is remembering which tracts cross in the medulla (dorsal columns, corticospinal) versus the spinal cord (spinothalamic). If the lesion is above T1, an ipsilateral [[c19010a3|Horner syndrome]] may also be present.</li></ul>",
      "takeAway": "<p><b>Brown-Séquard syndrome</b> is the ultimate clinical demonstration of spinal cord neuroanatomy, creating a striking dissociation of deficits where one side of the body loses motor function and proprioception, while the other side loses the ability to feel pain and temperature, all due to a unilateral cord lesion.</p>",
      "mermaid": "graph TD; A[Spinal Cord Hemisection at T10]; A --> B(Ipsilateral (Right) Deficits); B --> C(Loss of Motor, Proprioception, Vibration below T10); B --> D(Flaccid paralysis at T10); A --> E(Contralateral (Left) Deficits); E --> F(Loss of Pain & Temperature below T10);"
    },
    "connections": [
      {
        "type": "is_caused_by",
        "to": "spinal_cord_hemisection"
      },
      {
        "type": "damages",
        "to": "corticospinal_tracts"
      },
      {
        "type": "damages",
        "to": "e7f5cbbe"
      },
      {
        "type": "damages",
        "to": "07eecef1"
      }
    ]
  },
  "901f3180": {
    "title": "Bulbar Palsy",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Motor Neuron Diseases"
    ],
    "content": {
      "definition": "<p><b>Bulbar palsy</b> refers to a set of clinical signs resulting from damage to the <u>lower motor neurons (LMNs)</u> of the cranial nerves originating in the brainstem (medulla oblongata, or 'bulb'). Specifically, it involves cranial nerves IX (glossopharyngeal), X (vagus), XI (accessory), and XII (hypoglossal).</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Caused by LMN lesions of cranial nerves IX, X, XI, and XII.</li><li><b>Clinical Presentation:</b> Characterized by <mark>flaccid weakness</mark> of the muscles of the mouth, pharynx, and larynx. This leads to dysarthria (slurred speech), dysphagia (difficulty swallowing), drooling, and a hoarse or nasal voice.</li><li><b>Physical Exam Findings:</b> On examination, there is tongue wasting and <mark>fasciculations</'mark> (LMN signs), a diminished or absent gag reflex, and the palate may not elevate symmetrically.</li><li><b>Causes:</b> Can be seen in [[4ed629f9|Amyotrophic Lateral Sclerosis (ALS)]], Guillain-Barré syndrome, myasthenia gravis, and brainstem strokes or tumors.</li><li><b>USMLE Tip:</b> Differentiate from <b>pseudobulbar palsy</b>, which is caused by <u>upper motor neuron (UMN)</u> lesions. Pseudobulbar palsy presents with a spastic dysarthria, an exaggerated gag reflex, and emotional lability (pseudobulbar affect), without tongue atrophy or fasciculations.</li></ul>",
      "takeAway": "<p><b>Bulbar palsy</b> is a manifestation of lower motor neuron damage to the lower cranial nerves, resulting in a flaccid paralysis of the oral, pharyngeal, and laryngeal muscles, which must be distinguished from the spastic paralysis of the same muscles seen in the upper motor neuron condition, pseudobulbar palsy.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_sign_of",
        "to": "lower_motor_neuron_lesion"
      },
      {
        "type": "affects_cranial_nerves",
        "to": "glossopharyngeal_nerve"
      },
      {
        "type": "affects_cranial_nerves",
        "to": "vagus_nerve"
      },
      {
        "type": "affects_cranial_nerves",
        "to": "accessory_nerve"
      },
      {
        "type": "affects_cranial_nerves",
        "to": "hypoglossal_nerve"
      },
      {
        "type": "differentiated_from",
        "to": "pseudobulbar_palsy"
      }
    ]
  },
  "181a22b1": {
    "title": "Bupivacaine",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Anesthesiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Anesthetics"
    ],
    "content": {
      "definition": "<p><b>Bupivacaine</b> is a long-acting, amide-type <i>local anesthetic</i> commonly used for regional anesthesia, such as epidurals for labor and spinal anesthesia for surgical procedures.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Blocks voltage-gated Na<sup>+</sup> channels in nerve membranes, preventing the generation and conduction of nerve impulses.</li><li><b>Class:</b> Amide local anesthetic (has two 'i's in its name).</li><li><b>Pharmacokinetics:</b> Has a long duration of action, making it suitable for prolonged procedures and postoperative pain control.</li><li><b>Clinical Use:</b> Widely used for epidural analgesia, spinal anesthesia, and peripheral nerve blocks.</li><li><b>Adverse Effect:</b> The most notable adverse effect is <mark>severe cardiotoxicity</mark>. It is more cardiotoxic than other local anesthetics. Accidental intravascular injection can lead to severe ventricular arrhythmias and cardiovascular collapse that is difficult to resuscitate.</li><li><b>USMLE Tip:</b> Remember bupivacaine for its long duration of action and its significant risk of cardiotoxicity. This risk is a major consideration in its clinical use and dosing.</li></ul>",
      "takeAway": "<p><b>Bupivacaine</b> is a potent, long-acting amide anesthetic favored for epidurals and nerve blocks, but its use is shadowed by a significant risk of severe cardiotoxicity if accidentally injected systemically.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "local_anesthetics"
      },
      {
        "type": "has_adverse_effect",
        "to": "cardiotoxicity"
      },
      {
        "type": "blocks_channel",
        "to": "voltage_gated_sodium_channel"
      }
    ]
  },
  "5b2b854f": {
    "title": "Buprenorphine",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Psychiatry",
      "Pain Management",
      "USMLE"
    ],
    "classificationPath": [
      "Psychiatry",
      "Pharmacology",
      "Opioids"
    ],
    "content": {
      "definition": "<p><b>Buprenorphine</b> is a semi-synthetic opioid that acts as a <i>partial agonist</i> at the μ-opioid receptor and an antagonist at the κ-opioid receptor. It is used for both pain management and the treatment of opioid use disorder.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> As a <mark>partial μ-opioid agonist</mark>, it binds with high affinity but has lower intrinsic activity than full agonists like morphine. This creates a 'ceiling effect' on respiratory depression, making it safer in overdose than full agonists.</li><li><b>Clinical Use (Opioid Use Disorder):</b> Used for opioid detoxification and maintenance therapy. It can precipitate withdrawal if given to a patient who is currently using full opioids due to its high affinity and lower intrinsic activity. Often co-formulated with naloxone (Suboxone) to deter IV abuse.</li><li><b>Clinical Use (Pain):</b> Effective for moderate to severe chronic pain, available in various formulations including transdermal patches.</li><li><b>Reversal:</b> Its effects are not easily reversed by naloxone due to its high affinity for the μ-receptor, requiring higher doses of the antagonist.</li><li><b>USMLE Tip:</b> The key concept for buprenorphine is 'partial agonist.' This explains its ceiling effect on respiratory depression and its ability to precipitate withdrawal in an opioid-dependent individual.</li></ul>",
      "takeAway": "<p><b>Buprenorphine</b> is a unique opioid that acts as a partial agonist, providing analgesia and mitigating withdrawal symptoms with a lower risk of respiratory depression, but its high receptor affinity means it can displace full agonists and precipitate withdrawal if not initiated carefully.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "opioid_analgesics"
      },
      {
        "type": "acts_as",
        "to": "partial_mu_opioid_agonist"
      },
      {
        "type": "treats",
        "to": "opioid_use_disorder"
      }
    ]
  },
  "34217723": {
    "title": "Butorphanol",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Pain Management",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Opioids"
    ],
    "content": {
      "definition": "<p><b>Butorphanol</b> is a synthetic opioid analgesic that functions as a <i>mixed agonist-antagonist</i>. It is primarily used for the management of moderate to severe pain.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Acts as a <mark>κ-opioid receptor agonist</mark> and a <mark>μ-opioid receptor partial agonist or weak antagonist</mark>.</li><li><b>Analgesic Effect:</b> The κ-agonist activity provides strong analgesia.</li><li><b>Ceiling Effect:</b> Like other mixed agonist-antagonists, it exhibits a ceiling effect for respiratory depression, making it potentially safer in overdose compared to full μ-agonists.</li><li><b>Clinical Use:</b> Used for moderate to severe pain, particularly in labor (less neonatal respiratory depression) and for postoperative pain. Also available as a nasal spray for [[c8833bae|migraines]].</li><li><b>Adverse Effects:</b> Can cause sedation, nausea, and psychotomimetic effects (e.g., hallucinations, dysphoria) due to κ-receptor agonism. It can precipitate withdrawal symptoms in patients physically dependent on full μ-opioid agonists.</li><li><b>USMLE Tip:</b> Remember that mixed agonist-antagonists like butorphanol and nalbuphine can precipitate withdrawal in opioid-dependent patients. Their primary analgesic effect comes from κ-agonism.</li></ul>",
      "takeAway": "<p><b>Butorphanol</b> is a mixed-action opioid that provides potent analgesia through κ-receptor agonism while having a limited effect on μ-receptors, which gives it a better safety profile regarding respiratory depression but also the potential to induce withdrawal in opioid-dependent individuals.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "opioid_analgesics"
      },
      {
        "type": "acts_as",
        "to": "kappa_opioid_agonist"
      },
      {
        "type": "acts_as",
        "to": "mu_opioid_partial_agonist_antagonist"
      },
      {
        "type": "can_precipitate",
        "to": "opioid_withdrawal"
      }
    ]
  },
  "ca6ee143": {
    "title": "Cabergoline",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Endocrinology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Endocrine",
      "Pharmacology",
      "Hypothalamic and Pituitary Drugs"
    ],
    "content": {
      "definition": "<p><b>Cabergoline</b> is a long-acting ergot derivative that is a potent <i>dopamine D<sub>2</sub> receptor agonist</i>. It is the first-line treatment for hyperprolactinemia and prolactin-secreting [[5f3188bd|pituitary adenomas]] (prolactinomas).</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Stimulates D<sub>2</sub> receptors on lactotrophs in the [[76ba7f2e|anterior pituitary]], mimicking the natural inhibitory effect of dopamine on prolactin secretion. This leads to a decrease in serum prolactin levels and can cause shrinkage of prolactinomas.</li><li><b>Clinical Use:</b> <u>First-line treatment</u> for prolactinomas and hyperprolactinemia. Also used in [[acromegaly]] (can suppress GH secretion) and [[58c8ea03|Parkinson disease]].</li><li><b>Pharmacokinetics:</b> Has a long half-life, allowing for once or twice weekly dosing, which improves patient compliance compared to [[d24a5ff0|bromocriptine]].</li><li><b>Adverse Effects:</b> Nausea, headache, postural hypotension. Less nausea than bromocriptine. High doses have been associated with valvular heart disease, but this is rare at the doses used for hyperprolactinemia.</li><li><b>USMLE Tip:</b> Cabergoline is preferred over [[d24a5ff0|bromocriptine]] for treating prolactinomas due to its higher efficacy, better side-effect profile, and more convenient dosing schedule.</li></ul>",
      "takeAway": "<p><b>Cabergoline</b> is the superior dopamine agonist for treating hyperprolactinemia, effectively suppressing prolactin secretion and shrinking pituitary tumors by powerfully stimulating D<sub>2</sub> receptors, with the clinical advantage of a long half-life and better tolerability.</p>",
      "mermaid": "graph TD; A[Cabergoline] --> B(Stimulates D2 Receptors on Lactotrophs); B --> C(↓ Prolactin Secretion); C --> D(↓ Serum Prolactin & Tumor Shrinkage);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "dopamine_agonist"
      },
      {
        "type": "treats",
        "to": "hyperprolactinemia"
      },
      {
        "type": "treats",
        "to": "5f3188bd"
      },
      {
        "type": "is_preferred_over",
        "to": "d24a5ff0"
      }
    ]
  },
  "cbb4285c": {
    "title": "Café-au-lait Spots",
    "primaryType": "finding",
    "tags": [
      "Dermatology",
      "Neurology",
      "Genetics",
      "USMLE"
    ],
    "classificationPath": [
      "Musculoskeletal, Skin, and Connective Tissue",
      "Dermatology",
      "Pigmented Lesions"
    ],
    "content": {
      "definition": "<p><b>Café-au-lait spots</b> are well-demarcated, hyperpigmented macules or patches on the skin, with a color resembling 'coffee with milk.' While a few small spots can be normal, the presence of multiple, large spots is a hallmark of several genetic syndromes, most notably Neurofibromatosis Type 1.</p>",
      "atAGlance": "<ul><li><b>Description:</b> Flat, pigmented birthmarks with a light brown color and distinct borders.</li><li><b>Neurofibromatosis Type 1 (NF-1):</b> The presence of <mark>six or more</mark> café-au-lait spots greater than 5 mm in diameter in prepubertal individuals (or >15 mm in postpubertal individuals) is a key diagnostic criterion for NF-1. The spots in NF-1 typically have smooth borders ('coast of California').</li><li><b>McCune-Albright Syndrome:</b> Characterized by a triad of fibrous dysplasia of bone, endocrine abnormalities (like precocious puberty), and large, unilateral café-au-lait spots with irregular, jagged borders ('coast of Maine').</li><li><b>Other Associations:</b> Can also be seen in tuberous sclerosis, Fanconi anemia, and other syndromes, but are most strongly associated with NF-1.</li><li><b>USMLE Tip:</b> Multiple café-au-lait spots in a child should prompt a thorough evaluation for other signs of Neurofibromatosis Type 1, such as axillary freckling, Lisch nodules, and neurofibromas.</li></ul>",
      "takeAway": "<p>While often benign, multiple <b>café-au-lait spots</b> are a crucial dermatological clue to underlying systemic genetic disorders, with the number and border characteristics (smooth in NF-1, irregular in McCune-Albright) helping to narrow the differential diagnosis.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_sign_of",
        "to": "neurofibromatosis_type_1"
      },
      {
        "type": "is_a_sign_of",
        "to": "mccune_albright_syndrome"
      }
    ]
  },
  "24d36d58": {
    "title": "Calcitonin Gene-Related Peptide (CGRP)",
    "primaryType": "molecule",
    "tags": [
      "Neuroscience",
      "Pharmacology",
      "Physiology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Neurotransmitters"
    ],
    "content": {
      "definition": "<p><b>Calcitonin Gene-Related Peptide (CGRP)</b> is a 37-amino acid neuropeptide that is widely distributed in the central and peripheral nervous systems. It is a potent vasodilator and is critically involved in pain transmission, particularly in the pathophysiology of [[c8833bae|migraine headaches]].</p>",
      "atAGlance": "<ul><li><b>Function:</b> Acts as a potent arterial vasodilator and a neurotransmitter/neuromodulator in pain pathways.</li><li><b>Role in Migraine:</b> During a migraine attack, CGRP is released from trigeminal nerve endings. This release causes vasodilation of cranial blood vessels and promotes neurogenic inflammation, contributing to the pain of a migraine.</li><li><b>Therapeutic Target:</b> CGRP and its receptor have become major targets for migraine therapy.</li><li><b>Drug Classes Targeting CGRP:</b><br>1. <b>[[4770b8a2|Anti-CGRP Monoclonal Antibodies]]</b> (e.g., erenumab, galcanezumab): Used for migraine <u>prophylaxis</u>.<br>2. <b>Gepants</b> (e.g., ubrogepant, rimegepant): Small molecule CGRP receptor antagonists used for <u>acute</u> treatment of migraines.</li><li><b>USMLE Tip:</b> The central role of CGRP in migraine pathophysiology is a high-yield concept. Understand that blocking the CGRP pathway, either with monoclonal antibodies for prevention or gepants for acute attacks, is a modern, targeted approach to migraine treatment.</li></ul>",
      "takeAway": "<p><b>Calcitonin Gene-Related Peptide (CGRP)</b> is a key player in the generation of migraine pain, acting as both a powerful vasodilator and a pain-signaling molecule in the trigeminal system, making its blockade a highly effective strategy for migraine therapy.</p>",
      "mermaid": "graph TD; A[Trigeminal Nerve Activation] --> B(Release of CGRP); B --> C(Vasodilation & Neurogenic Inflammation); C --> D(Migraine Pain);"
    },
    "connections": [
      {
        "type": "is_implicated_in",
        "to": "c8833bae"
      },
      {
        "type": "is_targeted_by",
        "to": "4770b8a2"
      },
      {
        "type": "is_targeted_by",
        "to": "gepants"
      }
    ]
  },
  "e4b8298b": {
    "title": "Capsaicin",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Pain Management",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Analgesics"
    ],
    "content": {
      "definition": "<p><b>Capsaicin</b> is the active component of chili peppers and is used topically as an analgesic for neuropathic and musculoskeletal pain. It works by interacting with the transient receptor potential vanilloid 1 (TRPV1) receptor on nociceptive nerve fibers.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Initially, capsaicin activates TRPV1 receptors (also known as capsaicin receptors), causing an influx of calcium and the release of substance P, which leads to a burning sensation. With repeated application, it causes <mark>desensitization</-mark> of the nerve fibers and <mark>depletion of substance P</mark>, resulting in an analgesic effect.</li><li><b>Clinical Use:</b> Used topically for neuropathic pain (e.g., postherpetic neuralgia, diabetic neuropathy) and musculoskeletal pain (e.g., osteoarthritis).</li><li><b>Administration:</b> Available as a low-concentration over-the-counter cream or a high-concentration prescription patch.</li><li><b>Adverse Effects:</b> The most common side effect is a localized burning, stinging, or erythema at the application site, which typically diminishes with continued use.</li><li><b>USMLE Tip:</b> The key mechanism to remember is the initial activation followed by desensitization and depletion of substance P from sensory nerve endings.</li></ul>",
      "takeAway": "<p><b>Capsaicin</b> paradoxically relieves pain by first causing it; its initial stimulation of pain receptors leads to their eventual desensitization and the depletion of substance P, effectively silencing the pain signals from the affected area.</p>",
      "mermaid": "graph TD; A[Topical Capsaicin] --> B(Activates TRPV1 Receptors); B --> C(Initial Release of Substance P); C --> D(Burning Sensation); B --Repeated Application--> E(Desensitization & Depletion of Substance P); E --> F(Analgesia);"
    },
    "connections": [
      {
        "type": "treats",
        "to": "neuropathic_pain"
      },
      {
        "type": "acts_on_receptor",
        "to": "trpv1_receptor"
      },
      {
        "type": "depletes",
        "to": "substance_p"
      }
    ]
  },
  "a5ec55b5": {
    "title": "Caput Succedaneum",
    "primaryType": "finding",
    "tags": [
      "Pediatrics",
      "Obstetrics",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Neonatal Injuries"
    ],
    "content": {
      "definition": "<p><b>Caput succedaneum</b> is a benign, edematous swelling of the soft tissues of a newborn's scalp that is present at birth. It is caused by pressure on the infant's head from the cervix or vaginal wall during a prolonged or difficult delivery.</p>",
      "atAGlance": "<ul><li><b>Location:</b> The edema is located in the subcutaneous tissue, <u>superficial to the periosteum</u> of the skull.</li><li><b>Clinical Presentation:</b> A soft, puffy, and sometimes ecchymotic swelling on the scalp. A key feature is that it <mark>crosses suture lines</mark>.</li><li><b>Timing:</b> Present at birth and typically resolves spontaneously within a few days.</li><li><b>Differentiation:</b> It must be distinguished from a [[a1721d6f|cephalohematoma]].<br> - <b>Caput Succedaneum:</b> Soft, pits on pressure, crosses suture lines, resolves quickly.<br> - <b>Cephalohematoma:</b> Firm, does <u>not</u> cross suture lines (subperiosteal), resolves over weeks to months, may calcify.</li><li><b>USMLE Tip:</b> The ability to cross suture lines is the most important feature for distinguishing caput succedaneum from a cephalohematoma on an exam.</li></ul>",
      "takeAway": "<p><b>Caput succedaneum</b> is a benign and self-resolving scalp edema in newborns resulting from birth trauma, easily identified by its soft consistency and its ability to cross cranial suture lines, distinguishing it from the more localized and potentially complicated cephalohematoma.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "46ca72c2"
      },
      {
        "type": "differentiated_from",
        "to": "a1721d6f"
      }
    ]
  },
  "c1ad76f4": {
    "title": "Carbachol",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "Autonomic",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Glaucoma Therapy"
    ],
    "content": {
      "definition": "<p><b>Carbachol</b> is a <i>cholinomimetic agent</i> that acts as a non-selective agonist at both muscarinic and nicotinic acetylcholine receptors. It is primarily used in ophthalmology to treat glaucoma.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> As a direct cholinergic agonist, it mimics the effects of [[6a005559|acetylcholine]]. In the eye, it stimulates muscarinic (M<sub>3</sub>) receptors on the ciliary muscle and the sphincter pupillae muscle.</li><li><b>Ocular Effects:</b><br> 1. <b>Miosis:</b> Contraction of the sphincter pupillae muscle causes pupillary constriction.<br> 2. <b>↓ IOP:</b> Contraction of the ciliary muscle increases the outflow of aqueous humor through the trabecular meshwork, lowering intraocular pressure.</li><li><b>Clinical Use:</b> Used topically to treat [[5ea7b741|open-angle glaucoma]] and to produce miosis during ophthalmic surgery. It is less commonly used than pilocarpine.</li><li><b>Resistance to AChE:</b> Carbachol is resistant to hydrolysis by acetylcholinesterase, giving it a longer duration of action than acetylcholine.</li><li><b>USMLE Tip:</b> Remember carbachol as a direct-acting cholinomimetic that lowers IOP by increasing trabecular outflow, a mechanism shared with pilocarpine.</li></ul>",
      "takeAway": "<p><b>Carbachol</b> is a potent, long-acting acetylcholine mimic that effectively lowers intraocular pressure in glaucoma by contracting the ciliary muscle to open up the trabecular meshwork drainage channels.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "cholinomimetic_agent"
      },
      {
        "type": "treats",
        "to": "3ce6c035"
      },
      {
        "type": "acts_as_agonist_at",
        "to": "muscarinic_receptors"
      },
      {
        "type": "acts_as_agonist_at",
        "to": "nicotinic_receptors"
      }
    ]
  },
  "eddd2bc5": {
    "title": "Carbamazepine",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Neurology",
      "Psychiatry",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Anticonvulsants"
    ],
    "content": {
      "definition": "<p><b>Carbamazepine</b> is a narrow-spectrum <i>anticonvulsant</i> drug that works by blocking voltage-gated sodium channels. It is also used as a mood stabilizer and for the treatment of neuropathic pain.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Blocks voltage-gated Na<sup>+</sup> channels in their inactivated state, which prolongs the refractory period of the neuron and prevents repetitive firing.</li><li><b>Clinical Use:</b><br> - <b>Seizures:</b> First-line treatment for <mark>focal seizures</mark> (both simple and complex) and generalized tonic-clonic seizures.<br> - <b>Neuropathic Pain:</b> First-line treatment for <mark>trigeminal neuralgia</mark>.<br> - <b>Bipolar Disorder:</b> Used as a mood stabilizer.</li><li><b>Adverse Effects:</b> Diplopia, ataxia, SIADH (hyponatremia), and skin rashes. Two serious, rare side effects are <mark>agranulocytosis</mark> and <mark>aplastic anemia</mark>, requiring monitoring of CBC. It is also a potent inducer of cytochrome P450 enzymes, leading to many drug interactions.</li><li><b>Teratogenicity:</b> Associated with an increased risk of <mark>neural tube defects</mark> in pregnancy.</li><li><b>USMLE Tip:</b> Carbamazepine is the drug of choice for trigeminal neuralgia. Remember its major hematologic side effects (agranulocytosis, aplastic anemia) and its induction of the P450 system.</li></ul>",
      "takeAway": "<p><b>Carbamazepine</b> is a cornerstone therapy for focal seizures and trigeminal neuralgia, acting by stabilizing inactivated sodium channels, but its use requires careful monitoring due to the risk of severe hematologic toxicity and its potent induction of hepatic enzymes.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "f91a0cfa"
      },
      {
        "type": "treats",
        "to": "trigeminal_neuralgia"
      },
      {
        "type": "treats",
        "to": "focal_seizures"
      },
      {
        "type": "causes_adverse_effect",
        "to": "agranulocytosis"
      },
      {
        "type": "causes_adverse_effect",
        "to": "aplastic_anemia"
      },
      {
        "type": "causes_adverse_effect",
        "to": "siadh"
      }
    ]
  },
  "541cd176": {
    "title": "Carbidopa/Levodopa",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Parkinson Disease Therapy"
    ],
    "content": {
      "definition": "<p><b>Carbidopa/Levodopa</b> (trade name Sinemet) is the most effective and widely used combination drug for the symptomatic treatment of [[58c8ea03|Parkinson disease]]. Levodopa is a metabolic precursor to dopamine, while carbidopa is a peripheral DOPA decarboxylase inhibitor.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b><br> - <b>Levodopa (L-DOPA):</b> Can cross the [[dd47b9cc|blood-brain barrier]] (unlike dopamine) and is converted to [[90adc821|dopamine]] in the CNS by DOPA decarboxylase, replenishing the depleted dopamine stores in the striatum.<br> - <b>Carbidopa:</b> Inhibits peripheral DOPA decarboxylase. This prevents the conversion of L-DOPA to dopamine in the periphery, which <mark>increases the bioavailability of L-DOPA in the brain</mark> and <mark>reduces peripheral side effects</mark> (like nausea and arrhythmias).</li><li><b>Clinical Use:</b> The cornerstone of treatment for [[58c8ea03|Parkinson disease]], particularly effective for bradykinesia and rigidity.</li><li><b>Adverse Effects:</b> Nausea, hallucinations, postural hypotension. Long-term use is associated with motor fluctuations ('on-off' phenomenon) and dyskinesias (involuntary movements).</li><li><b>USMLE Tip:</b> The rationale for the combination is key: Carbidopa acts as a 'bodyguard' for Levodopa, ensuring more of it reaches the brain where it's needed, while minimizing side effects elsewhere in the body.</li></ul>",
      "takeAway": "<p>The <b>Carbidopa/Levodopa</b> combination is a brilliant pharmacological strategy that overcomes the blood-brain barrier by using a precursor (Levodopa) and then protecting that precursor from peripheral breakdown (with Carbidopa) to effectively deliver dopamine to the deficient basal ganglia in Parkinson's disease.</p>",
      "mermaid": "graph TD; A[Levodopa] --Peripheral DOPA Decarboxylase--> B(Dopamine - Periphery); C[Carbidopa] --x B; A --> D(Crosses BBB); D --> E[L-DOPA in CNS]; E --Central DOPA Decarboxylase--> F(Dopamine - CNS); F --> G(Treats Parkinson's Symptoms);"
    },
    "connections": [
      {
        "type": "treats",
        "to": "58c8ea03"
      },
      {
        "type": "is_a_precursor_to",
        "to": "90adc821"
      },
      {
        "type": "is_combined_with",
        "to": "carbidopa"
      }
    ]
  },
  "e1e7ac22": {
    "title": "Carotid-Cavernous Fistula",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Cerebrovascular Disease"
    ],
    "content": {
      "definition": "<p>A <b>Carotid-Cavernous Fistula (CCF)</b> is an abnormal communication between the internal carotid artery and the [[c260efc8|cavernous sinus]]. This creates a high-flow, high-pressure arteriovenous shunt within the sinus, leading to a characteristic set of signs and symptoms.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Can be traumatic (e.g., from a basal skull fracture) or spontaneous (e.g., from a ruptured intracavernous carotid aneurysm).</li><li><b>Pathophysiology:</b> Arterial blood from the internal carotid artery flows directly into the low-pressure [[c260efc8|cavernous sinus]]. This increases pressure in the sinus and reverses blood flow in the veins that drain into it, particularly the superior ophthalmic vein.</li><li><b>Clinical Triad:</b> The classic triad is <mark>pulsatile exophthalmos</mark> (protruding, pulsating eye), <mark>ocular bruit</mark> (a whooshing sound heard over the eye), and <mark>chemosis</mark> (conjunctival edema and redness).</li><li><b>Other Symptoms:</b> Patients also develop ophthalmoplegia (paralysis of eye muscles) due to dysfunction of cranial nerves III, IV, and VI, which all traverse the cavernous sinus. There may also be sensory loss in the V<sub>1</sub> and V<sub>2</sub> distribution.</li><li><b>USMLE Tip:</b> The combination of a pulsating eye and an audible bruit over the eye after head trauma is pathognomonic for a carotid-cavernous fistula.</li></ul>",
      "takeAway": "<p>A <b>Carotid-Cavernous Fistula</b> creates a high-pressure vascular storm within the cavernous sinus, engorging the orbital veins and compressing the cranial nerves that pass through it, resulting in the dramatic clinical picture of a pulsating, red, and paralyzed eye.</p>",
      "mermaid": "graph TD; A[Internal Carotid Artery] --Fistula--> B(Cavernous Sinus); B --> C(↑ Pressure in Sinus); C --> D(Reversal of flow in Superior Ophthalmic Vein); D --> E(Pulsatile Exophthalmos, Chemosis, Bruit); C --> F(Compression of CN III, IV, V1, V2, VI); F --> G(Ophthalmoplegia, Sensory Loss);"
    },
    "connections": [
      {
        "type": "affects",
        "to": "c260efc8"
      },
      {
        "type": "causes",
        "to": "ophthalmoplegia"
      },
      {
        "type": "presents_with",
        "to": "pulsatile_exophthalmos"
      }
    ]
  },
  "6696dd3a": {
    "title": "Carteolol",
    "primaryType": "drug",
    "tags": [
      "Pharmacology",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pharmacology",
      "Glaucoma Therapy"
    ],
    "content": {
      "definition": "<p><b>Carteolol</b> is a non-selective <i>β-adrenergic antagonist</i> (beta-blocker) used as a topical eye drop to reduce intraocular pressure (IOP) in the treatment of [[5ea7b741|open-angle glaucoma]] and ocular hypertension.</p>",
      "atAGlance": "<ul><li><b>Mechanism of Action:</b> Blocks both β<sub>1</sub> and β<sub>2</sub> adrenergic receptors on the ciliary epithelium. This leads to a <mark>decrease in aqueous humor production</mark>, thereby lowering IOP.</li><li><b>Class:</b> Non-selective beta-blocker, similar to [[ae28be6c|timolol]].</li><li><b>Clinical Use:</b> A first-line agent for [[5ea7b741|open-angle glaucoma]].</li><li><b>Adverse Effects:</b> Ocular side effects include stinging and burning. Systemic absorption can occur, potentially causing bradycardia, hypotension, fatigue, and bronchoconstriction.</li><li><b>Contraindications:</b> Should be used with caution in patients with asthma, COPD, bradycardia, or heart block due to its non-selective β-blockade.</li><li><b>USMLE Tip:</b> Like all non-selective beta-blockers used for glaucoma, carteolol's main mechanism is decreasing aqueous humor production. Be aware of the potential for systemic side effects, especially bronchospasm in patients with reactive airway disease.</li></ul>",
      "takeAway": "<p><b>Carteolol</b> is a non-selective beta-blocker that effectively treats glaucoma by turning down the 'faucet' of aqueous humor production in the ciliary body, but its systemic absorption carries the risk of β-blockade side effects throughout the body.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "beta_blocker"
      },
      {
        "type": "treats",
        "to": "3ce6c035"
      },
      {
        "type": "decreases_production_of",
        "to": "aqueous_humor"
      }
    ]
  },
  "85f03b02": {
    "title": "Cataracts",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Geriatrics",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Lens Disorders"
    ],
    "content": {
      "definition": "<p>A <b>cataract</b> is a painless, progressive opacification or clouding of the normally clear lens of the eye, which leads to a decrease in vision. It is the leading cause of blindness worldwide.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> Involves the denaturation and aggregation of lens proteins (crystallins), leading to loss of transparency and light scattering.</li><li><b>Risk Factors:</b> <mark>Increased age</mark> is the most common risk factor. Others include smoking, excessive alcohol use, excessive sunlight (UV) exposure, prolonged glucocorticoid use, trauma, and infection.</li><li><b>Systemic Disease Associations:</b> <mark>Diabetes mellitus</mark> (due to sorbitol accumulation via aldose reductase), classic galactosemia, galactokinase deficiency, and myotonic dystrophy.</li><li><b>Clinical Presentation:</b> Patients report painless, progressive blurring of vision, glare (especially at night with oncoming headlights), and often a myopic shift (nearsightedness). On exam, there is loss of the red reflex and the lens appears opaque.</li><li><b>Treatment:</b> The definitive treatment is surgical removal of the opacified lens and replacement with an artificial intraocular lens.</li><li><b>USMLE Tip:</b> Remember the association with diabetes and galactosemia, where excess sugars are converted to osmotically active polyols (sorbitol, galactitol) in the lens, causing hydropic swelling and opacification.</li></ul>",
      "takeAway": "<p><b>Cataracts</b> represent a clouding of the eye's lens due to protein aggregation, most commonly as a part of aging, which scatters light and causes progressive, painless vision loss that can only be definitively treated by surgical lens replacement.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "lens_disorder"
      },
      {
        "type": "is_associated_with",
        "to": "diabetes_mellitus"
      },
      {
        "type": "is_associated_with",
        "to": "galactosemia"
      },
      {
        "type": "is_treated_by",
        "to": "cataract_surgery"
      }
    ]
  },
  "1c4d7e8f": {
    "title": "Cauda Equina",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Spinal Cord",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Spinal Cord"
    ],
    "content": {
      "definition": "<p>The <b>Cauda Equina</b> (Latin for \"horse's tail\") is the bundle of spinal nerves and spinal nerve rootlets, consisting of the second through fifth lumbar nerve pairs, the first through fifth sacral nerve pairs, and the coccygeal nerve, all of which arise from the lumbar enlargement and the conus medullaris of the spinal cord.</p>",
      "atAGlance": "<ul><li><b>Anatomy:</b> Comprises the nerve roots from L2 to Co1 that descend through the lumbar cistern (subarachnoid space) below the termination of the spinal cord proper (conus medullaris, typically at L1-L2).</li><li><b>Function:</b> These nerve roots provide motor and sensory innervation to the lower extremities, perineum, and pelvic organs (including the bladder and anal sphincters).</li><li><b>Clinical Significance:</b> Compression of these nerve roots leads to <mark>[[2904b5c8|Cauda Equina Syndrome]]</mark>, a neurosurgical emergency.</li><li><b>Lumbar Puncture:</b> The cauda equina floats in the cerebrospinal fluid of the lumbar cistern, which is the target for a lumbar puncture. The needle is typically inserted at the L3-L4 or L4-L5 interspace to avoid injuring the spinal cord.</li><li><b>USMLE Tip:</b> Remember that the spinal cord ends at L1-L2 in adults. The collection of nerve roots continuing down the vertebral canal below this level is the cauda equina.</li></ul>",
      "takeAway": "<p>The <b>Cauda Equina</b> is the collection of descending lumbar and sacral nerve roots that resemble a horse's tail, filling the subarachnoid space below the end of the spinal cord; its compression results in the surgical emergency known as cauda equina syndrome.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "compression_of_causes",
        "to": "2904b5c8"
      },
      {
        "type": "is_located_inferior_to",
        "to": "conus_medullaris"
      }
    ]
  },
  "2904b5c8": {
    "title": "Cauda Equina Syndrome",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Emergency Medicine",
      "Neurosurgery",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Spinal Cord Lesions"
    ],
    "content": {
      "definition": "<p><b>Cauda Equina Syndrome</b> is a neurosurgical emergency caused by severe compression of the [[1c4d7e8f|cauda equina]], the bundle of nerve roots at the lower end of the spinal canal. This compression leads to a constellation of debilitating symptoms requiring urgent surgical decompression.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Most commonly caused by a massive midline lumbar disc herniation. Other causes include spinal stenosis, tumors, trauma, and epidural abscess or hematoma.</li><li><b>Clinical Presentation:</b> Characterized by a combination of symptoms including <mark>severe low back pain</mark>, radicular pain in one or both legs, and <mark>saddle anesthesia</mark> (loss of sensation in the perineum, buttocks, and inner thighs).</li><li><b>Red Flag Symptoms:</b> The most critical signs are <mark>bowel and/or bladder dysfunction</mark> (e.g., urinary retention or incontinence) and loss of the [[ce2052d6|anal wink reflex]].</li><li><b>Motor/Sensory Deficits:</b> Patients typically have asymmetric, flaccid paralysis or weakness in the lower extremities (LMN signs) and sensory loss.</li><li><b>Treatment:</b> <u>Urgent surgical decompression</u> is required to relieve the pressure on the nerve roots and prevent permanent paralysis and incontinence.</li><li><b>USMLE Tip:</b> The combination of low back pain, saddle anesthesia, and new-onset urinary retention is the classic triad for Cauda Equina Syndrome and warrants immediate surgical consultation.</li></ul>",
      "takeAway": "<p><b>Cauda Equina Syndrome</b> is a critical condition where compression of the lumbosacral nerve roots leads to a devastating loss of lower extremity and pelvic floor function; its hallmark 'red flag' symptoms of saddle anesthesia and bladder/bowel dysfunction signal the need for immediate surgical intervention to prevent permanent disability.</p>",
      "mermaid": "graph TD; A[Massive Lumbar Disc Herniation] --Compresses--> B(Cauda Equina); B --> C(Saddle Anesthesia); B --> D(Bowel/Bladder Dysfunction); B --> E(Lower Extremity Weakness);"
    },
    "connections": [
      {
        "type": "is_caused_by_compression_of",
        "to": "1c4d7e8f"
      },
      {
        "type": "presents_with",
        "to": "saddle_anesthesia"
      },
      {
        "type": "presents_with",
        "to": "bowel_and_bladder_dysfunction"
      },
      {
        "type": "requires",
        "to": "surgical_decompression"
      }
    ]
  },
  "3fa071ef": {
    "title": "Caudate Nucleus",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Movement Disorders",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Basal Ganglia"
    ],
    "content": {
      "definition": "<p>The <b>Caudate Nucleus</b> is a C-shaped nucleus that is a key component of the [[ed462927|basal ganglia]]. Together with the putamen, it forms the striatum, which is the main input station for the basal ganglia circuits involved in motor control and cognitive functions.</p>",
      "atAGlance": "<ul><li><b>Anatomy:</b> A large C-shaped structure with a head, body, and tail that follows the curve of the lateral ventricle.</li><li><b>Function:</b> The caudate is primarily involved in the <mark>cognitive</mark> aspects of movement, including motor planning and procedural learning. It also plays a role in reward and motivation.</li><li><b>Striatum:</b> The caudate and putamen are collectively known as the striatum.</li><li><b>Pathology:</b> Atrophy of the caudate nucleus is the hallmark pathological finding in <mark>[[ffd7e743|Huntington disease]]</mark>.</li><li><b>Imaging Finding:</b> The degeneration of the caudate head in Huntington disease leads to the characteristic appearance of <mark>enlarged lateral ventricles</mark> on brain imaging (ex vacuo ventriculomegaly).</li><li><b>USMLE Tip:</b> The association between caudate atrophy and [[ffd7e743|Huntington disease]] is extremely high-yield. A brain scan showing 'boxcar' ventricles due to a shrunken caudate in a patient with chorea is classic for Huntington's.</li></ul>",
      "takeAway": "<p>The <b>Caudate Nucleus</b> is a critical part of the basal ganglia's cognitive loop, and its profound atrophy in [[ffd7e743|Huntington disease]] is directly responsible for both the characteristic motor (chorea) and cognitive (dementia) decline seen in the disorder.</p>",
      "mermaid": "graph TD; A[Caudate Nucleus] --Atrophy in Huntington's Disease--> B(Enlarged Lateral Ventricles); A --Part of Striatum--> C(Receives Cortical Input); C --> D(Modulates Motor & Cognitive Function);"
    },
    "connections": [
      {
        "type": "is_part_of",
        "to": "ed462927"
      },
      {
        "type": "forms_striatum_with",
        "to": "putamen"
      },
      {
        "type": "atrophies_in",
        "to": "ffd7e743"
      }
    ]
  },
  "c260efc8": {
    "title": "Cavernous Sinus",
    "primaryType": "anatomy",
    "tags": [
      "Neuroanatomy",
      "Ophthalmology",
      "Vascular",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Anatomy and Physiology",
      "Dural Venous Sinuses"
    ],
    "content": {
      "definition": "<p>The <b>Cavernous Sinus</b> is a paired dural venous sinus located on either side of the sella turcica of the sphenoid bone. It is a unique venous structure because several critical cranial nerves and the internal carotid artery pass directly through it.</p>",
      "atAGlance": "<ul><li><b>Contents:</b> Mnemonic <b>O TOM CAT</b> (from superior to inferior on lateral wall, then medially):<br> - <b>O</b>culomotor n. (CN III)<br> - <b>T</b>rochlear n. (CN IV)<br> - <b>O</b>phthalmic n. (CN V<sub>1</sub>)<br> - <b>M</b>axillary n. (CN V<sub>2</sub>)<br> - <b>C</b>arotid artery (internal)<br> - <b>A</b>bducens n. (CN VI)<br> - <b>T</b> (ignore)</li><li><b>Location of CN VI:</b> The [[dd11dde6|abducens nerve (CN VI)]] is the only nerve that runs freely within the sinus, next to the internal carotid artery, making it particularly vulnerable to injury.</li><li><b>Drainage:</b> Receives venous blood from the superior and inferior ophthalmic veins and drains into the superior and inferior petrosal sinuses, which then drain to the internal jugular vein.</li><li><b>Clinical Syndromes:</b><br> - <b>[[9a089fd7|Cavernous Sinus Syndrome]]:</b> A mass effect (e.g., tumor, aneurysm) causing ophthalmoplegia, decreased corneal sensation, and Horner syndrome.<br> - <b>[[a830692a|Cavernous Sinus Thrombosis]]:</b> A blood clot in the sinus, often from a spreading facial or sinus infection, causing similar symptoms plus signs of infection and venous congestion (proptosis, chemosis).</li><li><b>USMLE Tip:</b> Any patient presenting with multiple cranial nerve palsies involving eye movement (CN III, IV, VI) should raise suspicion for a lesion in the cavernous sinus.</li></ul>",
      "takeAway": "<p>The <b>Cavernous Sinus</b> is a critical neurovascular crossroads where cranial nerves controlling eye movement and facial sensation travel alongside the internal carotid artery, making it a 'danger zone' where pathology can cause a complex ophthalmoplegia.</p>",
      "mermaid": "graph TD; A[Cavernous Sinus]; A --> B(CN III); A --> C(CN IV); A --> D(CN V1/V2); A --> E(CN VI); A --> F(Internal Carotid Artery);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "21f1c955"
      },
      {
        "type": "pathology_causes",
        "to": "9a089fd7"
      },
      {
        "type": "pathology_causes",
        "to": "a830692a"
      },
      {
        "type": "contains",
        "to": "dd11dde6"
      }
    ]
  },
  "9a089fd7": {
    "title": "Cavernous Sinus Syndrome",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Cranial Nerves"
    ],
    "content": {
      "definition": "<p><b>Cavernous Sinus Syndrome</b> is a clinical constellation of signs and symptoms resulting from any pathological process that affects the contents of the [[c260efc8|cavernous sinus]], leading to multiple cranial nerve palsies and potentially venous congestion of the orbit.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Caused by mass effect from tumors (e.g., [[5f3188bd|pituitary adenoma]]), aneurysms of the internal carotid artery, [[a830692a|cavernous sinus thrombosis]], or inflammation (e.g., Tolosa-Hunt syndrome).</li><li><b>Clinical Presentation:</b> A combination of:<br> - <b>Ophthalmoplegia:</b> Paralysis of eye movements due to involvement of CN III, IV, and VI.<br> - <b>Sensory Loss:</b> Decreased sensation in the forehead and cheek due to involvement of CN V<sub>1</sub> and V<sub>2</sub>.<br> - <b>Pupillary Changes:</b> Can have a dilated pupil (CN III compression) or a constricted pupil (Horner syndrome from sympathetic plexus damage).</li><li><b>Venous Congestion:</b> If caused by thrombosis or a fistula, may see proptosis (bulging eye) and chemosis (conjunctival swelling).</li><li><b>USMLE Tip:</b> The key to recognizing this syndrome is the involvement of <u>multiple</u> cranial nerves that all pass through one specific anatomical location: the [[c260efc8|cavernous sinus]]. The [[dd11dde6|abducens nerve (CN VI)]] is often the first nerve affected due to its medial location within the sinus.</li></ul>",
      "takeAway": "<p><b>Cavernous Sinus Syndrome</b> is the clinical manifestation of a 'mass lesion' within the cavernous sinus, presenting as a complex ophthalmoplegia with facial sensory loss, a direct result of compressing the tightly packed cranial nerves III, IV, V<sub>1</sub>, V<sub>2</sub>, and VI.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_caused_by_pathology_in",
        "to": "c260efc8"
      },
      {
        "type": "presents_with",
        "to": "ophthalmoplegia"
      },
      {
        "type": "can_be_caused_by",
        "to": "a830692a"
      },
      {
        "type": "can_be_caused_by",
        "to": "5f3188bd"
      }
    ]
  },
  "a830692a": {
    "title": "Cavernous Sinus Thrombosis",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Infectious Disease",
      "Ophthalmology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Infections"
    ],
    "content": {
      "definition": "<p><b>Cavernous Sinus Thrombosis</b> is the formation of a blood clot within the [[c260efc8|cavernous sinus]], a rare but life-threatening condition that is most often caused by a contiguous spread of infection from the face, sinuses, or teeth.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Most commonly a septic thrombosis resulting from infection. The most common pathogen is <mark><i>Staphylococcus aureus</i></mark>. Infection can spread from the 'danger triangle' of the face, sphenoid or ethmoid sinuses, or dental abscesses via the valveless facial venous system.</li><li><b>Pathophysiology:</b> The thrombus obstructs venous drainage and causes inflammation, leading to increased pressure within the sinus and compression of its contents.</li><li><b>Clinical Presentation:</b> Patients present with severe headache, high fever, and signs of [[9a089fd7|cavernous sinus syndrome]]: ophthalmoplegia (CN III, IV, VI palsy), periorbital edema, proptosis, and chemosis. The [[dd11dde6|abducens nerve (CN VI)]] is often affected first.</li><li><b>Diagnosis:</b> MRI with magnetic resonance venography (MRV) is the imaging modality of choice.</li><li><b>Treatment:</b> Requires prompt initiation of broad-spectrum IV antibiotics and consideration of anticoagulation.</li><li><b>USMLE Tip:</b> A patient with a recent facial furuncle or sinusitis who develops a severe headache, fever, and unilateral eye swelling with impaired eye movements is the classic presentation for cavernous sinus thrombosis.</li></ul>",
      "takeAway": "<p><b>Cavernous Sinus Thrombosis</b> is a septic clot in the brain's central venous drainage system, typically seeded by a facial infection, which rapidly evolves into a neuro-ophthalmologic emergency with high fever, headache, and paralysis of eye movements.</p>",
      "mermaid": "graph TD; A[Facial/Sinus Infection] --Staph. aureus--> B(Spread via Valveless Veins); B --> C(Cavernous Sinus); C --> D(Thrombosis & Inflammation); D --> E(Cavernous Sinus Syndrome);"
    },
    "connections": [
      {
        "type": "causes",
        "to": "9a089fd7"
      },
      {
        "type": "is_an_infection_of",
        "to": "c260efc8"
      },
      {
        "type": "is_commonly_caused_by",
        "to": "staphylococcus_aureus"
      }
    ]
  },
  "714f15fc": {
    "title": "Central Post-Stroke Pain Syndrome",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Pain Management",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Stroke"
    ],
    "content": {
      "definition": "<p><b>Central Post-Stroke Pain Syndrome</b>, also known as thalamic pain syndrome or Dejerine-Roussy syndrome, is a chronic neuropathic pain condition that develops after a [[c5da3c57|stroke]], most classically one affecting the [[afc0a64b|thalamus]].</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Caused by a stroke (usually ischemic) affecting the somatosensory pathways, particularly the ventroposterolateral (VPL) nucleus of the [[afc0a64b|thalamus]].</li><li><b>Timeline:</b> Pain does not occur immediately after the stroke. There is typically an initial loss of sensation (numbness) in the affected area, with the pain developing weeks to months later.</li><li><b>Clinical Presentation:</b> Characterized by severe, persistent, and often debilitating pain on the side of the body contralateral to the stroke. The pain is often described as burning, aching, or lancinating.</li><li><b>Key Feature:</b> <mark>Allodynia</mark> (pain provoked by a normally non-painful stimulus, like light touch) and <mark>hyperalgesia</mark> (exaggerated pain response to a painful stimulus) are hallmarks of the condition.</li><li><b>Treatment:</b> Very difficult to treat. Options include antidepressants (TCAs like [[c6814506|amitriptyline]]), anticonvulsants (e.g., gabapentin, pregabalin), and in refractory cases, deep brain stimulation.</li><li><b>USMLE Tip:</b> A patient with a history of a stroke who later develops severe, burning pain and allodynia on the previously numb side of their body is the classic presentation.</li></ul>",
      "takeAway": "<p><b>Central Post-Stroke Pain Syndrome</b> is a cruel paradox of sensory processing, where a thalamic stroke that initially causes numbness later gives rise to intractable neuropathic pain and allodynia due to maladaptive plasticity in the damaged central sensory pathways.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_complication_of",
        "to": "c5da3c57"
      },
      {
        "type": "is_caused_by_lesion_in",
        "to": "afc0a64b"
      },
      {
        "type": "presents_with",
        "to": "allodynia"
      },
      {
        "type": "treated_by",
        "to": "c6814506"
      }
    ]
  },
  "3334840f": {
    "title": "Central Retinal Artery Occlusion (CRAO)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Emergency Medicine",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Retinal Disorders"
    ],
    "content": {
      "definition": "<p><b>Central Retinal Artery Occlusion (CRAO)</b> is an ophthalmologic emergency characterized by the sudden, painless, and profound loss of monocular vision due to obstruction of the central retinal artery, which supplies the inner retina.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Most commonly caused by a thromboembolism. The most frequent source is an atherosclerotic plaque in the <mark>ipsilateral carotid artery</mark>. Other sources include cardiogenic emboli (e.g., from atrial fibrillation) or giant cell arteritis.</li><li><b>Pathophysiology:</b> Occlusion of the artery leads to acute ischemia of the inner two-thirds of the retina, causing rapid and irreversible death of ganglion cells and other neurons.</li><li><b>Clinical Presentation:</b> Sudden, painless, severe monocular vision loss.</li><li><b>Fundoscopy:</b> The classic fundoscopic finding is a <mark>pale retina</mark> (due to ischemia and edema) with a <mark>\"cherry-red spot\"</mark> at the fovea. The cherry-red spot represents the intact choroidal circulation (supplied by the posterior ciliary arteries) visible through the thinned, ischemic fovea.</li><li><b>USMLE Tip:</b> The triad of sudden, painless, profound monocular vision loss and a \"cherry-red spot\" on fundoscopy is pathognomonic for CRAO. It is essentially a stroke of the eye.</li></ul>",
      "takeAway": "<p><b>Central Retinal Artery Occlusion</b> is an acute ischemic stroke of the retina, where an embolus blocks its main arterial supply, leading to sudden, devastating vision loss and the iconic fundoscopic image of a pale retina with a contrasting 'cherry-red' macula.</p>",
      "mermaid": "graph TD; A[Embolus from Carotid/Heart] --> B(Occlusion of Central Retinal Artery); B --> C(Inner Retinal Ischemia); C --> D(Pale Retina); C --> E(Cherry-Red Spot at Fovea); D & E --> F(Sudden, Painless Vision Loss);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "retinal_artery_occlusion"
      },
      {
        "type": "is_caused_by",
        "to": "thromboembolism"
      },
      {
        "type": "presents_with",
        "to": "cherry_red_spot"
      },
      {
        "type": "is_a_form_of",
        "to": "ischemic_stroke"
      }
    ]
  },
  "b69e35b5": {
    "title": "Central Retinal Vein Occlusion (CRVO)",
    "primaryType": "disease",
    "tags": [
      "Ophthalmology",
      "Pathology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Ophthalmology",
      "Retinal Disorders"
    ],
    "content": {
      "definition": "<p><b>Central Retinal Vein Occlusion (CRVO)</b> is a common retinal vascular disorder characterized by the blockage of the central retinal vein at the optic nerve head, leading to venous stasis, retinal hemorrhage, and edema.</p>",
      "atAGlance": "<ul><li><b>Pathophysiology:</b> The primary mechanism is thrombosis of the central retinal vein, often at the lamina cribrosa where the vein is compressed by a sclerotic central retinal artery with which it shares a common adventitial sheath.</li><li><b>Risk Factors:</b> Strongly associated with systemic vascular diseases like <mark>hypertension</mark>, diabetes mellitus, hyperlipidemia, and glaucoma.</li><li><b>Clinical Presentation:</b> Sudden, painless, unilateral blurring or loss of vision. The severity can range from mild to severe.</li><li><b>Fundoscopy:</b> The fundoscopic exam is dramatic and described as a <mark>\"blood and thunder\"</mark> appearance. It shows diffuse, widespread retinal hemorrhages in all four quadrants, venous dilation and tortuosity, cotton-wool spots, and optic disc swelling.</li><li><b>USMLE Tip:</b> Differentiate from CRAO: CRVO is a venous 'backup' problem, leading to a hemorrhagic appearance ('blood and thunder'), while CRAO is an arterial 'blockage' problem, leading to a pale, ischemic appearance ('cherry-red spot').</li></ul>",
      "takeAway": "<p><b>Central Retinal Vein Occlusion</b> is a vascular 'plumbing backup' in the eye, where a thrombus in the central retinal vein causes a dramatic, widespread backup of blood, resulting in the classic 'blood and thunder' hemorrhagic retinopathy and vision loss.</p>",
      "mermaid": "graph TD; A[Hypertension/Atherosclerosis] --> B(Compression of Central Retinal Vein); B --> C(Thrombosis); C --> D(Central Retinal Vein Occlusion); D --> E(Venous Stasis & ↑ Pressure); E --> F(Diffuse Retinal Hemorrhages & Edema);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "retinal_vein_occlusion"
      },
      {
        "type": "is_associated_with",
        "to": "hypertension"
      },
      {
        "type": "differentiated_from",
        "to": "3334840f"
      }
    ]
  },
  "350f1c8b": {
    "title": "Central Vertigo",
    "primaryType": "finding",
    "tags": [
      "Neurology",
      "Otology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Vestibular Disorders"
    ],
    "content": {
      "definition": "<p><b>Central vertigo</b> is a sensation of spinning or dizziness that originates from a problem within the central nervous system, specifically the brainstem or cerebellum. It is generally more serious than peripheral vertigo.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Caused by lesions in the brainstem or cerebellum, such as [[c5da3c57|stroke]] (e.g., lateral medullary syndrome), [[45dd6d19|multiple sclerosis]], tumors, or migraines.</li><li><b>Nystagmus:</b> The nystagmus in central vertigo can be in any direction (horizontal, torsional, or <mark>purely vertical/downbeat</mark>). It is often non-fatigable and may change direction with gaze. It is <u>not</u> suppressed by visual fixation.</li><li><b>Associated Symptoms:</b> Often accompanied by other neurological signs that point to a central lesion, such as [[9914d433|diplopia]], dysmetria, [[9767fd6b|ataxia]], dysarthria, or focal weakness/sensory loss.</li><li><b>Onset:</b> The onset can be sudden or gradual, and the vertigo is often constant and less intense than in peripheral causes.</li><li><b>USMLE Tip:</b> The presence of <mark>purely vertical nystagmus</mark> is a red flag and is highly specific for a central cause of vertigo. Also, look for other 'central' neurological signs (the '5 D's': Dizziness, Diplopia, Dysarthria, Dysphagia, Dysmetria).</li></ul>",
      "takeAway": "<p><b>Central vertigo</b> is a sign of a CNS lesion, not an inner ear problem. It is distinguished from peripheral vertigo by its associated neurological deficits and a nystagmus that is often vertical and does not suppress with visual fixation, indicating a more ominous underlying cause like a brainstem stroke.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "vertigo"
      },
      {
        "type": "differentiated_from",
        "to": "5811ad9e"
      },
      {
        "type": "is_caused_by_lesion_in",
        "to": "582d8572"
      },
      {
        "type": "is_caused_by_lesion_in",
        "to": "bebe58d4"
      }
    ]
  },
  "bad81d37": {
    "title": "Central Transtentorial Herniation",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Neurosurgery",
      "Critical Care",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Herniation Syndromes"
    ],
    "content": {
      "definition": "<p><b>Central transtentorial herniation</b> is a type of brain herniation where downward displacement of the cerebral hemispheres, basal ganglia, diencephalon, and midbrain occurs through the tentorial notch. It is typically caused by a diffuse increase in intracranial pressure.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Caused by conditions that increase intracranial pressure symmetrically, such as diffuse cerebral edema, hydrocephalus, or midline tumors.</li><li><b>Pathophysiology:</b> The downward pressure causes a sequential caudal displacement of brainstem structures.</li><li><b>Clinical Progression:</b><br>1. <b>Early:</b> Altered level of consciousness, small reactive pupils (diencephalic compression).<br>2. <b>Later:</b> Mid-position, fixed pupils; decorticate then decerebrate posturing (midbrain/pons compression).<br>3. <b>Terminal:</b> Coma, loss of all brainstem reflexes, respiratory arrest (medulla compression).</li><li><b>Duret Hemorrhages:</b> A key pathological finding is the presence of <mark>Duret hemorrhages</mark>, which are secondary brainstem hemorrhages in the pons and midbrain caused by stretching and tearing of perforating arteries during the downward displacement.</li><li><b>USMLE Tip:</b> This is a rostrocaudal deterioration. Look for a progressive decline in consciousness accompanied by changes in pupillary response and motor posturing, often culminating in fatal brainstem hemorrhages (Duret hemorrhages).</li></ul>",
      "takeAway": "<p><b>Central transtentorial herniation</b> is a devastating downward spiral of the brainstem through the tentorial notch, leading to a predictable sequence of neurological decline from altered consciousness to posturing and death, often marked by the characteristic Duret hemorrhages from vascular shearing.</p>",
      "mermaid": "graph TD; A[↑ Intracranial Pressure] --> B(Downward Displacement of Diencephalon/Midbrain); B --> C(Compression of Brainstem); C --> D(Rupture of Paramedian Arteries); D --> E(Duret Hemorrhages);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "8c0728b7"
      },
      {
        "type": "causes",
        "to": "duret_hemorrhages"
      },
      {
        "type": "leads_to",
        "to": "c0b7a1ca"
      }
    ]
  },
  "a1721d6f": {
    "title": "Cephalohematoma",
    "primaryType": "finding",
    "tags": [
      "Pediatrics",
      "Obstetrics",
      "Neurology",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Neonatal Injuries"
    ],
    "content": {
      "definition": "<p>A <b>cephalohematoma</b> is a subperiosteal collection of blood on the scalp of a newborn, caused by the rupture of blood vessels between the skull and the periosteum during birth. It is a common birth trauma, especially with forceps or vacuum-assisted delivery.</p>",
      "atAGlance": "<ul><li><b>Location:</b> The hemorrhage is located <u>deep to the periosteum</u> (subperiosteal).</li><li><b>Clinical Presentation:</b> A firm, well-demarcated swelling on the scalp. A key feature is that it <mark>does <u>not</u> cross suture lines</mark>, as the periosteum is firmly attached at the sutures.</li><li><b>Timing:</b> May not be present at birth but develops over the first few hours to days. It resolves slowly over weeks to months.</li><li><b>Complications:</b> The breakdown of the collected red blood cells can lead to <mark>jaundice</mark> (indirect hyperbilirubinemia). Rarely, it may become calcified.</li><li><b>Differentiation:</b> It must be distinguished from a [[a5ec55b5|caput succedaneum]].<br> - <b>Cephalohematoma:</b> Firm, does <u>not</u> cross suture lines, appears hours after birth, resolves slowly.<br> - <b>Caput Succedaneum:</b> Soft, crosses suture lines, present at birth, resolves quickly.</li><li><b>USMLE Tip:</b> The inability to cross suture lines is the most important feature for distinguishing a cephalohematoma from a caput succedaneum on an exam.</li></ul>",
      "takeAway": "<p>A <b>cephalohematoma</b> is a subperiosteal bleed confined by cranial suture lines, appearing as a firm scalp swelling in a newborn after a difficult delivery; its key distinguishing feature is its respect for suture boundaries, and its main complication is neonatal jaundice.</p>",
      "mermaid": ""
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "46ca72c2"
      },
      {
        "type": "differentiated_from",
        "to": "a5ec55b5"
      },
      {
        "type": "can_cause",
        "to": "neonatal_jaundice"
      }
    ]
  },
  "fa8656bd": {
    "title": "Cerebellar Tonsillar Herniation",
    "primaryType": "disease",
    "tags": [
      "Neurology",
      "Neurosurgery",
      "Critical Care",
      "USMLE"
    ],
    "classificationPath": [
      "Neurology and Special Senses",
      "Pathology",
      "Herniation Syndromes"
    ],
    "content": {
      "definition": "<p><b>Cerebellar tonsillar herniation</b> is a life-threatening type of brain herniation where the cerebellar tonsils are displaced downward through the foramen magnum, leading to compression of the medulla oblongata.</p>",
      "atAGlance": "<ul><li><b>Etiology:</b> Caused by a mass or pressure increase in the posterior fossa (e.g., cerebellar tumor, hemorrhage, or edema). It can also be iatrogenically caused by performing a lumbar puncture in the setting of high intracranial pressure.</li><li><b>Pathophysiology:</b> The herniating tonsils directly compress the medulla oblongata.</li><li><b>Clinical Presentation:</b> This is a rapidly fatal event. Compression of the medullary cardiorespiratory centers leads to <mark>bradycardia, respiratory arrest, and death</mark>. Patients may also present with headache, neck stiffness, and loss of consciousness.</li><li><b>Associated Malformation:</b> This type of herniation is the defining feature of [[b96a6a07|Chiari I and II malformations]], although in those congenital conditions, the process is chronic rather than acute.</li><li><b>USMLE Tip:</b> The classic scenario is a patient with signs of increased intracranial pressure (headache, papilledema) who undergoes a lumbar puncture and then rapidly deteriorates with respiratory arrest. This highlights the danger of LP in the setting of unevaluated increased ICP.</li></ul>",
      "takeAway": "<p><b>Cerebellar tonsillar herniation</b> is the most lethal form of brain herniation, as the downward displacement of the cerebellar tonsils through the foramen magnum directly compresses the vital cardiorespiratory centers in the medulla, leading to swift respiratory and cardiac arrest.</p>",
      "mermaid": "graph TD; A[↑ Posterior Fossa Pressure] --> B(Cerebellar Tonsils Displace Downward); B --> C(Through Foramen Magnum); C --Compresses--> D(Medulla Oblongata); D --> E(Cardiorespiratory Arrest);"
    },
    "connections": [
      {
        "type": "is_a_type_of",
        "to": "8c0728b7"
      },
      {
        "type": "compresses",
        "to": "medulla_oblongata"
      },
      {
        "type": "is_a_feature_of",
        "to": "b96a6a07"
      },
      {
        "type": "can_be_precipitated_by",
        "to": "lumbar_puncture"
      }
    ]
  }
}